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ABSTRACT 
An ;mmunofluorescent technique has been developed with the aim of 
histochemically localizing cyclic AMP and cyclic GMP in the C.N.S., 
and determining the cellular sites where biochemical changes in 
tissue levels occur. 
Initial experiments revealed that the inmunoglobulin fraction of 
non -immune sera bound non -specifically to C.N.S. tissue, via a 
weak charge attachment between IgG and basic tissue proteins. 
Specific antibodies were raised in rabbits by immunization with 
succinyl cyclic nucleotide- protein conjugates, and radioiunological 
techniques with[3H]tracers were used to study binding characteristics. 
Of the large number of cyclic GMP antibodies studied in detail, 
specific staining of astrocytic fibres and capillaries (a contrasting 
localization to that of cyclic AMP), was found with only a small 
number of antibodies, although these could not be identified on the 
basis of titre, avidity or specificity however. 
Differences between RIA and immunohistochemistry, and different 
staining patterns with individual cyclic GMP antibodies, have been 
discussed as resulting from stereochemical differences between free 
and tissue -bound nucleotide. This may also explain why cyclic 
nucleotide antibodies have satisfied the criteria of specificity for 
RIA, but not for immunofluorescence. 
'In vivo' and 'in vitro' biochemical techniques, coupled with cyclic 
GMP immunofluorescence, failed to localize semi -quantitative changes 
in intensity and /or distribution of staining, under conditions where 
total nucleotide levels were significantly altered. 
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Quantifying cyclic nucleotide losses from frozen tissue sections, 
it was determined that more than 80% of cyclic GMP was lost during 
buffer -washing, and that the tissue -bound pool was unchanged when 
total levels were elevated - a possible explanation for the 
inability to localize biochemical changes using i mm nofluorescence. 
Recently developed antibodies to cyclic GMP- dependent protein kinase, 
and other cyclic nucleotide receptor proteins, were used to investigate 
the binding, and determine the function of, the pool of cyclic 
nucleotides localized in C.N.S. tissue sections by immunofluorescence. 
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1. CYCLIC AMP AND ITS ROLE IN THE CENTRAL NERVOUS SYSTEM - 
LITERATURE REVIEW. 
In 1957 Rall et al discovered a low molecular weight heat 
stable 'factor' which accumulated in particulate fractions of 
liver homogenates exposed to the hormone adrenaline (1). 
Since this'factor'alone could stimulate glycogen breakdown in 
the soluble fraction of homogenates, Rail et al proposed 
that this'factor'mediated hormonal stimulation of glycogenolysis. 
Subsequent experiments by Lipkin et al (2) identified this 'factor' 
as adenosine 31,5'- cyclic monophosphate (cyclic AMP), a nucleotide 
related to ATP, the ubiquitous energy source of the cell. 
Sutherland et al (3) soon found that the membranes of liver cells, 
and many other cells, contained an enzyme which they named 
adenylate cyclase, capable of converting ATP to cyclic AMP. 
Since ATP is found almost entirely in the cytoplasm it was 
reasoned that at least part of the enzyme must face the interior 
of the cell to synthesize cyclic AMP. 
Exposure of liver cells to adrenaline was found to substantially 
increase the rate of conversion of ATP to cyclic AMP. This 
observation, subsequently found with a large number of peptide 
hormones in different tissues, indicated that there was a 
functional link between the binding of these hormones at specific 
receptor sites on the outside of the membrane, and the activation 
of adenylate cyclase to elevate cyclic AMP concentration on the 
inside (4). This mechanism, transducing extracellular signals to 
the intracellular 'milieu', is fundamentally different from the 
actions of the other class of hormones, steroids,which are able to 
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diffuse through the cell membrane, carrying their 'message'. 
It is now generally accepted that cyclic AMP acts as a 'second 
messenger' molecule relaying the message of the hormone 
(1st message) from the cell membrane to the internal 
'biochemical machinery' of the cell in order to trigger the 
physiological response. A variety of biochemical steps are 
involved in this information transfer which allows amplification 
of the initial hormonal signal at each step (5). 
Two early observations suggested that cyclic AMP might mediate 
the physiological actions of neurotransmitters in the nervous 
system in a way analogous to hormonal effects. Adenylate 
cyclase was found to have its highest activity in the C.N.S (3), 
and the putative neurotransmitter noradrenaline, stimulated 
cyclic AMP production in homogenates of brain tissue (6). The 
following review considers the very large amount of information 
on cyclic AMP in the nervous system. Wh_fTht most interest has 
focused on the role of cyclic AMP in mediating post -synaptic 
potential changes induced by neurotransmitters involved in 
propogation of the nerve impulse, other possibilities exist and 
post -synaptic events of longer time -course e.g. regulation of 
protein synthesis, will be considered. Discussion on possible 
non -synaptic roles of this nucleotide will also be included. 
1.1. The enzymatic machinery involved in the synthesis, action 
and degradation of cyclic AMP in the C.N.S. 
1.1.A. Adenylate cyclase 
Adenylate cyclase is the membrane bound enzyme catalysing the 
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is dependent upon M 2+ (3). The C.N.S. contains very high 
levels of this enzyme with considerable regional and species 
variation in concentration. In rat the overall activity is 
highest in cerebellum followed by cortex. Activity is higher 
in grey matter than white, suggesting localization in cell 
bodies or synapses rather than along neuronal processes (7). 
Studies on the sub -cellular distribution showed the enzyme to 
be most concentrated in the synaptic membrane fraction (8). Both 
neuronal and glial cells were found to contain the enzyme (9). 
The demonstration of neurotransmitter -sensitive adenylate 
cyclases 'in vitro' has been one of the most important pieces 
of evidence linking neurotransmitter function with cyclic AMP. 
Extensive pharmacological receptor studies, and the recent 
availability of high- affinity radiolabelled ligands have been 
used to study binding at the receptor, and consequential 
activation of adenylate cyclase. 
There is evidence that the adenylate cyclase system is composed 
of at least two components: a receptor or regulatory unit, and 
a catalytic component since: i) The basal activities of the 
enzyme are quite similar in different tissues whilst hormonal 
regulation can be highly selective (10). ii) Two or more 
hormones or neurotransmitters can stimulate adenylate cyclase 
from the same cell type, with specificity at the receptor (10). 
iii) For most enzyme preparations, the hormonal sensitivity is 
readily lost under a variety of mildly stressful conditions, 
e.g. non -ionic detergents, whilst little or no change in basal 
activity may occur (3). 
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A number of models have been proposed for the arrangement of 
the receptor and catalytic units of adenylate cyclase in the 
membrane e.g. (11, 12). The key question is whether the units 
are on the same, or different molecules. Recent evidence from 
cell lines expressing the different units in different ways, 
suggests that they are distinct (13). 
Cell hybridization in turkey erythrocytes with one cell line 
expressing -catecholaanine receptor and inactive adenylate 
cyclase, and another expressing an active adenylate cyclase but 
no receptor, showed a receptor -sensitive adenylate cyclase. 
These 'fusion' results and other studies with glioma and 
neuroblastoma cells (14) support the 'mobile receptor hypothesis' 
which envisages hormone -receptor complexes separated from adenylate 
cyclase molecules, which can combine as a result of their location 
in the dynamic lipid matrix of the plasma membrane. Other agents 
are able to stimulate adenylate cyclase besides hormones and 
neurotransmitters. Millimolar concentrations of fluoride ions 
are able to stimulate adenylate-cyclase in broken cell preparations 
but not whole cells (although they almost certainly enter cells); 
the activation is markedly temperature- dependent (15) and appears 
to modify the requirement of the enzyme for Mgt} (16). Presumably 
fluoride ion activation 'by- passes' the regulatory unit of the enzyme 
and causes direct activation of the cyclase. Cholera toxin is another 
compound which probably acts like fluoride, causing irreversible 
activation of the adenylate cyclase (17). 
Recent work on brain, ha. _ho;:n that a snake venom (Russel viper) 
9 
can uncouple the dopamine receptor from striatal adenylate cyclase (18). 
The venom which irreversibly blocks the receptor is also able to 
eliminate the response of adrenal adenylate cyclase to stimulation 
by ACTH. Dopamine sensitivity can be restored to venom -treated 
caudate homogenates by treating with guanine nucleotides. GTP 
and other guanine nucleotides have been found to stimulate the 
responsiveness of adenylate cyclase to dopamine (19) and other 
hormones and neurotransmitters, perhaps due to allosteric regulation 
of the enzyme. 
Whilst the fluoride ion activation may be primarily of theoretical 
interest, it may be of more relevance physiologically that 
micromolar concentrations of calcium ions can inhibit brain adenylate 
cyclase while millimolar concentrations stimulate the basal but not 
the hormonal stimulated cyclase (20). Calcium ions can also 
modify the degradative enzyme for cyclic AMP, phosphodiesterase 
(see section 1.1.C. ), by binding to a specific calcium- binding 
protein. There is the intriguing possibility that this protein 
might serve to regulate both the synthesis and degradation of cyclic 
AMP. Basal and hormonal stimulated adenylate cyclase require 
millimolar concentrations of ionic co- factors, usually satisfied by 
2+ 
but Mn or Co may substitute (21). Low concentrations of other 
metals e.g. Pb, Hg, Cu, La are potent inhibitors (22, 23, 24). The 
effects of Pb, Hg and Cu which bind to cysteine residues, are reversed 
by sulphydryl reducing agents. The importance of phospholipids as 
factors affecting adenylate cyclase is born out by the observation 
that hormonal sensitivity can be restored to adenylAate cyclase 
inactivated with detergent treatment, by addition of specific 
phospholipids in a number of tissues (25). 
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Studies on the developing C.N.S. show that the activity of adenylate 
cyclase increases during post -natal life and that the capacity for 
hormonal stimulation is demonstrable after a basal level of adenylate 
cyclase has been established (26). The development of different 
neurotransmitter -sensitive adenylate cyclases may vary e.g. the 
serotonin- sensitive enzyme has maximal activity at birth, decreasing 
to negligible levels at six weeks (27), strongly suggesting a role 
in development. 
1.1.B. Cyclic AMP- dependent protein kinases and phosphorylation 
The physiological effects of cyclic AMP in mammalian systems are 
now all believed to be mediated by binding to specific protein 
kinases, and catalysing the phosphorylation of specific proteins (5). 
In brain, cyclic AMP kinases are found in both soluble and 
particulate fractions; the particulate cyclic AMP kinases are 
associated with nerve ending membrane fractions which can serve as 
substrates for the phosphorylation reactions (28). It should be 
noted at this point that cyclic AMP -independent kinases are also 
found in brain (29). Cyclic AMP activates the cyclic AMP kinase by 
binding to an inhibitory sub -unit which then causes dissociation of 
an active catalytic unit. Mammalian kinases are thought to exist 
in at least two forms with different inhibitory units, known as RI 
and RII but a common active catalytic unit. Membrane bound cyclic 
AMP kinase in brain might be type II since evidence from other 
tissues suggests that the type II form binds tightly to membrane 
components (30, 31). Greengard et al (32) have shown that in membrane 
fractions from the C.N.S. binding of cyclic AMP to the kinase 
specifically phosphorylates two proteins in the synaptic membrane. 
These proteins, named protein I and protein II have molecular weights 
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of approximately 86,000 and 49,000 respectively. Whilst protein II 
is found in membrane fractions from a number of tissues, protein I is 
found only in membrane fractions containing synapses. Protein I is 
absent from the brains of fetal rats at stages of development before 
synapse formation occurs between nerve cells, appearing when synaptic 
complexes form. Furthermore, recent evidence using the neurotoxin 
kainic acid , has been found to drastically reduce levels of protein I 
in rat striatum (33). The phosphorylation and dephosphorylation of 
this protein are extremely rapid, being an ideal mechanism to change 
post -synaptic membrane potentials. In incubated slices of rat brain, 
protein I is found almost entirely in the de- phosphorylated form and 
recently it has been shown that certain drugs and depolarizing agents 
can change the phosphorylation state of this protein (34). Dephosphorylation 
occurs via phosphoprotein phosphatases, also found in the synaptosomai 
membrane. 
Having commented upon the rapid phosphorylation / dephosphorylation 
mechanism it should be noted that very fast transmission at certain 
synapses e.g. neuromuscular junction,is not mediated via cyclic AMP. 
This is not surprising since, as already described, a number of steps are 
involved between neurotransmitter interaction and phosphorylation, which 
would take a long time course by synaptic transmission standards. 
Protein phosphorylation is presumed, but has not been directly shown, to 
cause changes in ionic permeability generating post -synaptic potential 
changes in the C.N.S. The problems are technical, due to the short time 
courses involved, definitive evidence probably being obtained only when 
the phosphorylating machinery can be 'dissected out' and reimplanted into 
an artificial membrane for study. However, indirect evidence has come 
from non -neural tissues. In the avian erythrocyte for example (35) 
catecholamine- induced phosphorylation of a/ 
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single membrane protein, mediated by cyclic AMP, agrees well both 
temporaly and on dose -dependency, with the increase in sodium 
ion transport across the membrane. Furthermore, agents that block 
this increase in sodium ion transport, also block catecholamine- 
induced phosphorylation. 
The presence of cyclic AMP kinase in the soluble fraction of the 
cell and also in the nucleus, suggests that cyclic AMP might control 
post -synaptic events with a longer time course than for permeability 
changes. Translocation of the kinase sub -units from cytoplasm to 
nucleus has been suggested in a number of tissues e.g. ovary, adrenal 
medulla and liver (36). In the nucleus, histone phosphorylation via 
cyclic AMP- dependent kinase can modify histone binding to D.N.A. and 
hence affect gene expression. A system is therefore available for 
control of protein synthesis by translocation of cyclic AMP kinase (37). 
Two heat -stable inhibitors of cyclic AMP protein kinase have been 
described (38), one of which binds to the catalytic unit of the kinase, 
whilst the other antagonizes the interaction between kinase and the 
phosphate -acceptor protein. 
1.1.C. Cyclic AMP phosphodiesterase. 
The actions of cyclic AMP are terminated not only by dephosphorylation 
of specific proteins, but also by removal of free cyclic AMP. Cyclic 
MP is degraded by the enzyme phosphodiesterase, which cleaves the 
315/ phosphodiester bond to form 51 AMP. It has been found that when 
cyclic AMP is complexed to the kinase, and therefore in its 
physiologically active form, it cannot be degraded by the enzyme (39). 
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Brain contains considerable phosphodiesterase activity and regional 
distribution shows high levels in cortex, striatum and limbic 
forebrain, with much lower levels in cerebellum and brain stem (40). 
Subcellular distribution shows high concentrations in synaptic 
membranes, synaptic vesicles and microsomes (8, 41, 42). 
Phosphodiesterase is not a single enzyme but a class of enzymes 
(isoenzymes) that have different physical and chemical properties. 
The multiple forms are found in different amounts in various areas 
of mammalian brain. All of the isoenzymes will hydrolyse cyclic 
AMP and its related nucleotide cyclic QUIP (see section 2.2. ) 
if the nucleotides are present in high enough concentration. However, 
at physiological concentrations, certain of the enzymes show 
specificity for one or other nucleotide, whilst at least one type 
hydrolyses both nucleotides equally well (43). 
Phosphodiesterase is found with a soluble and particulate distribution, 
most work having been carried out On the soluble form. The activity 
of at least one isoenzyme of phosphodiesterase is regulated by the 
ubiquitous calcium binding protein, CDR (44). In the presence of 
calcium, CDR complexes with phosphodiesterase increasing enzyme 
velocity and /or decreasing the Km of the enzyme for substrate. 
Whilst calcium- dependent activation increases the ability of 
phosphodiesterase to hydrolyse both cyclic AMP and cyclic GMP, the 
effect on cyclic GMP hydrolysis may be of more importance 
physiologically (see section 2.2.) 
Regulation of soluble phos?r,.iesterase has been shown recently by 
Uzonov et al (45),who demonstrated that cyclic AMP- dependent protein 
phosphorylation caused the release of particulate CDR into the cytosol 
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to stimulate hydrolysis of cyclic AMP; the release was calcium - 
independent and could not be triggered by cyclic GMP -dependent 
phosphorylation. 
A variety of compounds e.g. methyl xanthines, papaverine, puromycin, 
inhibit phosphodiesterase, many of which show behavioural effects. 
The inhibitors are important since they prolong the action of 
cyclic AMP by preventing its degradation, and should therefore 
prolong the physiological effects of neurotransmitters, if the 
nucleotide is acting as a 'second messenger'. Problems arise 
however from inhibitors differentially inhibiting certain of the 
phosphodiesterase isoenzymes (46). 
Whilst phosphodiesterase is the only proven mechanism for degrading 
cyclic AMP, a number of observations suggest that the levels of cyclic 
AMP may be reduced by active or passive release from cells, since 
cyclic AMP is transported into cerebrospinal fluid (C.S.F.) by a 
probenecid- sensitive mechanism. Probenecid is a competitive 
antagonist of organic acid transport which suggests that the efflux is 
a specific process (47). The C.S.F. concentration of cyclic AMP is 
increased following intraventricular injections of adrenergic agents. 
An uptake mechanism may also control levels since cortical slices have 
been shown to have a high affinity, temperature- sensitive uptake 
mechanism (48). 
The preceding discussion has considered the mechanism by which cyclic 
AMP is synthesized, acts and is broken down. Perhaps the most 
important point is the compartmentalization of the system for 
post -synaptic events, since every component of the 'machinery' is found 
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Figure 2 
Synthesis, action and 
degradation of cyclic AMP. 
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Perhaps the components exist in macromolecular complexes to 
limit still further, and therefore make more efficient, the 
distance which the biochemical 'signals' have to travel (49). Figure 2 
summarizes the salient features of the discussion so far. 
The following sections consider techniques that have been used 
to study the effects of neurotransmitters which elevate cyclic 
AMP levels, using 'in vivo ' and 'in vitró biochemical methods, 
and the alternative electrophysiological studies of neurotransmitters 
and cyclic AMP in the C.N.S. 
1.2. 'In vivo' biochemical studies. 
Levels of cyclic AMP in brain reflect both the activity of adenylate 
cyclase and phosphodiesterase, together with the availability of 
ATP as substrate. In cerebellum for example, which shows the 
highest basal level of cyclic AMP, total adenylate cyclase 
activity is relatively high, whilst phosphodiesterase is low. 
After decapitation, cyclic AMP levels rapidly increase up to 5 -fold 
depending on the brain area and species, reaching a maximum in 
one to two minutes, before slowly falling (50). The mechanism 
responsible for this increase is not well understood, but post- 
mortem increases are also found with other molecules showing 
high 'turnover rate'. The effect may be due to anoxia and release 
of an endogenous substance such as adenosine, which then activates 
adenylate cyclase (51). 
A number of techniques have been developed to determine the true 
'in vivo' levels prior to the decapitation increase. Rapid freezing 
of small whole animals, or the animal's head, has been used, but 
dissection of the brain from the frozen skull is very difficult 
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after this, and more importantly deep brain areas may freeze 
more slowly than superficial areas, yielding inaccurate results. 
'Freeze -blowing' (52) freezes the brain in less than one second, 
but requires exposure of the organ before sacrifice, and also 
prevents dissection of specific brain areas. The most common 
method now employs high energy microwaves focused onto the 
animals head,to cause rapid inactivation of enzymes within a 
few seconds,prior to the post -mortem elevation of cyclic AMP (53). 
A disadvantage of the method is that the animal may need to be 
restrained in order to focus the beam, which may stress the 
animal, and affect cyclic nucleotide levels (145). 
Employing techniques to prevent the post -mortem increase, a 
very large number of agents and conditions have been found to 
increase cyclic AMP levels 'in vivo', with marked regional and 
species variation. Due to the complexity of the C.N.S. and the 
large number of effects that these treatments have on different 
neurotransmitter systems, such studies are probably of little use 
in determining specific roles of the nucleotide in the C.N.S. 
A number of agents and conditions altering cyclic AMP levels 
'in vivo' are therefore listed for interest only: adenosine, 
noradrenaline, histamine, prostaglandins, steroids, morphine, 
phosphodiesterases, ethanol, electric foot -shock stress. For 
further details see (55). A similar argument holds for behavioural 
effects resulting from administration of cyclic AMP, or its more 
permeable lipid -soluble analogue, dibutyryl cyclic AMP, into the 
C.N.S. 
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1.3. 'In vitro' biochemical studies. 
Broken -cell homogenates of brain tissue have been extensively 
used to study neurotransmitter -sensitive adenylate cyclases. 
In general, the degree of responsiveness of the cyclase is 
less in nerve tissue homogenates than in other tissues, 
observations which hampered early work. Typically, homogenates 
of C.N.S. tissues show, at most,a 2 -4 fold increase in adenylate 
cyclase activity when exposed to putative neurotransmitters. The 
low responsiveness may be due to calcium ions released from 
intracellular sites on homogenization (54) which activates basal, but 
not stimulated, cyclases. This would cause the measured 
activation to be less than actually occurred. Additionally, the 
basal adenylate cyclase measured in homogenates, represents the 
sum total of different neurotransmitter -sensitive adenylate 
cyclases. Stimulation of one type might be 'diluted out' by 
non -responding pools (10). 
A number of putative neurotransmitters have been shown to be 
effective in stimulating adenylate cyclase in homogenates of 
C.N.S. tissue e.g. dopamine, noradrenaline, serotonin, substance P, 
prostaglandins, histamine (10). A marked degree of variation in 
response is found between species and brain area. Good correlation 
is generally found between magnitude of response of neurotransmitter - 
sensitive cyclase and extent of innervation by that neurotransmitter 
of the particular brain area, used for homogenates. The dopamine - 
sensitive adenylate cyclase will be discussed in some detail to 
illustrate this,and to demonstrate how pharmacological studies 
have been used to study the relationship between this neurotransmitter 
receptcr,and adenylate cyclase. 
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Dopamine- sensitive adenylate cyclases have been found in brain 
areas such as striatum rich in dopamine nerve terminals(as 
visualized by 'Falk- Hillarp1 fluorescence histochemistry),and 
rich in dopamine receptors as measured using high affinity 
radiolabelled ligands. The cyclase is stimulated by low 
concentrations of dopamine and structurally related analogues (56), 
and has its highest concentrations in synaptic membrane 
fractions (21). 
In general, there is good correlations between the potencies 
of anti -psychotic drugs to inhibit dopamine- sensitive adenylate 
cyclase in limbic forebrain homogenates and their clinical 
potencies (57). There are exceptions to this correlation 
however, e.g. haloperidol is less effective in inhibiting dopamine - 
sensitive adenylate cyclase than chlorpromazine, but haloperidol 
is much more effective clinically. (58). ._irniilst: considerations such 
as differences in solubility and absorption might explain this 
difference, haloperidol and related compounds have been reported 
to be potent inhibitors of the stimulation- evoked release of 
dopamine from nerve endings (58). This pre -synaptic action, by 
decreasing the amount of dopamine available to the post -synaptic 
receptors would tend to augment the effect of these drugs on 
blocking dopamine- sensitive adenylate cyclase, thus leading to 
enhanced clinical potency. 
A biochemical lesion in the dopaminergic pathway leading from 
the substantia nigra to the corpus striatum has been found to 
be responsible for the movement disorder known as rark_:_...,ri.;m. 
Degeneration of the dopaminergic nerve terminals in striatum 
reduces the amount of dopamine available to interact with its 
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receptors and the receptors become 'supersensitive'. The symptoms 
of this disorder are tremor, rigidity and delay in initiation of 
movement (59). High doses of anti -psychotic drugs whose prime 
effects lie in blocking dopamine receptors in limbic forebrain, 
sometimes result in Parkinson -like side effects presumably since 
they alsohlock striatal dopamine receptors (60). In general 
there is good correlation between the degree of these 'extra - 
pyramidal' side effects and inhibition of dopamine- sensitive 
adenylate cyclase in broken -cell striatal homogenates. The 
exceptions may be due to actions of anti- psychotics in blocking 
muscarinic receptors in the C.N.S. (61). 
The increased sensitivity of dopamine- sensitive adenylate cyclase 
to dopamine and its agonists which is found experimentally after 
chemical lesions of the nigro -striatal pathway (62) with 
6- hydroxydopamine demonstrates a very important function of cyclic 
AMP. Not only is cyclic AMP responding post- synapticaJiv to 
neurotransmitter, but it is also being modified by the sensitivity 
of the receptor. 
The use of dopamine receptor agonists and antagonists have shown 
that there is a good correlation between receptor occupation, and 
activation or inhibition of adenylate cyclase. This correlation 
has led to a new methodology for the rapid screening and development 
of drugs as dopamine receptor agonists (for replacing the dopamine 
deficiency in Parkinsonism), and antagonists (for use as anti - 
psychotics). 
The homogenate, whilst obviously of use as demonstrated above, is 
limited by its degree of responsiveness. The respiring incubated 
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brain slice has been used extensively for studying the actions 
of neurotransmitters on cyclic AMP and evokes larger increases 
in cyclic AMP levels. Since the cells are intact and respiring, 
the slice is closer to the 'in vivo' situation than the broken -cell 
homogenate, and allows fine control to be made over the external 
'environment'. Its disadvantage with respect to the homogenate, 
is that neurotransmitters causing elevations in tissue levels of 
cyclic AMP cannot automatically be attributed to direct activation 
of adenylate cyclase, even if a phosphodiesterase inhibitor is 
present. Increased levels might result from increased substrate 
availability, calcium mobilization, or release of an endogenous 
compound to activate the cyclase. (The same problems are inherent 
in a broken -cell vesicular preparation, an extension of the 
broken -cell homogenate technique (63) ). Whilst total levels of 
cyclic AMP are usually measured in slices, attempts to gain a 
measure of synthesis have been carried out using labelled adenine 
or ATP as precursor (64). The following points summarize the 
responses of cyclic AMP to neurotransmitters using the incubated 
respiring slice: 
i) Slices, usually 26 x 260/' x1mm, require a period of 
stabilization of 30 - 90 mires in oxygenated buffer to overcome 
the post- mortem elevation of cyclic AMP (50). 
ii) Putative neurotransmitters elevate cyclic AMP by stimulation 
of receptors for noradrenaline, dopamine, histamine, serotonin, 
adenosine and acidic amino acid compounds. Using blocking agents 
it appears that these compounds have independent sites of action, 
although various wmbinations may show synergistic responses (65). 
iii) The cyclic AMP response is rapid, and.. on removal of the 
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stimulating agent cyclic AMP levels return to normal. Restimulation 
usually gives much smaller responses, probably due to increased 
activation of phosphodiesterase (66). 
iv) Omission of calcium usually enhances responses, since calcium 
ions inhibit neurotransmitter stimulation of adenylate cyclases (67). 
v) Phosphodiesterase inhibitors usually enhance accumulation, 
though marked differences occur between different compounds. 
vi) A wide variation in response is found between different species, 
and strain differences have been reported (68). 
vii) Slices from different brain areas vary in response, usually 
in parallel with the known distribution of the pathways of the 
neurotransmitter used for stimulation. 
viii) Evidence from slices adds weight to a post- rather than a 
pre -synaptic distribution of cyclic AMP. Brain slices from animals pre- 
treated with 6 -_ hydroxydopamine to destroy pre -synaptic nerve 
terminals containing catecholamines, show increased cyclic AMP 
responses elicited by noradrenaline (69). 
ix) Incubated brain slices may not only accumulate, but also 
release cyclic AMP into the medium on stimulation (70) 
The cyclic AMP content of brain slices can be elevated several fold 
by electrical stimulation or depolarizing agents, due to indirect 
release of adenosine. Low concentrations of this purine base 
(10 -100f M) cause a 20 - 30 fold increase in incubated brain slices, 
an effect augmented by biogenic amines and completely antagonized 
by methyl xanthines (71). 
1.4. Cellular. " ^-;alization of the cyclic AMP system in the C.N.S. 
Incubated slices, whilst being responsive to neurotransmitters, 
are complex in that they contain a variety of cell types - neurones, 
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glia, vascular and connective tissue cells. In the present 
discussion, neurotransmitter responses have been assumed to 
occur in nerve cells, but there is evidence that other cell types 
may also respond. Tissue culture techniques have been used in 
an attempt to study responses of a single cell type, in contrast 
to the heterogenous cell types in the brain slice. The cyclic AMP 
content of glial tumour lines is increased by catecholamines, 
histamine and adenosine, acting via specific receptors e.g. (72), 
whereas neuroblastoma respond primarily to specific prostaglandins 
and certain other agents (73). catecholamine receptor agonists 
whilst increasing intracellular cyclic AMP levels in glioma, 
have been found to produce large increases in secretion of cyclic 
AMP into the medium; this secretion was probenecid- sensitive (74). 
It has been questioned whether these glial and neuronal differences 
might be unreal, and possibly explained by differences in 
metabolism. A closer approximation to the 'in vivo' situation 
would be anticipated using cell populations from normal fetal brains 
in culture)containing relatively normal proportions of neurones 
and glia. These cultures accumulate cyclic AMP in response to 
catecholamines in a similar fashion to brain slices, with a 5 - 10 
fold increase in cyclic AMP levels (75). However, catecholamine 
responses in fetal cells grown in monolayer culture which are 
selectively enriched in glial cells, show greater than 100 fold 
increase in response to noradrenaline (76). 
T}e orservations are taken to suggest that the catecholamine 
response 'in vivo' might occur in glial cells. Great care must 
be taken however, in extrapolating responses from culture to the 
living brain, as cells in culture may have responses which are 
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affected by the experimental culturing technique. 
'In vivo', destruction of neurones with kainic acid injection 
has been found to decrease a number of receptor -linked cyclic 
AMP systems in striatum. However, some receptor systems were 
unaffected or responses even enhanced, perhaps suggesting a 
glial localization (77). In determining whether glial cells 
have a role in the function of cyclic AMP in the C.N.S. it is 
of interest that adenylate cyclase, phosphodiesterase, cyclic 
AMP- dependent protein kinase and the calcium- dependent regulator 
have both a neuronal and a glial distribution (78, 79). A 
physiological function of cyclic AMP in glia may be in controlling 
glycogen breakdown to glucose (77). 
Homogenates of brain capillaries have been found to have 
histamine- sensitive adenylate cyclases, with responses antagonized 
by both H1 and H2 blockers. Joo et al (80) have proposed that 
cyclic AMP mediates the regulation of permeability in brain 
capillaries, and observed increased capillary permeability with 
dibutyryl cyclic AMP, using ferritin as a permeability marker at 
the electron microscope level. 
1.5. Electrophysiological studies. 
Having considered 'in vivo' and 'in vitro' biochemical techniques 
for studying the effects of neurotransmitters on cyclic AMP, an 
'in vivo' electrophysiological system will now be discussed in 
detail. The role of cyclic AMP in mediating the electrophysiological 
responses of noradrenaline in the locus coereleus- cerebellar 
Purkinje cell pathway has been extensively studied, principally 
by Blooms group. This pathway is ideally suited to '2nd messenger' 
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analysis since: 
i) The pathway has been well characterized as noradrenergic. 
ii) Electrophysiological responses are clearly defined in the 
large Purkinje cells, on stimulation of this pathway. 
iii) A noradrenaline-sensitive adenylate cyclase has been 
biochemically well characterized in cerebellum. 
Noradrenaline- containing axons in the cerebellar cortex were 
shown to be visible at the light microscope level using the 
Falk- Hillarp fluorescence histochemical technique (81). Employing 
a high sensitivity electron microscopic technique with uptake 
of [3H] noradrenaline, a large number of terminals were found to 
synapse on the dendrites of the large Purkinje cells which 
control output from the cerebellum (81). The source of these 
noradrenergic terminals was found in the locus coereleus. When 
stimulating electrodes were placed in locus coereleus and recording 
microelectrodes in Purkinje cells, delayed and long duration 
inhibition resulted. This type of inhibitory response could 
only be observed following stimulation of locus coereleus (82). 
Inhibition which resulted from stimulating certain other areas 
of the brain stem, could be clearly distinguished by its fast 
latency, short duration characteristics. Several different 
approaches were used to provide evidence that the locus coereleus- 
cerebellar Purkinje cell pathway was noradrenergic, and mediated 
via cyclic AMP (83, 84, 85). 
i) Iontophoretic application of noradrenaline or cyclic AMP 
slowed the spontaneous firing rate of Purkinje cells by the 
same type of inhibition as stimulation of locus coereleus. 
Whilst phosphodiesterase inhibitors had no effect on their own, 
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this form of inhibition, by stimulation, or iontophoretic 
cyclic AMP, was potentiated in the presence of phosphodiesterase 
inhibitors. receptor blockers and prostaf landins El and E2 
( ?receptor blockers in the periphery), prevented the inhibition 
by stimulation or iontophoretic noradrenaline, but not cyclic 
AMP. 
ii) Chronic pre -treatment of rats with reserpine (to inhibit 
catecholamine uptake) or o(-methyl paratyrosine (to inhibit 
catecholamine synthesis), abolished the inhibitory response 
of Purkinje cells to locus coereleus stimulation or inhibition 
by iontophoretic noradrenaline, but not by cyclic AMP. Pre- 
treatment with-intracisternal 6- hydroxydopamine to destroy 
catecholamine neurones, prevented the inhibition by locus 
coereleus stimulation. 
Other studies have demonstrated that cyclic AMP may mediate 
noradrenergic responses in the system. For example, incubated 
slices of cerebellum increase their cyclic AMP content when exposed 
to noradrenaline via activation of receptors (70) and a specific 
noradrenaline -sensitive adentilate cyclase is found in cerebellar 
homogenates (6). 
Direct evidence has been presented for the presence of / receptors 
on Purkinje cells of rat cerebellum using a specific fluorescent 
ligand (86) but the validity of this technique has been recently 
questioned (87). 
It should be noted that difficulties were experienced by a number 
of groups in repeating the electrophysiological studies of Bloom's 
group. These now appear to have been explained by technical 
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difficulties in iontophoretic application of cyclic AMP (88). 
In an attempt to circumvent iontophoretic problems Gáhwiler (89) 
studied the actions of noradrenaline and cyclic AMP on firing 
rates in Purkinje cells from explants of rat cerebellum. Whilst 
cyclic AMP had little effect, high concentrations of noradrenaline 
and phosphodiesterase inhibited firing. Evidence suggesting 
that cyclic AMP mediated noradrenergic inhibition came from 
the observation that phosphodiesterase inhibitors enhanced the 
the inhibition by noradrenaline and cyclic AMP. Whilst 
phosphodiesterase activity was probably very high in this system, 
thus preventing clear cyclic AMP inhibitory responses, the results 
support Bloom's data. 
Indirect evidence 'in vivo', suggested that the cyclic AMP - 
dependent protein kinase mediated changes in post -synaptic 
potential in the Purkinje cell membrane. Siggins et al (90) 
showed that the ability of cyclic AMP and its derivatives to 
activate a bovine brain protein kinase closely correlated with 
their ability to depress Purkinje cell discharge. 
Many of the studies described for the locus coereleus -cerebellar 
Purkinje cell pathway have now been carried out on the noradrenergic 
projection from locus coereleus to the hippocampal pyramidal 
cells, with similar results (91). Noradrenaline inhibition 
in the C.N.S. may therefore be generally mediated via cyclic AMP. 
Electrophysiology and further biochemical studies on slices have 
added to the suggestion from dopamine- sensitive adenylate cyclase 
in homogenates, th ' the post -synaptic actions of this transmitter 
are also mediated by cyclic AMP. Clearly, similar electrophysiological 
studies on other defined neurotransmitter systems are required. 
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1.6. Extension of the classical 'second messenger' role of cyclic AMP 
If cyclic AMP mediates post -synaptic potentials in response to 
neurotransmitters released from adjacent pre -synaptic terminals, 
restoration of potential to its pre -excitatory phase should occur 
with removal of cyclic AMP in a very short time course. 
Why then: 
i) Are cyclic AMP levels elevated in slices for periods from 
10 - 30 minutes, upon neurotransmitter or brief electrical 
stimulation (71, 92) i.e. 104 or 105 times longer than the 
duration of inhibitory or excitatory post -synaptic potentials? 
ii) Do sub -cellular fractionation studies show cyclic AMP 
unbound within synaptosomes for 6 - 10 minutes after electrical 
stimulation (93)? 
In framing these questions, Mcllwain (94) has suggested that cyclic 
AMP is transported to other brain areas by diffusion or active 
transport to influer^e electrical activity there, after formation 
at a specific post -synaptic site. In extending the'second messenger' 
role of cyclic AMP, McIlwain has proposed that this nucleotide 
may have a role to play in memory. Evidence in favour of movement 
of cyclic AMP comes from the demonstration of translocation of 
adenine nucleotides including cyclic AMP. Schubert et al (95) 
have shown that electrical stimulation of specific axonal tracts 
in the C.N.S. can increase the transfer of radioactive compounds 
derived from [3H] adenosine, to post -synaptic sites. If cyclic 
AMP does indeed translocate, this may occur via microtubules. A 
link between microtubules and cyclic AMP was first found by Goodman 
et al (96) who showed that isolated microtubular proteins contained 
a cyclic AMP- dependent protein kinase, and that tubulin, the major 
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component of microtubules, was phosphorylated by cyclic AMP 
'in vitro'. Subsequent work by Greengards group (34) has shown 
not only phosphorylation of tubulin, but also of microtubule- 
associated proteins which may have a function in microtubule 
assembly. 
Regulation of neuronal microtubules via cyclic AMP may be 
responsible for the role of this nucleotide in a variety of 
other events besides mediating post -synaptic potentials e.g. 
growth and intracellular transport of various substances 
including enzymes. 
1.7. Pre -synaptic role of cyclic AMP in the C.N.S. 
Pre -synaptic regulation of transmitter release has been studied 
mostly in the adrenal medulla and superior cervical ganglion, but 
the following example considers pre -synaptic control in dopamine 
neurones in the C.N.S. 
Electrical stimulation of nigro -striatal dopaminergic neurones 
results in an increase in the formation of labelled dopamine 
from exogenous tyrosine, through kinetic activation of the 
rate -limiting enzyme tyrosine hydroxylase, without synthesis of 
new enzyme (97). Dibutyryl cyclic AMP, the lipid soluble analogue 
of cyclic AMP, has a similar specific effect in synaptosomal 
fractions of striatal homogenates (98). This analogue also 
increases the formation of dopamine from labelled tyrosine in 
slices of rat striatum (99). Further studies have suggested that 
the effects of cyclic AMP on tyrosine hydroxylase might be mediated 
through the activation of a pre -synaptic cyclic AMP- dependent 
protein kinase. 
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It has been found that the addition of cyclic AMP- dependent 
protein kinase to hippocampal soluble fractions results in a 
several fold increase in tyrosine hydroxylase activity which 
is cyclic AMP -dependent. Substances known to inhibit the kinase, 
such as inhibitory modulator, or adenosine, antagonize this 
activation (100). 
Pre -synaptic in addition to post - synaptic cyclic AMP systems, 
may therefore be operative in certain neurones in the C.N.S. 
1.8. Conclusion 
Considerable evidence suggests that cyclic AMP mediates the 
post -synaptic effects of dopaanine, noradrenaline and probably 
other putative neurotransmitters at certain synapses in the 
C.N.S., via specific protein phosphorylation. Whilst mediation 
of rapid post -synaptic potentials in determining communication 
between nerve cells has been studied in most detail, it is clear 
that cyclic AMP has a variety of other functions not only in 
neurones, but also in other cell types, and mediates events of 
longer time course, e.g. receptor sensitivity, protein synthesis, 
and growth. 
The chain of biochemical events in the cyclic AMP system 
between stimulus and response, together with compartmentalization 
of components within the cell, enables this ubiquitous molecule to 
exert its variety of effects. 
2. CYCLIC GMP AND ITS ROLE IN THE CENTRAL NERVOUS SYSTEM - 
LITERATURE REVIEW. 
Discovered as a natural constituent of rat urine in 1963 by 
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Figure 3 Structure of cyclic AMP and cyclic GMP. 
Ashman et al (101), cyclic GMP has a similar structure to cyclic 
AMP, differing only in the groups and their positions on the 
purine nucleus (see Figure 3). 
The levels of cyclic GMP in tissues are generally much lower than 
for cyclic AMP, but very high levels,of the same order of cyclic 
AMP, are found in the C.N.S. in the cerebellum (102, 103). In the 
search for a physiological function for the nucleotide, George et 
al (104) in 1970 showed that acetyl choline rapidly elevated cyclic 
GMP levels in heart, in parallel with negative inotropic, but not 
chronotropic events. 
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Together with subsequent observations in different tissues, a 
'second messenger' role for the muscarinic actions of acetyl 
choline was suggested, similar to that established for cyclic 
AMP. In a number of tissues it was found that agents that changed 
cyclic GMP levels could antagonistically effect cyclic AMP levels. 
An intracellular control system via the two cyclic nucleotides 
was coined the 'Yin -Yang' hypothesis by Goldberg et al (105), 
applicable to bidirectional systems. In its simplest form it 
states that when cyclic AMP levels are elevated, cyclic GMP 
levels are lowered, and vice -versa. It has become apparent in 
recent years that in certain systems the 'Yin -Yang' hypothesis 
explains the observations well, whilst in others it is totally 
inapplicable. 
It is also a matter of dispute as to whether cyclic GMP can be 
regarded as a true 'second messenger'. To quote from a recent 
-7tensive review on cyclic GMP by Goldberg: 
Attempts to deal with the findings (on cyclic c) 
within the framework of the cyclic AMP 'second messenger' models 
are often futile, although in some cases a reasonable fit can be 
made' (106. 
The man difficulty in evaluating cyclic GMP as a neurotransmitter 
or hormonal'second messenger' has been in showing activation of 
the cyclic GMP synthesizing enzyme (guanylate cyclase) 'in vitro' 
by these agents. This contrasts with adenylate cyclase which, 
as a general rule, is activated by hormones or neurotransmitters 
in broken -cell homceenat -. 21ost of the reports which have 
shown stimulation of guanylate cyclase by these agents, have 
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not been confirmed. In some instances effects have been attributed 
to contaminants in the hormonal preparation (107) or non - 
enzymatic formation of cyclic GNP (108). 
2.1. Guanylate cyclase. 
Guanylate cyclase, catalysing the formation of cyclic GMP from 
the substrate GTP is, unlike adenylate cyclase, found in both 
soluble and particulate forms - the particulate form being 
detected in plasma membrane, endoplasmic reticulum, mitochondria 
and nucleus (109, 110). The listribution varies from being 
totally soluble in platelets (111) to totally particulate in 
sea -urchin sperm (112). Generally however, comparable activity 
is found distributed between both forms. It has been argued that 
the soluble form might be an artefact of homogenization deriving 
from a totally particulate fraction. This now seems unlikely 
however, since important physico- chemical differences have been found 
between the two forms, and recently it has been shown that soluble 
and particulate guanylate cyclase are antigenically discrete (113). 
It is interesting that the enzyme exists in two forms. For a 
'second messenger' role of cyclic GMP the enzyme should be membrane 
bound to mediate the intracellular response resulting from the 
extracellular'first message'. A soluble distribution would be 
expected if the hormone or neurotransmitter diffused through the 
membrane like steroid hormones, or if the enzyme had a general 
role in mediating intracellular processes. 
Guanylate cyclase shows an absolute requirement for divalent 
cations, the substrate assumed to be the dizralerì' - .a.tion -GTP 
complex. In general, the particulate enzyme requires two- to 
five -fold higher substrate concentrations than the soluble enzyme. 
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Whilst early studies demonstrated that Mn2+ was required in 
high concentration for activation of both forms of the cyclase 
it now seems likely that when the enzyme is stimulated, 
physiological concentrations of Mgt+ or Cat+ may substitute 
for Mn2+ (106). 
Two further points may have particular interest physiologically. 
The soluble enzyme is more sensitive to inhibition by ATP than 
the particulate form, leading Kimura and Murad (114) to speculate 
that under normal conditions in the cell, little of the soluble 
guanylate cyclase activity may be expressed unless the ATP 
inhibition is overcome. Secondly, calcium ions stimulate the 
soluble enzyme but inhibit the particulate form. 
The relationship between the distribution of guanylate cyclase 
and cyclic GMP levels is of interest; this relationship may be 
tissue specific. In the rat kidney for example, cyclic GMP 
levels in different anatomical regions are best correlated with 
the particulate activity of the region (115). In the testis, 
however, increased levels of cyclic GMP are clearly associated 
with an increase in the soluble activity (116). 
Whilst a number of reports have shown selective modulation of each 
form of guanylate cyclase 'in vivo' e.g. increased particulate and 
decreased soluble guanylate cyclase in regenerating liver, fetal 
liver and hepatoma (117), as mentioned previously, hormone and 
neurotransmitter stimulation has not been convincingly demonstrated 
'in vitro' and may occur indirectly via 'modulators'. Activation 
of guanylate cyclase has recently been observed with lipids, free 
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radicals, nucleophilic compounds and substances affecting oxidation 
and reduction state, effects which may modulate both the soluble 
and particulate guanylate cyclase. 
Studies on platelets were the first to show that the soluble 
enzyme could be activated by arachidonic and other structurally 
related fatty acids (118). Subsequent studies have shown 
- modulation of both forms of the cyclase by a number of fatty acids, 
in a number of tissues. It is not yet known whether the micromolar 
levels of fatty acids required for modulation, represent a 
physiological control system or not. 
The first indication that guanylate cyclase might be influenced 
by an alteration in redox state, was the description by Boehme 
et al (111) of spontaneous auto -oxidation in air of soluble 
platelet guanylate cyclase, which was prevented by the reducing 
agent DTT. Subsequent reports have shown auto -oxidation of the 
soluble, but not particulate enzyme, from other tissues ( e.g.119). 
The oxidized form of ascorbic acid (vitamin C) but not the reduced 
form, elevates cyclic GMP levels in spleen (106). This effect is 
probably of little physiological importance though, since it is 
only seen after cell disruption. It is also of interest in view of 
redox state effects, that in umbilical artery and kidney, the 
partial pressure of oxygen together with calcium levels, regulate 
cyclic GMP levels (120, 121) and that it has recently been reported 
in cerebellum that cyclic GMP levels may in part be regulated by 
the partial pressure of oxygen and carbon dioxide (148). 
Strongly nucleophilic compounds e.g. sodium azide, and hydroxylam;ne, 
have been found by Yimura and Murad (122) unexpectedly to increase 
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soluble or particulate guanylate cyclase from a number of tissues. 
In tissues such as cerebral cortex where the soluble enzyme was 
not found to be activated by azide but the particulate was, the 
soluble enzyme was activated on addition of a 'non -dialyzable, 
heat labile, macromolecular factor', isolated from liver and 
resembling catalase (123). Guanylate cyclase has also been found 
to be activated by nitrosamines, compounds which readily form free 
radicals in tissues. The relative effectiveness of nitosamines 
to activate hepatic guanylate cyclase has been found to correspond 
with their relative potencies as carcinogens (124). The importance 
of guanylate cyclase in mediating the toxic effects of not only 
nitrosamines, but also azide and related compounds with C.N.S. 
effects, is not yet understood. The gaseous phase of cigarette 
smoke has been found to activate soluble and particulate guanylate 
cyclase from a number of tissues, reportedly due to the nitric 
oxide component of the smoke. An involvement of cyclic GMP in the 
suspected carcinogenicity of cigarette smoking has been suggested 
from these results (125). An endogenous activating factor for 
guanylate cyclase has been found in the synaptosomal fraction of 
rat brain (126) which may be another indirect mechanism for 
'modulating' the enzyme. 
Analogous to the cyclic AMP system, the levels of cyclic GMP in a 
tissue reflect a balance between its rates of synthesis and 
degradation. Whilst many of the changes in cyclic GMP levels are 
modulated via the cyclase, the phosphodiesterase, which acts to 
degrade cyclic GMP. may be an important site of regulation. 
2.2. Cyclic GMP phosphodiesterase 
Phosphodiesterase, as discussed in section 1.1.0 is a group of 
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isoenzymes. One form is found which hydrolyses cyclic GMP 
specifically, and evidence that the cyclic GMP and cyclic AMP 
phosphodiesterases are separate isoenzymes comes from the finding 
that they are under separate genetic control (127). Control of 
cyclic GMP phosphodiesterase occurs by a variety of agents, the 
most important physiologically being calcium ions. The regulation 
of cyclic nucleotide hydrolysis by calcium might be more directed 
to the control of cyclic GMP rather than cyclic AMP metabolism 
since in brain cyclic GMP phosphodiesterase is associated with 
the calcium- dependent regulator (CDR), and addition of CDR and 
calcium to brain phosphodiesterase increases the hydrolysis rate 
of the cyclic GMP phosphodiesterase (44). It is evident that the 
intense interest being focused on CDR at the moment will give us 
more information on cyclic nucleotide function in the near future. 
A clear example of regulation of cyclic GMP levels via the 
phosphodiesterase r Cher than guanylate cyclase, is found in retinal 
dystrophic diseases. Due to an inherited genetic mutation in mice 
of the strain C3H /REJ, all the photoreceptor cells in the retina, 
whilst forming normally, degenerate during the second and third 
weeks of post -natal life, causing blindness. Normally the cyclic 
GM!? phosphodiesterase increases about six -fold as the photoreceptors 
differentiate and mature, but in the diseased retina, the relatively 
low activity present at birth remains throughout life, causing 
elevated cyclic GMP levels in the photoreceptor cells (128). Lolley 
and Farber have proposed that the high cyclic GMP levels cause 
degeneration of photoreceptors, and therefore blindness. This was 
born out by their study (129) showing selective and dose -dependent 
induction of photoreceptor degeneration, by the drug iso -butyl 
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methyl xanthine (IBMX) using Xenopus eye rudiments in culture. 
This drug is a potent phosphodiesterase inhibitor and caused 
accumulation of cyclic GMP in the preparation with increasing 
concentrations of drug. 
Another inherited retinal dystrophy in rats (RCS type) has been 
found to be associated with alteration of the kinetic characteristics 
of the cyclic GMP phosphodiesterase affecting the high Km 
phosphodiesterase (128) and recently, inherited retinal degeneration 
of Irish setters has been found to be due to the same mechanism (130). 
Whilst phosphodiesterase is the only enzymatic method for degrading 
cyclic GMP, secretion and diffusion may control levels of the 
nucleotide to some extent. Analogous to cyclic AMP, cyclic GMP 
is secreted into the cerebro- spinal fluid (CSF), by a probenecid- 
sensitive mechanism, and CSF cyclic GMP levels are influenced by 
the systemic injection of drugs (131). Efflux of cyclic GMP as 
observed from incubated pineal glands, could act to remove cyclic 
GMP from its site of action, thereby controlling levels (132). 
2.3. Cyclic GMP - 'second messen er'? 
Before considering a 'second messenger' function for cyclic GMP 
in the C.N.S., two examples from the periphery will be cited to 
indicate the controversy in the literature. 
In smooth muscle, original observations associated increases in 
cyclic GMP levels with muscarinic stimulation causing contraction (133), 
observations in line with the original observations of George et 
al (104) in heart. Subsequent work on smooth muscle however has 
dissociated the cyclic GMP increases from contraction and agents 
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with no effect on contraction,or even those causing relaxation, have 
been found to increase cyclic GNP levels (133 ). 
Whilst cyclic GNP has always been associated with the muscarinic 
actions of acetyl choline, Greengard et al (135) have recently 
reported that cholinergic agonists can increase cyclic GNP levels 
in striated muscle by acting at nicotinic cholinergic receptors. 
In the peripheral nervous system, the sympathetic ganglion has been 
extensively studied as a system where cyclic AMP and cyclic GNP 
show opposing electrophysiological responses (136, 137). Pre - 
ganglionic fibre stimulation causes release of dopamine from 
inhibitory inter- neurones synapsing on the post -ganglionic neurones, 
and release of acetyl choline that acts directly on these post - 
ganglionic neurones. Amongst the post -synaptic potentials resulting 
from pre -ganglionic fibre stimulation, cyclic AMP is considered to 
mediate the slow excitatory post -synaptic potential (slow EPSP) 
elicited by dopamine, whilst cyclic GMP mediates the slow inhibitory 
post -synaptic potential (slow IPSP) elicited by acetyl choline. The 
integrative capacity of the ganglion is believed to be due to the long 
duration of these clearly defined potentials. Recent work, however, has 
cast doubt on the specificity of the cyclic nucleotides in acting as 
'second messengers' mediating the neurotransmitter and electro- 
physiological responses. Busis et al (138) using the sucrose gap 
technique, whilst confirming the elevation of the cyclic nucleotides by 
dopamine and acetyl choline, were unable to demonstrate slow post -synaptic 
potentials by applying cyclic AMP, cyclic GMP or their more permeable 
dibutyryl analogues. The cl.a,sical 'second messenger' test of using 
a phosphodiesterase inhibitor to prevent cyclic nucleotide degradation, 
instead of extending slow post -synaptic/ 
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potentials, produced complex electrophysiological responses 
with theophylline, markedly different from those obtained with 
another phosphodiesterase inhibitor, papaverine. 
In slices of bovine superior cervical ganglion, depolarizing 
agents have been found to elevate cyclic GMP levels; these 
observations might be explained by release of acetyl choline. 
However, sodium azide has also been found to elevate cyclic GMP 
levels, independent of calcium, in the ganglion, raising further 
questions as to the specificity of cyclic GMP as a 'second 
messenger' for acetyl choline in this tissue (139). 
In another peripheral nervous tissue, Horn and Mcaffee (140) 
have shown hormonal changes in cyclic AMP and cyclic GMP levels, 
in frog sciatic nerve. The ability of nervous tissue to respond 
to hormones with changes in cyclic nucleotides in a non -synaptic 
preparation, without effects on excitability, suggests caution in 
attributing cyclic nucleotiae changes in nerve tissue to synaptic 
events. 
It is becoming increasingly clear in a number of systems, that 
whilst specific receptor stimulation can cause increases in cyclic 
GMP levels, increases in the nucleotide levels are not necessarily 
responsible for initiating the physiological effect, and therefore 
acting as true 'second messengers'. It seems more likely that 
cyclic GMP increases are somehow involved indirectly, in linking the 
actions of neurotransmitters or hormones with their physiological 
effects, perhaps by mediating ion fluxes. 
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2.4. Cyclic GMP in the C.N.S. 
Is cyclic GMP a 'second messenger' to acetyl choline in the 
central nervous system? 
Since very high levels of cyclic GMP are found in the cerebellum (103), 
extensive studies have been carried out in this brain area where 
cyclic GMP might be expected to have an important function. The 
distribution of neither the soluble, nor particulate guanylate 
cyclase, nor the muscarinic receptor, show any correlation with 
cyclic GMP levels in different brain areas, which might have been 
expected if cyclic GMP was a 'second messenger' to acetyl choline (141). 
Following the work of George et al (104) on acetyl choline and cyclic GMP 
in heart however, Ferrendelli et al (142) showed that the centrally 
acting cholinergic agent, oxotremorine, increased cyclic GMP levels 
in mouse cerebellum and cortex. The time of maximal tremor produced 
by the drug, coincided with maximal cyclic GMP increase, tremor and 
elevation in nucleotide level being blocked by the a ti- cholinergic 
drug atropine. This result suggested that oxotremorine was acting 
via central muscarin.ic receptors to cause tremor. The cerebellar 
cyclic GMP increase must have been an indirect effect, since 
1 
cholinergic receptors have not been found in this brain area. Goldberg 
et; al (143) showed that elevation of acetyl choline levels 'in situ' 
increased cyclic GMP levels, since administration of malaoxone, 
a centrally acting cholinesterase inhibitor, elevated acetyl choline 
levels in the C.N.S. together with cyclic GMP. 
It has been subsequently found, however, that a variety of agents 
and conditions, assumed to act on a variety of neurotransmitter 
systems can modify cyclic GMP levels 'in vivo' e.g. amphetamine, 
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chlorpromazine, reserpine, halothane and stress (144, 145, 146, 147). 
Post -mortem decapitation effects are also found with cyclic GMP as 
previously described for cyclic AMP. Whilst similar reservations 
hold for cyclic AMP as for cyclic GMP in interpreting 'in vivo' 
data, it is possible to generalize that drugs or conditions that 
increase general neuronal activity e.g. tremorogenic drugs 
and convulsants, increase cyclic GMP centrally, whilst decreased 
levels are associated with depression of neuronal activity 
e.g. after administration of morphine and ethanol (55). 
Recent data suggests that decreases in cerebellar cyclic GMP 
caused by drugs may be secondary to decreased motor function or 
respiratory depression produced by the drugs (148). The 'in vivo' 
data suggests, therefore, that a basic neuronal mechanism might 
underly changes in cyclic GMP levels in the C.N.S. 
2.5. 'In vitro' biochemical studies. 
The inability of neurotransmitters to stimulate guanylate 
cyclase in broken -cell homogenates has led to a large number of 
studies on the respiring slice. A number of putative 
neurotransmitters have been shown to elevate cyclic GMP levels 
in slices e.g. acetyl choline, glutamate, GAGA, glycine, 
noradrenaline, histamine and enkephalin. There appears to be a 
marked species and brain area variation in the response (147, 149) 
Recently, Ferrendelli's group have demonstrated that far greater 
elevations can occur in brain slices exposed to depolarizing 
agents (150, 151). Exposure to high levels of g+ (17 -120 mM), 
and depolarizing agents acting by different mechanisms(veratridine 
ouabain, glutamate) caused a 30 -50 fold increase in slices of mouse 
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cerebellum, which was prevented by membrane stabilizing agents 
e.g. local anaesthetics. Depolarization causes a number of 
changes in biochemical and functional processes e.g. change in 
cell membrane permeability, increased cellular respiration and 
augmented neurotransmitter release. Examining the effect of 
divalent cations on the depolarization- induced increases in 
cyclic GMP, Ferrendelli's group demonstrated that all the 
depolarizing agents required calcium ions in order to elevate 
cyclic GMP levels. Furthermore, the divalent cation requirement 
for elevations in cyclic GMP paralleled that for neurotransmitter 
release at the neuromuscular junction and other synapses. This 
suggested that cyclic GMP might be involved in neurotransmitter 
release as suggested in the pineal gland, for regulation of 
noradrenaline release (152). 
A large number of putative neurotransmitter agonists and 
antagonists were then examined in incubated brain slices, to 
determine the effect of released neurotransmitters on cyclic 
GMP levels. A number of observations suggested that depolarization - 
induced increases in cyclic GMP were not due to release, or action, 
of these putative neurotransmitters, or to presently unidentified 
neurotransmitters since: 
i) the extent of the increase was far less than those produced 
by depolarizing agents, 
ii) whilst g} ions were found to increase tissue levels of 
cyclic GMP in slices of a number of species, and in a number of 
different brain areas, the neurotransmitter increases showed both 
species and tissue selectivity. 
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iii) The K+ induced increases in cyclic GMP were not blocked 
by any putative neurotransmitter antagonist. 
iv) Acid extracts of rapidly frozen mouse cerebellum, or aqueous 
extracts of boiled mouse cerebellum had no effect on cyclic GMP 
levels in mouse cerebellum. 
Having discussed variability in response between species and brain 
area, recent data (153) has shown a marked age- dependency in the 
response of rat cerebellar slices to depolarization induced by 
glutamate. Tne supersensitive response was found to peak post- 
natally at day 10, causing greater than a 200 -fold increase in 
cyclic GMP over basal levels, contrasting with approximately a 
2 -fold increase in adult slices. Decreased responses of cerebellar 
slices to accumulate cyclic GMP after stimulation by kainic acid, 
have also been observed in rats between 3 months and 2 years old; 
basal levels were also reduced (154). 
Depolarization induced increases in cyclic AMP in brain slices, 
assumed to be due to release of intracellular adenosine, markedly 
contrast with cyclic GMP increases, by dose and time -dependent 
differences in response (150). 
It is of interest, however, that a recent report shows that 
adenosine can increase cyclic GMP levels in guinea -pig cerebellar 
slices 3 - 4 fold, dependent upon calcium; AMP, ADP and ATP 
produced similar increases (155), whilst adenine and other 
nucleotides rad no effect. Perhaps the most important difference 
between cyclic AMP and cyclic GMP responses in slices is that the 
latter are dependent upon calcium ions. The importance of calcium 
for this response is born out by the observation that cyclic GMP 
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levels are increased in brain slices incubated with the calcium 
ionophore, A23187, which acts as a mobile carrier, to transport 
calcium across cell membranes (150). Calcium ion flux may 
underly the cyclic GMP increases observed with depolarizing agents, 
by regulating the calcium- dependent soluble guanylate cyclase. 
The importance of calcium ions for maintaining basal cyclic G1T 
levels and eliciting responses in a wide variety of tissues outside 
the C.N.S., has led Schultz et al (156) to propose that calcium 
may act as the intracellular 'second .messenger' for muscarinic 
stimulation of guanylate cyclase. In this respect it may be of 
importance that drugs which decrease 'neuronal activity' can deplete 
regional brain calcium (157). 
Calcium- dependent elevation of cyclic GMP in slices is probably due 
to an action on guanylate cyclase rather than the phosphodiesterase, 
inferred from studies where inhibitors of phosphodiesterase were 
used (151). Since neurotransmitter activation of guanylate cyclase 
has not been convincingly demonstrated 'in vitro', calcium- dependent 
elevations of cyclic GMP may result from increasing availability 
of calcium ions to the soluble enzyme. Kimura and Murad (122) have 
demonstrated calcium- independent elevation of cyclic GMP levels 
in brain slices using sodium azide, resulting from stimulation of 
the particulate guanylate cyclase. 
The 'in vivo' and 'in vitro' data presented suggest that neurotransmitters 
probably influence cyclic GMP indirectly by a basic mechanism such 
as changing calcium ion flux or effecting modulators, 
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2.6. Electrophysiological studies 
Electrophysiological data is not only far more limited than 
for cyclic AMP, but also conflicting. Stone et al (158) have 
shown good correlation between the excitatory effects of acetyl 
choline and cyclic GMP in pyramidal neurones of the rat 
cerebral cortex. Noradrenaline and cyclic AMP elicited 
opposing inhibitory responses in these cells, conforming to 
the 'Yin -Yang' hypothesis of biological regulation described 
previously. In contrast to these results, a study by Phyllis (159) 
using extracellular application of acetyl choline onto pyramidal 
neurones and other neurones caused excitation, whereas cyclic GMP 
depressed firing rate. An intracellular iontophoretic study of 
acetyl choline and cyclic GMP in the large spinal motor neurones of 
the cat, produced different effects.of the two substances. Cyclic 
GMP decreased input resistance, whilst acetyl choline was found 
to increase it (160). Again in contrast, intracellular studies 
by Woody (161) in awake cats in the coronal pericruciate cortex, 
showed that cyclic GMP increased input resistance in about half the 
cells tested. Similar responses were elicited in the same cells 
with acetyl choline, which were blocked with atropine. Iontophoresis 
of acetyl choline or cyclic GMP to these neurones, held under 
repeated discharge by electrical stimulation, caused long lasting 
increased resistance (up to 12 hours in unanaesthetized awake cats). 
Woody (161) suggests that the persistent increased membrane 
resistance may mediate learned behaviour. This is clearly in line 
with McIlwain's extended 'second messenger' hypothesis for cyclic 
nucleotides (94). 
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Wnilst the electrophysiological data on cyclic GMP in the C.N.S. 
is controversial, it is clear at least that the nucleotide is 
associated with changes in neuronal excitability in the C.N.S. 
2.7. Cellular localization of the cyclic GMP system in the C.N.S. 
A neuronal rather than glial distribution of guanylate cyclase 
is inferred from the following data: 
i) The sub -cellular distribution of soluble guanylate cyclase 
resembles that of other enzymes considered as neuronal markers 
e.g. glutamate decarboxylase and tyrosine hydroxylase, but differs 
from that of soluble non -specific cytoplasmic markers such as 
lactate dehydrogenase and the two glial soluble markers, S -100 
protein and butyryl cholinesterase (162). 
ii) Studies of chick embryo brain cells in culture show that 
guanylate cyclase activity is always higher in cultures with a 
significantly greater ratio of neurones to glia (163). 
iii) In glial or meningeal cell cultures, guanylate cyclase is 
below the limit of detection (163). 
The above data suggests that guanylate cyclase is mainly if not 
exclusively, concentrated within neurones. 
Experiments with neuronal and glial cells in culture have been 
carried out to determine whether only neuronal or both cell 
types, respond to stimulation. As discussed with this experimental 
approach for cyclic AMP, care should be taken in extrapolation of 
results to the fin vivo' situation. In the presence of the 
phosphodiesterase inhibitor IBMX, cells of the mouse neuroblastoma 
line NIE 115 were found to respond to muscarinic stimulation with 
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a 200 -fold increase in cyclic GMP, which was blocked by atropine 
and was dependent upon calcium. The importance of calcium ions 
in eliciting the response in this nerve cell line, was shown by 
the large increases which were generated using the calcium 
ionophore A 23187, in the presence of 1mM Ca 
2+ 
, a response which 
could not be blocked by atropine (141). Elevations in cyclic GMP 
in neuroblastoma have also been observed with non- cholinergic 
agents e.g. histamine has been found to increase cyclic GMP levels 
in mouse neuroblastoma via H1 receptors (164). 
Using C6 rat gild]: cells in culture, catecholamines have been found 
to elevate cyclic GMP levels, acting via a receptor. Carbamylcholine, 
a cholinergic agonist, was found to decrease cyclic GMP levels, a 
response partially antagonized by hexamethonium, suggesting 
nicotinic characteristics (165). In human astrocytoma cells however, 
carbamylcholine was found to increase cyclic GMP levels (166). 
A number of neurotransmitters were found to increase cyclic GMP 
levels in a vascular endothelial cell line. The cyclic GMP response 
to noradrenaline was blocked by the o< antagonist phentolamine, 
whilst atropine blocked the response to acetyl choline (167). 
An interesting observation on neuronal and glial cyclic GMP has 
come from a study by Taylor et al (168) who micro- dissected a 
large number of insect nerve cords to prepare neuronal and glial 
enriched fractions. Cyclic GMP was concentrated in the glial 
fractions, levels being significantly higher than for cyclic AMP 
which had similar levels in both fractions. 
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2.8. Control of cyclic GMP levels in the cerebellum. 
The cerebellum, with very high levels of cyclic GMP, and highly 
responsive to a large number of agents and conditions, contains a 
number of different neuronal and glial cell types. In an attempt to 
determine which cells contain cyclic GMP and respond to stimulation, 
Ferrendelli et al (169) have employed micro- dissection of the 
clearly defined layers of the cerebellar cortex, coupled with a 
highly sensitive radioimmunoassay for cyclic CHIP. After drug 
treatment, most of the changes in cyclic GMP levels were found in 
the molecular layer which contains predominantly fibres and synapses; the 
remainder of the changes occurred in the granule cell layer. 
The lack of a significant pool of the nucleotide in the Purkinje 
cell layer contrasted with the findings that mutant ataxic mice 
lacking Purkinje cells, had significantly reduced cerebellar 
cyclic GMP levels, suggesting that the nucleotide was concentrated 
in these cells (170). The molecular layer contains Purkinje cell 
dendrites however, which might make the observations compatible, 
Subsequent 'in vitro' data using these mutant mice has shown that 
large increases in cyclic GMP can be elicited in cerebellar slices 
with K+ depolarization, noradrenaline and kainic acid (171). 
Evidently, even if there is a Purkinje cell pool of cyclic GM?, 
it cannot be the only one. 
Information is now accumulating that the neural input to the 
cerebellum controls cyclic GNP levels. The tremorogenic drug 
harmaline increases cyclic GMP in the cerebellum by stimulating 
nerve impulse flow in the climbing fibre input .072,173). Specific cham;cal 
lesion of the climbing fibres using the drug 3- acetylpyridine 
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Figure 4 Neuronal systems regulating input and output 
of information in the cerebellum. 
fibres is stimulated by the drug isoniazid; this response is 
unaffected by climbing fibre lesions (172). The neuronal output 
from Purkinje cells is inhibitory on neurones in the deep 
cerebellar nuclei and mediated by ' -arninobutyric acid (GABA). 
Biggio et al (173) have shown that the cyclic GMP content of 
these nuclei is decreased following activation of GABA receptcD.Q 
by muscimol and diazepam, and is increased following a reduction 
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of GABA control caused by isoniazid. Climbing fibre lesions have 
no effect, neither does harmaline, on the cyclic GMP content of 
these nuclei (173). 
Recent data has shown that dopaminergic agonists, acting in the 
striatum, produce increases in cyclic GMP in the cerebellum, with 
no change in cyclic AMP levels. The dopaaninergic effects are 
blocked by specific antagonists (174, 175), and after intra- striatal 
kainic acid injection (176). The cerebellar cyclic GMP 
increase could also be blocked by the centrally acting anti - 
cholinergic agent, soopnlamine (175). A balance between the cholinergic 
and dopaminergic system in striatum could not control cerebellar 
cyclic GMP however, since dopamine receptor blockade increases the 
activity of intra- striatal cholinergic neurones - scopolamine 
would be expected to enhance the response to agonists if this was 
the cholinergic site of action. It must be assumed therefore that 
there is a cholinergic link somewhere between the striatum aaa 
cerebellum. 
Two possible caudato- cerebellar pathways may exist. One pathway 
passing through the red nucleus and mediating activation of mossy 
fibre input, and the other relaying in the substantia nigra and 
inferior olive, and mediating the activation of the climbing fibre 
input to Purkinje cells. Experiments are being carried out in a 
number of laboratories on the specific pathways mediating 
cerebellar cyclic GMP levels. 
The role of cyclic GMP in the C.N.S. is clearly complex and not 
well understood at present. Attempting to summarize the 'in vivo' 
and 'in vitro' data, it seems that neuronal activity regulates 
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cyclic GMP levels perhaps by mediating calcium ion fluxes. The 
data previously described demonstrates that cerebellar cyclic GMP 
levels are influenced by neural input. Whilst this response 
may occur through activation of the soluble, calcium- dependent 
guanylate cyclase, what of the function of the particulate form 
which is inhibited by calcium? Increased particulate guanylate 
cyclase activity has been found in liver after partial hepatectomy, 
a model of proliferating cell growth 'in vivo' (117). In the 
C.N.S. Kamakura et al (177) have shown that in certain brain 
tumours (meningomas and oligo- dendrogliomas) the apparent Km 
of GTP for particulate guanylate cyclase is considerably lower 
than for normal cortex. Perhaps this form of guanylate cyclase 
regulates growth in the C.N.S., since a number of reports for 
non -nervous tissues have suggested that cyclic GMP is one of the 
intracellular mediators involved in cell growth and cell division 
( e.g.178, 179). In the C.N.S., cyclic GMP levels increase 
post -natally with marked regional variation. Levels are very low 
at birth and up to 12 days, but between this time and adulthood, 
cerebellar levels show a particularly marked increase (103, 180). 
Guanylate cyclase activity shows an opposite pattern however, 
immature rats having very high activity which decreases towards 
adulthood (180). 
2.9. Cyclic GMP- dependent protein kinase and protein phosphorylation 
In a similar manner to cyclic AMP, cyclic GMP is proposed to exert 
its physiological effects by binding to naturally occurring kinases, 
which have recently been found with high specificity for cyclic 
GMP as substrate (181, 55, 106). Difficulty has been experienced 
in showing dissociation of the regulatory and catalytic units of the 
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cyclic GMP- dependent kinase in the past, suggesting that 
dissociation may not be required for activation. Kuo (182) 
has recently demonstrated, however, that a modulator protein is 
essential to demonstrate dissociation on cyclic GMP binding. 
In the C.N.S. cyclic GMP kinase is mainly distributed in the 
soluble fraction, the major cyclic GMP binding sites being 
associated with the cyclic GMP- dependent kinase (181, 183). 
Studies on the cellular localization of cyclic GMP kinase in 
the cerebellum using mutant mice with Purkinje cell deficiencies, 
and 3- acetyl pyridine lesions in normal mice, have shown that the 
kinase is associated with Purkinje cells and their dendrites (184). 
It is of interest that similar techniques have shown similar 
localization of cyclic GMP. An inhibitory modulator of cyclic 
GMP kinase has been described in the cerebellum (185). Harmaline, 
which increases cyclic GMP levels in cerebellum, decreased the 
activity of the inhibitor; both of these biochemical effects were 
prevented after 3- acetyl pyridine lesion of the climbing fibres. 
In contrast, diazepam which lowers cyclic GMP levels in cerebellum, 
increased the activity of the inhibitor by 100%. 
In searching for the natural substrates phosphorylated by the cyclic GMP 
kinase, Greengard's group first showed phosphorylation of two 
membrane proteins in smooth muscle by cyclic GMP (186). Recently 
they were able to show phosphorylation of a specific 23,000 M.W. 
protein in the soluble fraction of cerebellar homogenates (187). 
Two points are of special interest: 
i) That a soluble .La,ther than membrane protein perhaps controlling 
ion fluxes, should be phosphorylated. 
ii) That this phosphorylated protein should be demonstrated in 
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cerebellar homogenates, but not homogenates of caudate, 
hippocampus, or cerebral cortex. 
Further work is required to determine whether phosphorylation 
mediates physiological effects of cyclic GMP. 
2.10. Conclusion. 
The role of cyclic GMP in the C.N.S. is considerably less well 
understood than for cyclic AMP. It is becoming increasingly 
apparent that in contrast to the specificity of cyclic AMP 
'second messenger' effects, cyclic GMP levels are influenced 
by a number of common biochemical conditions e.g. ion fluxes 
and redox state, which probably mediate the 'indirect' effects 
of neurotransmitters on cyclic GMP. 'In vivo', cyclic GMP levels 
specifically in the cerebellum, may mediate long -term 
electrophysiological events by responding to dopamin_ergic /cholinergic 
neural input. The soluble and particulate distribution of guanylate 
cyclase, allowing specialization of effects due to different 
distribution in the cell, may have very different functions. The 
particulate form might play a role in affecting growth, whilst the 
soluble, calcium- dependent enzyme, coupled with the finding that 
cyclic GNP phosphorylates a soluble protein in cerebellum, might 
suggest a soluble neuronal system. 
3. CYCLIC NDCTROTIDE IMMIINOHISTOCEEMISTRY 
3.1. Principles of immunhistochemistry 
Histochemistry aims to localize substances 'in situ' in tissue 
sections with high specificity and high see- tivity. A substance 
may be visible under a normal light or ultra- violet light 
microscope or be rendered visible by means of a specific 
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dye. Alternatively a dye or radioactive label may bettaggedtto 
a molecule which will bind the substance in the tissue section, 
or a specific chemical reaction be employed to form a coloured 
reaction product to identify the substance. 
Immunohistochemistry is an advanced histological technique 
employing the high specificity and sensitivity of immunological 
reactions for localizing molecules as antigens within tissue 
sections. Antibodies have to be made visible by linking them 
with 'tags' in such a way that their characteristics for 
recognizing and binding with antigen are not changed. This 
'tagging' was first attempted with azo dyes in 1933 (188), but 
the low sensitivity of the antibody -dye conjugates, prevented 
general usage. Hopkins et al (189) tried to use fluorescent 
dyes with the hope of increasing sensitivity, but the antibody - 
dye linkage interfered with the interaction with antigen. In 
1941 -2, Coons et al (190, 191) succeeded fc, the first time in 
linking a fluorescent dye with an antibody, and preserving antigen 
binding, which enabled localization of soluble polysaccharide 
antigen in tissue sections, from mice infected with pneumococcus. 
Conjugates of the antibody and the dye fluorescein isocyanate, 
showed high intensity greenish- yellow fluorescence in high dilution, 
but the chemical procedures required for labelling, together with 
the instability of the dye, prevented widespread use of the technique. 
In 1958 however, Riggs et al (192) synthesized a more stable compound, 
fluorescein isothiocyanate, which was easily conjugated with antibody. 
Its widespread commercial availability opened up the field of 
immunofluorescence to a very large number of investigators. Whilst 
antibodies are only produced by immunization of animals with large 
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molecules such as proteins, polysaccharides and nucleic acids, 
antibodies have now been raised to a large variety of small 
molecules (haptens) coupled with high molecular weight immunogenic 
'carrier' molecules (193). The power of immunofluorescence 
therefore is that any substance can theoretically be used as 
an antigen and localized histologically with high sensitivity and 
specificity. Practically, the technique is simple, but considerations 
such as the solubility and diffusion of small molecules, and fixation, 
may limit the applicability of the method. Extension of the 
original work of Coons to techniques with higher sensitivity and 
wider applicability e.g. at the ultrastru.ctural level, has made 
immunohistochemistry the fastest growing histochemical technique 
for visualization and identification of bacterial, viral and animal 
tissue antigens, both native and foreign, and in modified form for 
localization and characterization of serum antibodies in tissues (194) 
The original technique, known as the direct technique, employs 
labelled antibody in a single step to localize the antigen in 
the tissue section. Fluorescein isothiocyanate is still, today, 
the most widely used dye for immunofluorescence, showing bright 
apple green fluorescence under ultra- violet light. Antibody is 
simply coupled to the dye under alkaline conditions. In certain 
tissues where endogenous tissue fluorescence (autofluorescence) is 
a problem the use of a contrasting coloured dye has often proved 
useful. Lissamine rhodamine, imparting a red fluorescence is 
most commonly employed for this purpose. In the direct technique, 
two or more antibodies may be labelled with different coloured dyes 
and used to view different antigens in the same tissue section. 
The other dyes that have been developed for use in immunofluorescence (194) 
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Figure 5 Comparison of the direct and indirect 
immunofluorescence techniques. 
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show no general improvements over fluorescein isothiocyanate 
to warrant wide usage. 
In contrast to direct localization of antigens, the indirect 
technique, which is now the most widely used immunofluorescence 
technique, employs an unlabelled antibody as the first step, 
followed by a labelled second antibody. Using this technique 
only one commercially available fluorescent anti- species 
antibody is required to visualize any number of antigens which 
have antibodies raised in that species. The indirect technique 
is stated to be more sensitive than the 'direct' technique, 
presumably due to the additional number of combining sites made 
available by the antibody molecules of the middle layer (see Figure 6 ). 
Coons assessed approximately a 10 -fold increase in sensitivity (195), 
whilst in a different system a 4 -12 fold increase has been 
estimated (196). 
(In cases where decreased sensitivity of the indirect method 
have been reported, compared with the direct technique, these may 
be attributed to non -specific prozone effects e.g. 197). 
Antibodies have also been coupled to enzymes and used for 
immunohistochemistry. Peroxidase has been most widely employed, 
but other enzyme 'tags' such as cytochrome C and lactate 
dehydrogenase have also been used. Peroxidase is coupled to 
antibody using gluteraldehyde or periodate oxidation, and visualized 
'in situ' by the formation of a dark brown reaction product, with 
the specific substrate diaminobenzidine hydrochloride (DAB); the 
reaction requires hydrogen peroxide (198). Tmmunoperoxidase has 






Figure 6 Diagram explaining the increased sensitivity of the 
indirect im munofluorescence technique in comparison 
with the direct technique. 
i) The sensitivity should be increased by extending the 
histochemical incubation times with substrate to increase the 
number of product molecules, without losing specificity. In 
a study by Petts and Roitt (199) however, no significant difference 
was found in sensitivity for localization of tissue antibodies 
using fluorescent and peroxidase 'tags'. 
ii) An ordinary light microscope can be used to visualize reaction 
product, rather than expensive and complex fluorescent microscopes. 
In situations where extensive microscopy must be carried out by 
a single observer, light microscopy should give appreciably less 
eye fatigue compared with fluorescence. 
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iii The reaction product is permanent whereas immunofluorescent 
specimens fade on storage, even in the dark at 4 °C, requiring 
photography soon after preparation. 
iv) The reaction product can be made electron dense by post - 
fixation with osmium, making the immunoperoxidase technique 
applicable to electron -microscopy, for localization of antigens 
at the ultrastructural level. Immunofluorescence is restricted 
to light microscopy. 
The disadvantages of immunoperoxidase are: 
i) Endogenous peroxidase activity in tissues may interfere with 
specific staining. Techniques are available for removing 
endogenous peroxidase however , e.g. 0.074% H Cl in 10% 
ethanol (200), but care must be taken to ensure that tissue 
antigenicity is not interfered with. 
ii) The reaction product may be a cause of diffusion artefacts, 
although this is only really a problem at the el -tron- microscope 
level (201, 202). 
iii) Fluorescence probably has a better resolution, particularly 
of fine fibres (203). 
iv) The most serious objection to the immunoperoxidase technique 
is on safety grounds however, since the DAB substrate may be 
carcinogenic (204) which has led to its withdrawal from a number 
of laboratories. Recently, non -carcinogenic compounds have been 
developed, which appear to be as useful as DAB in localizing 
peroxidase in axonal transport techniques (205), but information 
on their use in immunoperoxidase techniques is at present very 
limited. 
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The indirect technique has been shown to be more sensitive than 
the direct technique due to interposition of a second antibody 
layer. Increasing the number of layers still further has been 
found to produce greater increases in sensitivity. More 
sensitive immunoperoxidase techniques were developed simultaneously 
by Mason (206) and Sternberger et al (207). 
The peroxidase anti -peroxidase (PAP) technique (see Figure 7 ) 
of Sternberger is now very widely used for localization of 
antigens particularly at the ultra -structural level, despite the 
complexities that a multi- layered technique introduces. A soluble 
complex of peroxidase and antibody to peroxidase, is employed as 
the third reagent; this PAP complex appears ultrastructurally as 
black flattened rings, pentagons or spots at the sites of localization 
of the tissue antigen. The technique is claimed to be 100 - 1000X 
more sensitive than the indirect fluorescent method at the light 
microscope level, very low dilutions of first antibody being required. 
The main advantage, however, is that it is not necessary to conjugate 
peroxidase to any of the specific antibodies, which may possibly 
disturb their specificity. This is probably another source of 
increased sensitivity of the PAP method, since in the indirect 
immunoperoxidase technique, some antibodies will remain unlabelled 
with peroxidase, and as these cannot be removed, they may compete 
with labelled antibodies on the tissue section, thus decreasing the 
sensitivity of the indirect method. 
It is of interest that some reports have claimed no increase or 
decrease in sensitivity of the PAP technique over the indirect 
technique. This may be due to inability of PAP molecules) because 
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Figure 7 The peroxidase anti- peroxidase. (PAP) immunohistochemical 
technique. 
Tissue antigen 
Rabbit antibody against 
tissue antigen 
Excess sheep anti -rabbit 
immunoglobulin 
Specific reaction product 
'fi -nualized using specific 
substrate 
Rabbit PEROXIDASE 
ANTI -PEROXIDASE (PAP) 
complex 
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of their size, to localize all the antigen at every site (203). 
The choice of enzyme marker is dependent to a large extent on 
its molecular size e.g. peroxidase is much smaller than the 
marker ferritin, improving its penetration into tissue sections 
for electron microscopy.Ibdification of antibody- enzyme conjugates has 
been made to reduce molecular size still further, by cleaving 
the antibody to obtain its smaller molecular weight antigen 
binding fragment prior to conjugation. 
Other methods have been used for the amplification of the 
sensitivity of the indirect technique. One technique for example, 
depends on the demonstration of complement bound by an antigen - 
antibody reaction using fluorescent anti -complement (194). The 
great advantage of this technique is that only a single fluorescent 
conjugate is required to demonstrate immune complexes of all types, 
provided that they bind complement. The method has not been used 
extensively, probably because the specificity is uncertain. A 
different amplification technique has been employed by Wachsmuth 
and Lachman (209) who prepared partially purified antigen -antibody 
complexes in antibody excess and used them to detect antigen in 
tissue sections - the complex was localized with labelled antibody. 
Having considered fluorescent and enzyme 'tags' in the search for 
more sensitive and specific histochPmical methods, the possibility 
of using radiolabelled antibodies should be considered. Tracing of 
radiolabelled substances is generally hampered by time -consuming 
autoradiographic techniques and poor resulting cytological 
localization, but a recently developed 'radioimmunocytochemical' 
technique shows that success can be achieved, for high sensitivity 
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localization of antigen in tissue sections (210). 
3.2. Immunohistochemistry - methodological considerations 
3.2.A. Tissue preparation: 
Light microscope immunhistochemistry is carried out on tissue 
sections from either frozen blocks as commonly employed, or 
freeze -dried paraffin or resin- embedded blocks. 'Snap- freezing' 
of small tissue blocks using isopentane pre -cooled with liquid 
nitrogen (temperature of isopentane whilst thawing, -160 °C.) is 
a rapid technique which minimizes the formation of intracellular 
ice crystals detrimental to good histology, and reduces diffusion 
of soluble substances (194). Direct freezing in liquid nitrogen 
cannot be used since gas bubbles rapidly surround and insulate 
the specimen. An alternative freezing method employs solid 
carbon dioxide and ethanol (- 76 °C), but this technique is neither 
as rapid nor as successful as isopentane - liquid nitrogen, particularly 
for brain tissue where the high lipid content reduces the rate of 
freezing. 
To permit access of antibody to intra- cellular antigen, cells are 
cut open by cutting sections from frozen or embedded blocks at 
approximately 4- 10rm.(For immunofluorescence of cell surface 
antigens which will not be discussed in detail, suspensions may 
be used for immunfluorescent staining). Frozen sections are cut 
in a cryostat at approximately -25 °C, optimal temperature being 
dependent on the tissue type and the required thickness of sections 
to be cut out. Whilst tissue fixation will often be required to 
fix soluble antigens and obtain good tissue morphology, it is 
essential that good tissue preservation is coupled with maintenance 
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of tissue antigenicity. There are only empirical fixation 
techniques for immunohistochemistry, certain tissue 
antigens being destroyed by the fixative or the fixation 
process (dehydration, clearing etc). Experimentation for each 
antigen in each tissue is therefore required. Immunohistochemistry 
is frequently carried out on unfixed sections which may be aided 
by the rapid freezing method, reported by Nairn (194) to involve 
less need for chemical fixatives. Particular care is required 
for low molecular weight antigens which may be lost in the tissue 
water when frozen sections thaw out, or during immunohistochemical 
processing. 
The accessibility of antigen to antibody may be improved by fixation 
and even detergents. Hartmann (211) has reported that brain sections 
lipid - extracted with chloroform- methanol, show increased sensitivity 
for dopamine hydroxylase localization,if low concentrations of 
Triton X -100, a non -ionic detergent, are added to reae,nts and washes. 
For ultrastructural localization of tissue antigens the problem of 
tissue fixation is considerably more complex since the choice of 
fixatives is more limited. 
3.2.B. Antibody characteristics 
Antibody activity is found in the ó - globulin fraction of serum. 
Five classes of antibody molecules are recognized in most species 
within this fraction: IgG, IgA, IgM,IgD, IgE. IgG is by far the 
most important antibody molecule and the s -globulin fraction is 
predominantly IgG. An antibody contains a het erogenous population 
of IgG molecules even when prepared to an antigen which is 100% 
pure, since most pure antigens contain multiple sites (determinants) 
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each one giving rise to a specific type of molecule (193). 
The amount of specific antibody in an antiserum is termed its 
titre. Affinity is the measure of the 'strength' of interaction 
between an antibody and antigen, whilst the term avidity takes 
into account the heterogeneity in affinity of antibody molecules 
and represents the net interaction between an antiserum and antigen. 
Antiserum specificity reflects the molecular 'fit' between antigen 
and antibody. These antiserum characteristics, titre, avidity and 
specificity, are affected by a number of immunization factors 
e.g. inter -species and inter -animal variations, quantity of immunogen 
for injection, time course between immunizations (see Chapterlll). 
It is generally accepted that antigens must be highly purified 
prior to immunization and that antiserum must be of high titre, 
and low cross -reactivity for successful immunohistochemistry (194, 203). 
Antibodies are therefore'screened' prior to use in immunohistochemistry. 
The choice of 'screening method' is dependent upon antibody. Optimal 
concentrations of multi -valent antigens mixed with bivalent 
antibodies in solution will combine to form three dimensional 
lattices which can aggregate and precipitate (193). An agar or 
agarose gel is commonly used to visualize these precipitates from 
small amounts of reagents placed in wells in the gel. The technique 
is known as immunodiffusion. Increased resolution of immunodiffusion 
may be made by applying a potential difference to separate antigen 
on the basis of charge; this technique is known as immunoelectrophoresis. 
Other effects e.g. agglutination and anaphylaxis which may occur 
after the primary reaction between ai ibody and antigen, may be used. 
A technique that will be discussed in some detail is radioimmunoassay 
(RIA) a highly sensitive technique which can be employed for 
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'screening' antibodies. The basis of RIA is a high specific 
activity radiolabelled antigen and a specific antibody. 
This technique is employed for antigen molecules which do not 
precipitate with their specific antibody. Small molecules: which 
may only prove antigenic as 'haptens' when coupled with high 
molecular weight 'carriers' will give rise to antibodies directed 
to themselves and to the carrier. If the antigen can be 
radiolabelled, the characteristics of the hapten antibody can 
be determined by RIA without interference from 'carrier' antibody 
molecules (212). 
Radio mm noassay was originally developed in 1960 by Yalow and 
Berson (213) for the measurement of peptide hormones; previous 
bio -assay methods had proved both inaccurate and insensitive. 
High specific activity radiolabelled antigen competes with 
unlabelled antigen for binding sites on specific antibody. Free 
and bound antigen may be separated by a variety of techniques 
e.g. paper electrophoresis, precipitation with a second antibody 
directed against the first antibody,precipitation with ammonium 
sulphate, or adsorption with talc or charcoal. 
The titre of a number of antisera may be easily compared by 
determining the antiserum dilution required to bind, for example, 
50% of labelled antigen. An antiserum of high titre will bind 
50% of labelled antigen in high dilution, in contrast to an 
antiserum of low titre. The sensitivity of different antisera 
for measuring unlabelled antigen may be compared giving an indication 
of the avidity of interaction between the antisera and antigen. This 
forms the basis of the RIA standard curve for measuring amounts 
-68- 
of substances with high sensitivity. Mathematical treatments of 
avidity will be considered in chapter III. 
The specificity of an antiserum may be studied by determining 
whether molecules related to the antigen are able to compete 
with and to displace radiolabelled antigen, when added to the assay. 
For example, an antibody with high specificity for the antigen 
will require large amounts of related molecules to reduce binding 
of radiolabelled antigen. An antiserum found to cross -react with 
a known substance may have the interfering antibodies removed by 
solid -phase absorption (214). 
The principles of this radioimmunological technique have been 
discussed in some detail to demonstrate how the characteristics 
of an antiserum may be examined prior to use in immunohistochemistry. 
3.2.C. Quantification 
Immunohistocr,.mistry has been discussed up to this point as a 
technique for studying the location of substances within tissues. 
A logical extension is the quantification or semi- quantification of 
specific staiiing. The technique might be able to localize changes 
with drugs, for example, of the specific fluorescence of a molecule, 
within a specific compartment of the cell, its intensity in other 
parts of the cell remaining unaltered. An important specificity 
control might correlate changes in the intensity of specific staining 
with biochemical tissue levels. It is important to note for 
immnnohistochemical localization of enzymes, that increased 
fluorescence represents increased numbers of molecules rather than 
increased activity of the enzymes. 
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At a semi-quantitative level, photography of tissue sections from 
'control' and 'stimulated' tissues with the same time exposure, 
have been used to detect differences in intensity,(e.g. 215). 
Optimizing the differences required appropriate diluting of the 
immunological reagents. At the quantitative level, care must be 
taken regarding variables such as section thickness and fading 
of immunofluorescence on exposure to ultra -violet light. Complex 
microspectrophotometric equipment has been used for quantification 
of immunofluorescence in tissue sections and recent work has used 
as a model, antigen covalently coupled to Sepharose beads for 
quantification (216). 
The high sensitivity of 'PAP' immunohistochemistry, often equivalent 
to or greater than RIA (217), raises the interesting possibility 
that antigen may be localized in tissue sections even when it 
cannot be measured. Immunohistochemistry can reveal a high 
concentration of antigen in a very ,all and restricted population 
of cells, amongst a vast majority which do not possess the material. 
It is equally possible that immunohistochemistry could detect a 
change in localization of antigen, without a change in total tissue 
levels. 
Immunohistochemistry has also proved to be useful in determining 
how an antigen is linked to its receptor site in the tissue. 
Sternberger (218) has shown that pre -treatment of pituitary tissue 
sections with LH -RH increases specific immune- staining for this 
peptide. In this instance, immunohistochemistry is localizing 
increased amounts of exogenous LH -RH binding to active receptor 
sites in the tissue. 
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3.3. Application of histochemical techniques to the study of 
cyclic nucleotide systems. 
The preceding sections of this introduction have demonstrated the 
importance, and the diversity of actions, of cyclic AMP and cyclic GMP 
in cell function. Whilst biochemical measurements give us precise 
information on the amount of cyclic nucleotides in a group of cells, 
they cannot tell us which cell types contain the nucleotides in a 
heterogenous tissue, and diffusion and degradation of cyclic nucleotides 
would also be expected to limit the value of sub- cellular studies. 
Micro- dissection, coupled with sensitive biochemical assay is a step 
closer if individual cell types can be dissected out, but the resolution 
of the technique is clearly limited, and information on localization 
in sites within cells cannot be obtained. An alternative -approach of 
cells in culture, may help us to localize the nucleotides to neurones, 
glia or vascular cell types, but extrapolation 'in vivo' must be 
treated with caution. 
Prior to the advent of cyclic nucleotide iunohistochemistry therefore, 
no information was available on the cell types in a tissue containing 
the nucleotides, or the distribution within these cells, factors 
essential to the understanding of cyclic AMP and cyclic GMP function. 
Indirect evidence for the localization of cyclic AMP and cyclic GMP 
has come from attempts to localize components of the 'enzyme machinery' 
by conventional histochemical techniques, as described in the 
following section. 
3.3.A. Conventional histochemical techniques. 
Adenylate cyclase was localized by Reik et al in liver in 1970 (219), 
and was followed by reports of localization of catecholamine- sensitive 
adenylate cyclase in isolated capillary endothelium and/ 
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pancreatic islets of Langerhans (220, 221). 
These histochpmical reactions used lead as a 'trapping' agent 
to visualize inorganic phosphate released from the cleavage of 
ATP by adenylate cyclase. A more specific substrate for adenylate 
cyclase has recently been used, which closely resembles ATP 
(5' - adenyl imidodiphosphate, AMP-PNP). Severe criticism was 
levelled at the use of lead in these reactions by Lemay and 
Jarrett (222) who showed that the concentrations of lead used 
could actually inhibit adenylate cyclase. The value of these 
reported localizations is clearly questionable therefore. Guanylate 
cyclase localization has also been similarly reported using 
G -PNP substrate (223, 224). Rechardt and Hörkönen_ (225) 
recently used cobalt as a 'trapping agent', and carefully controlled 
the histochemical reaction for localizing adenylate cyclase in 
C.N.S. tissue under the electron microscope. Reaction product 
was localized to the post -synaptic membrane; in the cerebral cortex, 
reaction product was localized in synapses using noradrenaline in 
the reaction medium, whilst in the striatum positive staining of 
synapses was observed with dopamine. Reaction product was also 
located in the plasma membrane of some nerve fibres, suggesting 
pre -synaptic as well as post -synaptic localization in the C.N.S. 
Alloxan, a specific inhibitor of adenylate cyclase, inhibited the 
reaction and haloperidol, a dopaminergic antagonist reduced, but did 
not eliminate specific staining in the striatum. These results 
clearly contrast with the astroglial and capillary distribution of 
adenylate cyclase found in the cerebral cortex by Joo et al 
using lead as the phosphate 'trapping' agent (226). 
A post -synaptic localization of cyclic nucleotide phosphodiesterase 
in rat cerebral cortex was reported by Florendo et al (227) using 
an electron microscopic histochemical technique in 1971. 5'AMP 
formed from the breakdown of cyclic AMP with phosphodiesterase, 
was converted to adenosine and inorganic phosphate using purified 
5' nucleotidase from snake venom; inorganic phosphate was trapped 
with lead. Lead was found to inactivate phosphodiesterase in 
homogenates, but was not found to inhibit phosphodiesterase after 
the gluteraldehyde fixation step used in the technique. However, 
a serious disadvantage of this technique was that gluteraldehyde 
fixation itself, was found to destroy approximately 3 of the 
phosphodiesterase activity as measured biochemically. An approach 
to the question of fixation artefact was made in a study which showed 
the histochemical localization of phosphodiesterase in mouse cerebral 
cortex during development. Similar post -synaptic localization was 
found in fixed and unfixed tissue, although tissue preservation in 
unfixed tissue was naturally poor. This study showed localization 
of reaction product at developing synapses during the first 
post -natal month (228). 
Recently, both cyclic AMP and cyclic GMP phosphodiesterase have 
been localized in rat brain, confirming post -synaptic localization (248). 
The technique was modified from the original procedure of Florendo 
et al in using crude snake venom rather than purified 51 nucleotidase. 
An interesting observation was that whilst cyclic GMT phosphodiesterase 
was clearly localized post -synaptically in cerebellum, cyclic AMP 
phosphodiesterase could not be histochemically detected in this 
brain area (229). Together with the possibility of phosphodiesterase 
loss from sections due to fixation and tissue buffer washing, a 
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further reservation concerns the high (3mM) substrate concentrations 
of the cyclic nucleotide required. The histochemical technique 
probably only localizes particulate, high Km phosphodiesterase. 
Another component of this cyclic nucleotide enzymatic machinery, 
phosphoprotein phosphatase, has been localized post -synaptically 
in rat cortex (229). 
Conventional enzyme histochemical techniques have been of some 
use therefore in localizing components of the cyclic nucleotide 
system. Their specificity due to lack of 100, specific substrates 
has caused complications, and prevented localization of enzymes 
such as the cyclic nucleotide -dependent protein kinases. The close 
similarity of cyclic AMP and cyclic GMP not only to each other but 
also to a large number of structurally related nucleotides, clearly 
prevented the localization of these small molecules by conventional 
histochemistry. 
3.3.B. Cyclic nucleotide immunohistochemistry 
In 1969, Steiner et al (230) developed specific and sensitive 
antisera to cyclic AMP, and subsequently cyclic GMP, for use in 
radiolmm»noassay (102, 103, 231). These antibodies allowed 
measurement of not only tissue levels of these nucleotides, but 
also, indirectly, measurement of adenylate cyclase and guanylate 
cyclase. To develop antibodies to these low molecular weight 
molecules, Steiner had postulated that in coupling them as 'haptens' 
to high molecular weight carriers in order to function as ;mmunogens, 
the 3'5'phosphodiesterase moiety, and the groups on the purine 
nucleus, would have to remain intact. Consequently, cyclic nucleotides 
were substituted with a succinyl group at the 2'0 position on the 
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ribose sugar, and conjugated to the 'carrier' at this position. 
The hapten- protein conjugates produced a reasonable titre of 
high specificity antibodies, when used to immunize rabbits and 
goats. Using antigen or succinylated antigen, radiolabelled with 
tritium or iodine, a radioimm nassay was developed enabling cyclic 
AMP Or cyclic GMP to be measured in the range of 10 -8M to 10 -9M 
in tissue extracts, without prior purification. Previous 
techniques for measuring cyclic nucleotides using biological and 
chemical methods required the separation of cyclic nucleotides 
from other tissue nucleotides (232). The number of steps involved 
in these procedures precluded rapid analysis of large numbers of 
tissue samples, and generally the amount of tissue required was 
rather large due to limited sensitivity. The low cross -reactivity 
of cyclic nucleotide antibodies to ATP was especially important 
since this nucleotide is found in very high concentrations in the 
cell (231). 
The development of a specific and sensitive radioimmunoassay to the 
cyclic nucleotides 'triggered' the expansion of the whole field of 
cyclic nucleotide research. Studies on cyclic GMP were perhaps most 
greatly affected, since the advent of RIA allowed measurement of 
the low tissue levels of this nucleotide simply and specifically. 
Recently5Cailla et aí(233, 234) have exploited the fact that the antisera 
have higher avidity for the succinyl cyclic nucleotide rather than 
the natural nucleotide, by developing a radioimmumassay for cyclic 
AMP and cyclic GMP that succinylates tissue samples prior to RIA. 
This modification results in assay sensitivity of the femtomolar 
level, 
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In 1972, following the development of these specific cyclic 
nucleotide antisera, three laboratories in the United States 
of America collaborated in the development of an 'indirect' 
immnnofluorescence technique, to specifically localize cyclic 
nucleotides within unfixed frozen tissue sections, containing 
heterogenous cell types (215). 
The first report (235) showed the specific localization of cyclic 
AMP in cryostat sections of rat salivary gland. In saline - 
injected control animals, positive staining was minimal, but in 
animals treated with isoproterenol, a drug known to increase 
levels of cyclic AMP in tissues, a marked increase in cyclic AMP 
fluorescence was seen in the basal portion of the acinar cells 
and the basket cells beneath them. The acinar cells are believed 
to be the target cells for adrenergic stimulation. This increase 
in fluorescence, shown to be specific for cyclic AMP, was not 
seen in other cell types. The following points summarize the :.:2ient 
features from this first paper employing cyclic nucleotide 
immunohistochemistry: 
i) Localization of cyclic AMP to specific cell types in a tissue, 
and to a particular location within the cells, using a rabbit 
antibody to detect cyclic AMP in a rat tissue. 
ii) Cyclic AMP must be 'bound' to receptor sites in some way and 
therefore localized; soluble or losely bound nucleotides would be 
washed away during the staining procedure. 
iii) Biochemical increases in tissue levels of cyclic AMP 
correlate with increased staining of 'bound' cyclic AMP at 
specific sites. 
The immunofluorescent localization of cyclic AMP in cerebellum 
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reputed by Bloom et al (236) shortly after this report will be 
considered in detail, as the first application of the technique 
to the C.N.S. The biochemical and electrophysiological evidence 
for an involvement of cyclic AMP in the cerebellum has already 
been discussed. 
Bloom et al localized this nucleotide to specific cell types 
in frozen sections taken from the rat cerebellum. When the 
cerebellum was frozen in isopentane pre- cooled with liquid 
nitrogen immediately after decapitation, positive staining was 
seen in the granule cell layer, the white matter, and 15 -20% 
of the Purkinje cells; minimal fluorescence was observed in the 
molecular layer. Outside the cerebellar cortex, positive 
staining was seen in certain neurones of the cerebellum and 
underlying brain stem. The specificity of the cyclic AMP 
immnnofluorescence was checked by the following criteria: 
i) No staining was observed with the iunoglobulin fraction of 
control serum from unimmunized rabbits. 
ii) Identical staining patterns were observed with antibodies from 
rabbits injected with hapten conjugated with either human serum 
albumin or keyhole -limpet hemocyanin carriers. This demonstrated 
that the specific staining pattern was not due to carrier antibody 
molecules, or cross -reacting protein antigens in the tissue. 
iii) Specific staining was removed by prior incubation of antibody 
with cyclic AMP, but not related nucleotides. 
When the time between decapitation and freezing was increased to 
-150 seconds, the number of Purkinje cells showing positive staining 
for cyclic AMP, rose to 80 -90%, correlating with the post -mortem 
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decapitation increase in cyclic AMP. There was no change in 
the other cell types which showed positive staining for cyclic 
AMP. 
In order to examine the neurotransmitter mechanism responsible 
for the increase in the number of Purkinje cells fluorescing, 
Siggins et al (237) applied solutions of neurotransmitters in 
Krebs- Ringer solution to the exposed surface of the cerebellar 
cortex. Immunofluorescence of sections from cerebella 
frozen after each treatment, were semi -quantified, by recording 
the number of Purkinje cells fluorescing in a number of folia 
in the cerebellar cortex, and calculating the mean percentage 
responding. Noradrenaline at 10 -5M caused 65% of Purkinje 
cells to fluoresce, in contrast to 15 -20% response using control 
Krebs- Ringer or any other of the putative neurotransmitters 
tested. 10 -3M Noradrenaline caused approximately 90% of Purkinje 
cells to respond. In additional experiments, Sigginst group 
showed that electrical stimulation of locus coereleus, which 
innervates Purkinje cells in the cerebellar cortex via a 
noradrenergic pathway, increased the percentage of Purkinje cells 
fluorescing from 15 -74 %. This increase was not observed with sham 
stimulation of normal rats or after catecholamine- containing nerves 
had been selectively destroyed by prior treatment with 6- hydroxydopamine. 
In all these studies, changes in fluorescence were only observed in 
Purkinje cells and not in any of the other cell types showing 
cylic AMP fluorescence under basal conditions. 
These ;mmvnofluorescence studies support the biochemical and 
electrophysiological studies suggesting that post -synaptic cyclic 
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AMP mediates noradrenergic transmission in the locus 
coereleus- Purkinje cell pathway. Three interesting points 
are raised by the immnnofluorescent data: 
i) What is the function of cyclic AMP found in the cell types, 
besides Purkinje cells, which did not respond to stimulation? 
ii) Glial cells did not show positive staining for cyclic AMP 
in cerebellum, whilst tissue culture suggests both a neuronal 
and a glial pool for cyclic AMP (see section 1.4.). 
iii) The immunofluorescert distribution of cyclic AMP is at 
variance with the distribution obtained by Rubin and 
Ferrendelli (169, 238 ), employing micro- dissection coupled with 
radioimmnoassay. These workers show that in freeze -dried 
cerebellar folia of mice, 43% of cyclic AMP is found in the 
molecular layer, 45% in the granular layer and 12% in the white 
matter. Cyclic AMP immunofluorescence shows very little staining 
in the molecular or white matter, the majority occuring in the 
granular layer and Purkinje cell bodies. 
It seems apparent, therefore, that immunofluorescence may not 
localize all the cyclic AMP. Perhaps the fixation techniques are 
not adequate for preventing losses of cyclic AMP from the tissue 
sections during processing, or immunofluorescence is not sensitive 
enough to localize total cyclic AMP. 
Immunofluorescent studies of cyclic nucleotides in cerebellum were 
limited to cyclic AMP, but indications that cyclic cP might also 
be studied in the C.N.S, came from the work of Kebabian et al (239), 
who demonstrated that specific neurotransmitters elevate cyclic 
AMP and cyclic GMP is a. peripheral nervous tissue, as demonstrated 
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by ,mnrrunofluorescence. Using incubated slices of bovine superior 
cervical ganglion, from which frozen sections were subsequently 
cut and processed for cyclic nucleotide immunohistochemistry, 
dopamine increased cyclic AMP fluorescence predominantly in 
post -ganglionic neurones; no change in cyclic GMP fluorescence 
was observed. Acetyl choline was found to increase cyclic GMP 
fluorescence in axons and cell bodies of the post -ganglionic 
neurones, without affecting cyclic AMP fluorescence. The changes 
in cyclic nucleotide immu ofluorescence with either acetyl choline 
or dopamine, in the presence of a phosphodiesterase inhibitor, 
correlated with increased tissue levels of the respective nucleotide, 
as measured by radioimmunoassay. In this study immu ofluorescence 
demonstrated that specific increases in either cyclic AMP or cyclic 
GMP could occur in the same cell type, depending upon the 
neurotransmitter used for stimulation. Cyclic AMP /cyclic GMP 
changes at the same site clearly supported as 'Yin -Yang' control 
mechanism, possibly mediating post -synaptic potentials. 
These examples cited, together with others which will be discussed 
in the text, show the successful use of cyclic nucleotide 
immunohistochemistry in localizing, and semi- quantifying, changes 
in cyclic nucleotides to specific cell types and loci within cells, 
amongst tissues with heterogenous cell types. Cyclic AMP is 
generally found cytoplasmically, but plasma membrane and nuclear 
membrane staining is found - in some tissues there is intranuclear 
fluorescence. Cyclic GMP is generally found in plasma membrane 
or nuclear elements, but cytoplasmic staining is also seen in 
certain cells (215). 
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It is perhaps remarkable that the technique is indeed successful. 
Cyclic nucleotides might be expected to be lost completely during 
buffer washes in the tissue processing,preventing any localization 
at all. Since cyclic nucleotides are localized, we are probably 
visualizing cyclic nucleotides at their site of action - bound 
to tissue receptors. The increases in fluorescence that have been 
observed in a number of tissues after different treatments, might 
suggest that a 'bonus' of the technique is that it is localizing 
'physiologically important' nucleotides. 
Cyclic nucleotide mm nohistochemistry has also yielded information 
on the way in which cyclic AMP and cyclic GMP are bound to tissue 
sections (215). Cyclic GMP immnnofluorescence in rat liver is 
substantially reduced at certain intracellular sites by exposure 
of tissue sections to 10-4M EGTA or EDTA in buffer for 30 minutes 
at 37 °C, prior to application of specific antibody. Staining of 
the nuclear membrane is not reduced, but fluorescence is lost in 
intranuclear elements and is reduced on the plasma membrane. This 
effect is blocked by addition of equi -molar concentrations of 
calcium chloride, whereas calcium chloride alone increases 
fluorescence at these sites. In sections from rat renal cortex 
from animals pre -treated with paratlyroid hormone, a similar effect 
has been observed. In sections from saline- injected rats, this was 
not found (240). 
These observations give us information on the importance of calcium 
ions for linking cyclic GMP at certain sites in the tissue. Whilst 
EGTA, EDTA and calcium chloride have no effect on cyclic AMP 
immunofluorescence in rat liver, cyclic AMP staining is markedly 
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diminished by exposure of the tissue to phosphate -buffered saline 
for 30 minutes at 37 °C (215). This effect is prevented by reducing 
the sodium chloride concentrations of the buffer from 0.15 to 
0.015M, or by adding Mg - ATP. These observations may be of 
interest in the binding of cyclic AMP to receptor proteins, 
since Corbin et al (241, 242) have shown that the activity of 
one form of cyclic AMP- dependent protein kinase is activated in 
a number of tissues by the high concentration of sodium chloride 
used in these experiments; additionally, the effect of saline on 
the kinase 'in vitro' is reduced by Mg -ATP. 
A further point of interest regarding the binding of cyclic 
nucleotides to receptor sites in tissues, comes from the 
observations of Steiner et al (215) that in liver,different 
antibodies to cyclic GMP, although highly specific by RIA, may 
show slightly different abilities to localize different positive 
staining structures in tissues. This may be due to the heterogenous 
antibody population recognizing different structures with different 
avidity, perhaps due to stereospecific differences between the 
binding of cyclic GMP at different sites. Photo- affinity labels 
for cyclic GMP /cyclic AMP kinase should also be of use histologically 
for localizing receptor sites (243, 244). 
Summarizing, cyclic nucleotide immunohistochemistry has yielded 
information not only on the distribution of cyclic nucleotides, but 
also on some of their characteristics to specific receptor sites. 
Whilst semi- quantitive increases in cyclic nucleotide 
immunofluorescence often correlate well with increases in tissue 
levels measured biochemically, there are a number of examples where 
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fluorescence intensity and distribution may vary, without net 
change in tissue levels, e.g. changes in distribution of cyclic 
GMP immunofluorescence during the course of liver regeneration, 
with no change in tissue levels of cyclic GMP (245). An added 
advantage of this technique, therefore, may be in detecting 
translocation of cyclic nucleotides and increases in bound:free 
nucleotide, sufficient to elicit a physiological response, without 
change in tissue levels of the cyclic nucleotide(246). A logical 
extension of the technique pioneered by Steiner et al, is its 
application for ultrastructural localization of cyclic AMP and 
cyclic GMP. This is currently being attempted by Steiner's group 
using 'PAP' techniques, and should prove to be a great use for understanding 
cyclic nucleotide function at different sites in the cell. 
The most recent advance in cyclic nucleotide immunohistochemistry, 
however, has been the development of antisera to the receptor and 
ca'lytic sub -units of cyclic AMP and cyclic GMP- dependent protein 
kinases. These antisera are currently being used by Steiner's group 
for immunofluorescent localization in various tissues (247). In 
regenerating rat liver for example, trap ocation of cyclic AMP 
receptor sub -units from cytoplasm to nucleus has been detected, 
confirming biochemical data. Bloom et al (34) have very recently 
used antisera to the synaptic phosphorylated protein, protein I, 
to show a neuronal distribution using immunohistochemistry. 
Clearly the use of immunohistochemistry for studying cyclic nucleotide 
systems, and interaction with other systems (e.g. using antisera 
to calcium- dependent regulating protein, CDR) is essential for 
understanding the roles of cyclic AMP and cyclic GMP as cellular 
regulators. 
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In the following chapters, experiments will be described which have 
attempted to confirm and extend the immunofluorescent localization 
of cyclic AMP in the C.N.S, and to develop a similar technique to 
localize cyclic GMP under a variety of 'in vivo' and 'in vitro' 
experimental conditions. Preliminary studies with antibodies to 
the cyclic nucleotide receptor proteins will be described in the 
final chapters,to demonstrate the potential of this approach for 
studying cyclic nucleotide systems in the C.N.S. 
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CHAPTER II 
IMMONOFLUORESCENCE METHODOLOGY AND NON- SPECIFICITY STUDIES 
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1. IlKMUNOFLUORESCENCE METHODOLOGY. 
The indirect immunofluorescence technique adopted by Wedner 
et al (235) for cyclic nucleotide immunohistochemistry was 
employed, with certain modifications, throughout these studies. 
1.1. Tissue preparation 
Rat cerebellum was used in all experiments unless stated otherwise. 
Male, adult, albino Wistar rats weighing approximately 200g were 
obtained from the Bush Estate Animal Breeding Station, Penicuik, 
Scotland. Rats were housed not more than four to a cage, with food 
pellets and water available (ad libitum) and under normal lighting 
conditions, in the Pharmacology Animal House, University of Edinburgh. 
On transfer to the laboratory a period of at least 15 minutes was 
allowed prior to sacrifice, to enable the rats to settle down. 
Animals were killed by being stunned with a sharp blow, followed by 
decapitation with shears. The. top of the skull and surrounding areas of bone 
were carefully removed to expose the cerebellum. This was then 
removed together with part of the underlying brain stem, and placed 
on a metal frame support which was plunged into a freezing mixture of 
isopentane (2- methyl butane) pre- cooled with liquid nitrogen (194) 
The time between decapitation and freezing was 2 minutes unless stated 
otherwise. For preparation of the freezing mixture approximately 
200 ml of isopentane were placed in a Pyrex glass U -tube clamped and 
suspended in a Dewar flask (British Oxygen Co.) containing the 
liquid nitrogen. The tube was suspended until the contents formed a 
white crust at the bottom. At this time the tube was removed from the 
liquid nitrogen allowing the crust to thaw, and the metal tissue holder 
was immersed. After freezing for 1 minute, the holder was removed 
and the tissue rapidly transferred to a cryostat (Linde, West Germany) 
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situated close by, having an interior temperature of -25 °C; the 
tissue was allowed to equilibrate inside the cryostat for at least 
30 minutes. After this period of time, the tissue was fixed onto 
a small cork mat with a drop of water, and allowed to freeze inside 
the cryostat. The mat,with the attached tissue, was then affixed 
to a cryostat chuck in a similar manner. The chuck was subsequently 
assembled in the cryostat and 6-10/"'m coronal frozen sections were 
cut. 
A number of factors determined the 'quality'of the tissue sections 
e.g. i) the position of the P.T.F.E. coated glass slide,which 
rested against the blade to prevent sections 'curling' during 
cutting ii) the angle which the cryostat knife was mounted at. 
The most important factor, however, was that the knife was very sharp 
and free from 'burrs' or scratches. A paint brush was used to 
remove damaged sections adhering to the knife during cutting. 
Selected sections were removed by positioning a gelatin /chrome -alum 
coated glass slide (see appendix 1) over the section; the temperature 
differential between the 'warm' slide (at room temperature) and 'cold' 
blade, caused the section to attach, and with experience,sections free 
from wrinkles could be obtained. 'Coating' prevented sections being 
lost from the slides during the tissue processing for immunofluorescence. 
Tissue sections were allowed to dry at róom temperature for 
approximately 30 minutes, prior to processing for immmmnofluoresc.ence. 
After cutting, tissue blocks were either discarded or could be stored 
over ice in a small beaker sealed with 'cling -film' (C.E. Payne & Sons 
Ltd) in the cryostat, to prevent freeze -drying. 
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Note: For experiments referred to in Dr Steiner's laboratory in 
the University of North Carolina, male,adult Sprague -Dawley rats 
of approximately 200g (Charles River, U.S.A.) were employed, and 
sections were cut on a Damon MC cry ostat at 41"-m. 
1.2. Immunofluorescence staining. 
Experiments were performed on unfixed frozen tissue sections unless 
stated otherwise. Phosphate- buffered saline (PBS, see appendix 2) 
was used for all antibody dilutions and buffer washes. 
Tissue sections were incubated for 30 minutes or overnight (15 hours) 
where stated, with 10 -20/1 of diluted rabbit antibody (;mmunoglobulin 
fraction), which had been centrifuged for 3 minutes at 13,000g (Eppendörf 
centrifuge) to remove aggregates. Incubations were performed in glass 
Petri dishes (4" diameter) containing damp filter paper circles, to 
act as humid containers,preventing evaporation of antibody solutions. 
The dishes were rested on a flat surface and left undisturbed at 
room temperature for the duration of the incubation period. On 
completion of incubation, slides were carefully removed and blotted 
dry with paper tissues around the sections. A glass Pasteur pipette 
was used to carefully wash the antibody solutions away from the tissue 
sections with buffer. The slides were then placed in a stainless 
steel rack and completely immersed in a glass staining trough 
containing approximately 400m1 of buffer. A maximum of 6 slides with 
4 sections on each were processed in each experiment, sections 
being positioned such that adjacent antibody solutions would not 
'runt and contaminate each other during the incubation. It was very 
important to ensure that the tissue sections were not allowed to dry - 
out at any stage during processing, since this resulted in fluorescent 
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artefacts due to concentration of buffer salts on the tissue. The 
staining rack was gently agitated during the buffer washes, and after 
3 minutes was transferred to a similar staining trough containing 
fresh buffer; the slides received a total of 3 x 3 minute washes. 
Sections were then incubated at room temperature for a further 30 
minute period with a 1:10 dilution of FITC swine anti -rabbit serum 
IgG (Dakopatts, Denmark. Supplied by Marcia Diagnostics, Watford, 
England)c.entrifuged prior to use as described previously. The 
fluorescent 'second antibody' was used to detect sites of 
IgG binding by the 'first' rabbit antibody. The buffer washings 
were repeated as before. On completion, slides were removed, blotted 
dry around the sections and covered with a drop of mountant, 50% 
glycerol in PBS, followed by careful positioning of a clean glass 
cover slip (Chance- Proper Ltd, England). Excess mountant was 
removed,and slides were viewed under ultra- violet light using a 
Carl Zeiss 'large fluorescent microscope' with type III FL vertical 
illuminator, which incorporated transmitted and reflected light 
(Episcopic) illumination systems. For low magnification microscopy 
using transmitted light, a x10 FL- NEOFLUAR objective of numerical 
aperture (N.A.) 0.3 was used, whilst for higher magnification a x40 
Ph2 FL- NEOFLUAR objective of N.A. 0.75 was employed,with reflected 
light illumination. Additional microscope magnification was provided 
using a x8 ocular and x1.25 Zeiss Optovar. Illumination was provided 
by means of an HBO 200 'super pressure' mercury lamp (Osram, Germany). 
The filter system employed BG3 primary and 50 Schott secondary filters 
together with FL-500 reflector. A sub -stage condensor of N.A. 1.4 
yielded a dark background for transmitted light fluorescence microscopy. 
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The power source was switched on approximately 30 minutes prior to 
use, to stabilize fluorescence intensity. During observation it 
was important to minimize 'fading' of the fluorochrome,by preventing 
exposure of one area of fluorescence on the tissue for an extended 
period of time. 
An adjustable 'beam splitter' on the microscope enabled 100% of 
visible light to reach the ocular during observation, and 100% of 
light to reach an Olympus 0M -1 35mm camera for immunofluorescence 
photomicrography. Sections were photographed using 1 minute exposure 
time on Ilford EP5 high -speed black and white film (A.S.A 400). 
Exposed films were developed with Ilford Microphen developer according 
to the manufacturers instructions. Negatives were enlarged and printed 
on Ilford Ilfospeed grade 5 high- contrast photographic paper. Sections 
were usually photographed directly after imm»nofluorescent processing, 
but slides could be stored at 4 °C in a 'light- tight' box for 2 - 3 
days without causing significant fluorescence fading. 
Also mounted in the microscope was a 120W white light source enabling 
sections stained by conventional toluidine blue histology to be 
photographed; exposure times were selected between 1/15 and 1/60 second. 
For calibration of photomicrographs, a graticule engraved at 10t6 m 
intervals on a microscope slide was photographed using the different 
objectives, and the negatives were printed identically to those of 
the experimental sections. 
Note: For experiments referred to in Dr Steiner's laboratory there 
were two modifications to the previously described methodology: 
i) the fluorescent antibody employed was supplied by Miles Laboratories) 
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Indiana, U.S.A.: -FITC goat anti- rabbit serum IgG, code number 65 -173, 
which was employed at a 1:50 dilution. ii) A Leitz Orthoplan 
fluorescent microscope with 480 -510J m filters and x10, x40 and x63 (OIL) 
fluorescent objectives was used,coupled with a Leitz Orthomat 
automatic camera containing Kodak Tri -X black and white film (A.S.A. 400). 
1.3. Preliminary attempts to localize cyclic AMP in rat cerebellum 
The neuronal components and histological structure of the mammalian 
cerebellum by toluidine blue staining (see appendix 4),are shown 
in figures 8 and 9. 
Preliminary experiments on cyclic nucleotide immunofluorescence 
were carried out using the immunoglobulin fraction of a number of 
rabbit antibódies to cyclic AMP and cyclic GMP prepared in the 
M.R.C. Brain Metabolism Unit by Mr T Attree prior to the start of 
my work. Surprisingly, similar staining patterns were found not only 
between the cyclic nucleotide antibodies, but also with rabbit non- 
immune imm noglobulins. The staining in the granule and Purkinje 
cell body layers of the cerebellar cortex was very similar to that 
reported for the specific localization of cyclic AMP in rat cerebellum 
(236, 237), and raised considerable doubts as to the specificity of 
the technique. 
The following section considers the possible causes of the non -specific 
immunofluorescence which was encountered. 
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Figure 8 Neuronal components of adult mammalian cerebellum 
Redrawn from (249) 
Cell layers are shown on the right side of the diagram: 
Mol - Molecular layer 
P - Purkinje cell body layer 
Gr - Granule layer 
(White matter lies below the granule layer) 
Inputs: Mossy fibre (MF) and climbing fibre (CF) 
Principal neurone: Purkinje cell (P) 
Intrinsic neurones: Granule cell (Gr), stellate cell (S), 
basket cell (B) and Golgi cell (Go) 
Parallel fibre (pf) 
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Figure 9 Histological cell layers of adult rat cerebellum stained 
using toluidine blue. 
a) Low magnification. Calibration bar = 5OO m 
b) High magnification. Calibration bar = 100 f'm 
g/G - granule layer 
P - Purkinje cell body layer 
M - Molecular layer 
W - White matter 
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2. NON- SPECIFIC ThIMUNOFLUORESCENCE 
By definition, non -specific ;mmunofluorescence is that which is 
not due to the specific interaction between antibody and antigen 
under investigation. The diagram below shows the possible causes 
of non -specific fluorescence in the 'indirecte technique, when non- 
immune serum/immunoglobulin is employed as the first layer. 
Non -specific fluorescence 
Tissue autofluorescence Fluorescent 




reacting non -specifically with 
tissue 
a) Immunological non- 
specificity contaminating antibodies 
b) Non-immunological 
non -specificity - charge reaction between I'G 
and tissue 
To determine which form of non -specificity was responsible for the 
staining observed in cerebellar sections, buffer was applied instead 
of non -immune immunoglobulin as the first Tlayer', followed by 
fluorescent conjugate. The absence of fluorescent staining indicated 
that the binding of the conjugate was not the cause of the non- 
specificity. Occasionally, however, small yellow -red autofluorescent 
granules were observed in the cytoplasm of Purkinje and other large 
cells, probably representing lipofuchsin, although the colour of fluorescence 
could be clearly distinguished from the apple -green FITC 
fluorescence. Non -specificity in cerebellar sections with non -immune 
immunoglobulin, however, was most clearly observed as staining of the 
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granule and Purkinje cell body layers, but was also found in the 
walls of large blood vessels, scattered throughout the white matter, 
and at the apex of ependymal cells of the choroid plexus and lining 
the ventricles.(for example, see figures 10 and 37). 
2.1. Immunological non -specificity 
Non -specificity due to the unlabelled immunoglobulin fraction of 
the first layer in the indirect technique, can result from circulating 
antibodies in normal animal serum against tissue components (194, 250). 
Naturally occurring circulating auto -antibodies may also be found 
in diseased states (194) e.g. anti -heart antibodies in human sera 
from patients with ischaemia, and human smooth muscle auto -antibodies 
in hepatitis. 
2.2. Non -immunological non -specificity 
Whilst a large amount of data exists on protein -protein reactions 
between fluorescent conjugates and tissues in direct immunofluorescence 
e.g. (251, 252, 253) few reports have studied non -specific reactions 
due to unlabelled antibody and tissue (254, 255). This may be because 
non- specific reactions only occur with high concentrations of primary 
antiserum and not with specific antiserum of high titre in the indirect 
technique (256), allowing dilution to remove non -specific staining, 
whilst retaining specific immunofluorescence. 
A number of attempts to increase immunofluorescence staining intensity 
in the indirect technique by producing a concentrated immunoglobulin 
fraction of the unlabelled antiserum, have indicated that non -specific 
reactions are associated with this antibody fraction (255). In brain, 
for example, Hartman (257) has found that the use of IgG rather than 
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whole serum significantly increases non -specific background staining. 
In 1964 Allerand and Yahr (258) demonstrated binding of the IgG 
fraction of normal human sera on ethanol -fixed cryostat sections of 
normal human and monkey nervous tissue, using indirect immunofluorescence. 
The reaction, which was not dependent upon complement, was not seen 
with other serum fractions, indicating a degree of specificity for the 
IgG binding. 
IgG contains a heterogeneous population of molecules with respect to 
charge, as observed by the range of electrophoretic mobility of IgG 
(193). The different charges on the different molecules are indicative 
of variations in amino acid structure (259). At neutral pH however, 
IgG has a net negative charge. 
Fractionation employing carboxymethyl- cellulose has been used to 
separate IgG into 'fastX and 'slow' fractions with respect to 
mobility (260); X1is resistant to papain cleavage (see page 104) 
whilst L. is sensitive. A non -specific reaction of the fraction 
of human IgG with erythrocytes has been reported (261). The charge 
heterogeneity of IgG might suggest that one electrophoretic component 
could be responsible for non -specific binding of IgG in cerebellar 
tissue sections. 
Immunofluorescent studies on skeletal muscle, to determine whether 
sera from myasthenia gravis patients have a muscle auto -antibody (262), 
showed non -specific reactions due to IgG in normal sera with similar 
staining patterns in normal and myasthenic sera. Aarli et al (263, 264) 
were able to show by Lcpetitive tissue absorptions that the non- 
specific reactions were not due to a small part of the serum IgG 
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e.g.L or L, but that most of the IgG had the capacity to bind 
to muscle tissue non -specifically. Similar results were found with 
not only human IgG but also rabbit IgG, suggesting that the non- 
specific reactions with muscle tissue were a general feature of IgG 
molecules. 
2.2.A Experiments to determine whether non -specificity was 
mediated by IgG. 
Experiments were performed using frozen sections of rat cerebellum. 
i) Immunoglobulin fractions obtained from non -immune sera from a 
number of rabbits showed identical staining patterns at concentrations 
of approximately 1mg protein /ml, the intensity of non- specific 
staining increasing with immunoglobulin concentration. 
ii) The non- specific binding of immunoglobulin was not dependent 
upon complement since no effect was found by heating rabbit 
immunoglobulin to 65 °C for 30 minutes. 
iii) A generalized form of protein -binding to the tissue section 
could not account for staining non -specificity since substitution 
of 10mg /ml of crystallized rabbit albumin (Sigma Chemical Co, 
Norbiton, Surrey) and a 1:10 dilution of FITC goat anti- rabbit 
albumin (Nordic Immunologicals, Maidenhead, Berkshire) as immnno- 
histochemical reagents,failed to show non -specific immunofluorescence. 
iv) Purified rabbit IgG (Pentex, Miles Laboratories, Slough, 
Buckinghamshire, Code No. 64 -147, Lot No. 47) showed clear non- 
specific staining at concentrations of approximately 0.5mg /m1, the 
intensity of non -specific staining increasing with IgG concentration. 
v) To determine whether the binding of IgG to C.N.S...tissue was 
species- specific, cerebellar sections from either rats or mice 
(CH ' strain) were stained with rabbit IgG as above, or human IgG 
(Scottish National Blood Transfusion Service) using an FITC swine 
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Figure 10 Non- specific immnnofluorescence of unfixed rat 
cerebellar sections with non -ivre rabbit and 
human imm noglobulin and IgG. 
a) Normal rabbit immunoglobulin. Calibration bar = 100ím 
b) Normal rabbit immunoglobulin. High magn. Calibration bar = 50 f m 
c) Normal rabbit IgG. Calibration bar = 100rm 
d) Normal human IgG. Calibration bar = 100J m 
g - granule layer 
P - Purkinje cell body 
m - molecular layer 
w - white matter 
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Figure 10 (Continued) 
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anti -human serum IgG conjugate (Nordic Immunologicals); similar 
results were obtained in all cases. 
2.2.B. Experiments to determine whether a component of IgG 
responsible for non -specificity could be separated 
by ion -exchange chromatography. 
Fractionation of rabbit IgG on DEAE -cellulose ion -exchange gel..__ 
Diethylaminoethyl (DEAE)- cellulose (medium mesh, Sigma Chemical 
Co) was swollen and washed with distilled water in a beaker to remove 
'fines', followed by extensive washing with 0.01M sodium -potassium 
phosphate buffer, pH7.4. A Pyrex 35x1cm2 glass column was then filled 
with gel to a height of approximately 25cm, and run through several 
times with buffer from a reservoir, ensuring that the gel was packed 
well. The flow rate of the eluate was controlled by means of a clip 
on the plastic outlet tube. 2m1 of buffer containing 30mg of 
immuir-electrophoretically pure rabbit IgG (Pentex, Miles Laboratories, 
Code No. 64 -147, Lot No. 47) were then carefully layered onto the top 
of the column with a Pasteur pipette, and the buffer was passed 
through, ensuring that the level did not fall below the top of the gel. 
The optical density of the column eluate was recorded continuously 
at 280nm using an ultra- violet spectrophotometer coupled to a pen - 
recorder (LIB, Sweden) in order to monitor protein elution (see 
figure 11). Samples were collected using a fraction collector 
(LEB, Sweden) with pre -set tube change at 20 drops (approximately 
1.5m1),peak I being collected between fractions 16 and 25. After baseline 
optical density level had been re- established, the molarity of the 
column buffer was changed to 0.3M sodium -potassium phosphate, pH 7.4. 
A broad peak was eluted from fraction 44 and was collected (peak II), 
its shape suggesting that it might be further resolved using a 
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Figure 11 Fractionation of rabbit IgG by DEAE-cellulose 













continuous gradient elution system (265). The eluted fractions, peaks 
I and II, were extensively dialyzed at 4 °C against 5 litres of distilled 
water (see page121) over an 18 hour period. The fractions were froze_ 
at -25 °C and freeze -dried (see also page 121). 
To determine whether non -specific staining resided in peak I or peak 
II eluates,immunofluorescence was performed under identical conditions 
with 5mg protein /ml of each peak eluate. Strong staining was observed 
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with the peak I fraction, whilst peak II eluate staining was very 
weak (see figure 12). 
Since peak I eluate contains a relatively homogeneous population of 
IgG molecules with respect to charge, whilst peak II eluted with 
high molarity buffer contains a more highly electronegative pópulation 
(265), the results suggest that non -specific immunofluorescence in 
cerebellar tissue sections is a general feature of electrophoretically 
homogeneous IgG, rather than associated with a highly negatively 
charged pool which could be separated using this technique. 
The first attempts to investigate the structure of IgG were made by 
Porter (266) who demonstrated cleavage of rabbit IgG using the 
proteolytic enzyme papain, and subsequent separation of the resulting 
fragments on carboxymethyl- cellulose ion -exchange chromatography. 
One of the fragments could be crystallized (subsequently called Fc, 
fragment crystallizable), whilst the other two fragments were 
identical, and unlike Fc were able to bind antigen (FAB, fragment 
antigen binding). Subsequent work by Nisonoff et al (267) showed 
that the enzyme pepsin, could cleave IgG to form an (FAB)2 complex 
and further work by Porter and Edelman using reduction and alkylation, 
isolated the constituent 'heavy' and 'light' chains of IgG (268). 
Porter's model of IgG (see figure 13) has been confirmed using electron 
microscopy of antigen -linked IgG molecules, which clearly show a 
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Figure 13 Porter's model of IgG showing sites of 
cleavage by pepsin and papain. 
The FAB portion of IgG, responsible for antigen binding, exhibits 
specificity of immune reaction due to the linear and three -dimensional 
structure of amino acid sequences at the ends of the heavy and light 
chain regions of the FAB molecule. In contrast, the Fc portion of the 
molecule has been shown to be involved in the 'biological' properties 
of IgG e.g. binding to macrophages and mast cells,and regulation of 
the placental transfer of IgG (193). Some of these biological 
effects e.g. complement fixation, are only expressed after the 
antibody has bound antigen. 
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Knapp and Pateisky (262), in their immunofluorescent study on sera 
from myasthenic patients,separated (FAB)2 fragments from normal 
human sera and showed that these did not stain muscle tissue sections, 
but that fragments prepared from patient's sera showed specific, 
positive staining. These results indicated that myasthenic patients 
might have an auto -antibody against muscle, but more importantly in 
terms of specificity, that IgG binding of normal sera was not due to 
binding of the NB)2 fragment. Aarli et al (263, 264) subsequently 
showed that the non -specific interaction of human and rabbit IgG 
with muscle tissue was due to the binding of the Fc fragment of IgG. 
Extending the study on muscle tissue to evaluate auto -immune diseases 
of the nervous system, _Aarli et al (269) demonstrated that normal 
human IgG binds to myelin she glia and neurones of the C.N.S. 
Immunofluorescence and tissue absorption studies demonstrated that the 
non -specific binding was due to interaction of the Fc region of IgG 
with C.N.S. tissue. Their results demonstrated that the method of 
tissue fixation influenced the staining pattern,and that maximal non- 
specific fluorescence was obtained after lipid extraction of the 
tissue sections with chloroform -methanol (2 :1). The'patchy'staining 
observed with unfixed tissue was interpreted as being due to the high 
lipid content of tissue sections from the C.N.S. The need for 
fixation to remove lipid, interfering with specific immunofluorescence 
in C.N.S. tissue sections,has been commented upon (270). 
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2.2.C. Experiments to examine the effect of lipid extraction 
of rat cerebellar tissue sections on non -specific 
i Tmmunofluorescence. 
6f m frozen sections of rat cerebellum were immersed in ice -cold 
chloroform -methanol (2 :1) for 30 minutes, followed by washing of 
the sections for 3 x 3 minutes in phosphate -buffered saline. 
Sections were then processed for imrmunofluorescence. Lipid 
extraction was found to eliminate the diffuse staining as observed 
in unfixed sections, whilst intensifying non -specific staining in 
other structures (see figures 10 and :14). 
The Fc interaction with C.N.S. tissue sections reported by Aarli et 
al (269) was shown to be due to binding of the fragment with small 
tissue protein molecules of high basic charge. Less intense non- 
specific reactions were also observed in other tissues e.g. liver and 
kidney. Fc interaction has also been suggested as the reason for 
frequent non -specific staining of collagen due to binding of IgG to 
basic groups on the fibres (271). 
In sections of rat cerebellum processed for immnnofluorescence with 
Fc fragment from human non -immune IgG, Aavli et al (269) reported 
that staining of the granule layer was the most prominent feature, 
with Purkinje cells also being stained. These observations with Fc 
binding are clearly comparable with my observations using rabbit and 
human IgG. 
It is important to point out that thetbiologicalteffects of IgG 
mentioned previously, may be mediated via binding to specific Fc 
receptors e.g. in lymphoreticular tissue sections (272). These Fc 
receptors are assumed to be distinct from the binding sites 
contributing to non -specific immtnofluorescent staining, since 
Figure 14 
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Non -specific immunofluorescence of lipid -extracted 
rat cerebellar tissue sections with rabbit IgG. 
a) Low magnification. Calibration bar 
b) High magnification. Calibration bar 
c) Toluidine blue histological staining 
High magnification. Calibration bar 
granule layer 
molecular layer 
Purkinje cell body 
100rß m 
50rm 
for comparison with b) 
= 50 t'm 
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antigen- antibody complexes are required for Fc receptor binding, 
the antibodies often showing sub -class specificity (273). 
Whilst non -specific staining due to the first antibody is rarely 
considered in standard texts, it is clear that many workers have 
experienced similar problems often vaguely described as resulting 
from 'protein -protein' interactions or contaminating antibodies, 
which are due to Fc reactions. An example is cited from a review 
of immunocytochemistry of GABA -ergic systems in the brain by 
Roberts (274): 
"the blank reaction observed in control sections treated 
with non-immune serum must be reduced to an absolute minimum. Too 
early compromises with a high blank and the resultant attempts to 
interpret shades of differences between similarly stained sections 
can be disastrous." 
If non -specific staining is clearly distinct in distribution from 
specific staining, separation may be a simple task- This point is 
stressed by Pearse (275) who states that if the specific distribution 
of a molecule e.g. using another technique, is known in advance, 
immunofluorescence can give precise and accurate results. In these 
studies reported here, however, non- specific staining patterns in 
cerebellum were similar to those reported for specific localization of 
cyclic AMP; difficulties in interpreting specific and non -specific 
staining using liver antigens has also been reported (255). 
2.2.D. Attempts to remove non -specific staining. 
i) Dilution of immune and non -immune immunoglobulin. 
Parallel dilutions of immune and non-immune immunoglobulin fractions 
were made in an attempt to'dilute- out'weak non -specific staining 
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present at approximately 1mg protein /ml and above, whilst retaining 
specific staining. Removal of non -specific staining by dilution, was 
associated with removal of staining with immune sera, however, preventing 
any distinction. A variety of antibodies to cyclic AMP and cyclic GNP 
of differing titre were used unsuccessfully in an attempt to 'select' 
an antibody showing differences from non -immune immunoglobulin,at 
similar protein concentrations. 
ii) Absorption of unlabelled antibody with tissue powders has been 
used by a number of workers with some success e.g. (274). Hartman 
(257) reported limited success in removing non-specific fluorescence 
with acetone powders for localization of dopamine -` -hydroxylase 
in C.N.S. tissue. 
Care should be taken in experiments using tissue powder absorptions 
to remove non -specific iunofluorescence, since the powder may 
remove normal IgG by Fc binding, instead of having the desired effect 
of removing 'anti- tissue'antibodies. A reduction in specific staining 
or background staining might therefore bé observed, simply as a result 
of a decreased IgG concentration. To demonstrate this 500/j6,1 of non- 
immune immunoglobulin were incubated for 30 minutes at room temperature 
(with occasional shaking) with 100mg óf PBS-washéd liver powder (see 
appendix 6). After centrifugation at 13,000g for 3 minutes (Eppendorf cent. 
supernatant was removed and the procedure was repeated. 5/41 of the 
centrifuged supernatant were then assayed for IgG using a Miles 
agarose radial immunodiffusion kit (Miles Laboratories, Slough, 
Buckinghamshire). A 46% reduction in IgG was found compared with un- 
incubated non -immune immunoglobulin. A further consideration in the use 
of tissue powders for removing 'anti -tissue' antibodies,is that the 
tissue antigen might be destroyed by the acetone used for preparation 
of the powder. 
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iii) In PAP i munohistochemistry, sections are first treated with 
serum from a different species to that in which the specific un- 
labelled antibody is raised, to 'block' background staining (276). 
Experiments carried out with concentrations of human IgG up to 15mg /m1 
to pre -treat sections for 30 minutes in the indirect technique, failed 
to prevent non -specific binding of rabbit iunoglobulin however. This 
was presumably due to interchange between human and rabbit IgG for 
non -specific b nding sites. 
iv) . Oxidative deamination of cerebellar tissue sections -was carried out 
with 2% nitrous acid (1 minute) followed by a short wash in 2% acetic 
acid and finally 3 x 3 minute washes in PBS, in an attempt to block the 
basic groups in C.N.S. tissue sections believed to be responsible for 
non -specificity (253). No reduction was found in non -specific 
imm nofluorescence however. 
v) An experiment was performed using 1% Triton X -100 (Sigma Chemical Co) 
incorporated in the antibody solutions and buffer washes. This compound, 
which is a non -ionic detergent,has been shown by Hartman (257) to 
reduce non -specific staining, presumably by interfering with the low avidity 
binding of non-immune immunoglóbulin.No significant effect was found however. 
vi) The possibility of increasing antibody pH to remove non -specificity 
by decreasing the charge interaction between antibody and basic 
tissue proteins (277) was not attempted on the grounds that it would 
probably be detrimental to the specific antigen -antibody interaction. 
vii) The use of (FAB)2 fragments of immune and non -immune IgG was 
considered in order to circumvent Fc binding, but the approach is 
technically complicated (208, 278) and would only have been attempted 
if the non -specific staining component could be clearly distinguished 
from specific staining. 
2.3. Discussion. 
The experiments reported on non -specificity were carried out over 
a period of 12 months. During this time a variety of antibodies 
to cyclic AMP and cyclic GMP had been produced (see ionization 
schedule I page 127)which specifically bound the respective 
nucleotide but which showed non -specific immunofluorescence in C.N.S. 
tissue sections. Personal communication with Drs Floyd Bloom and 
Alton Steiner showed that they had not experienced problems with 
non -specificity in brain tissue using identical methodology, but 
different antibodies. This suggested that they might be employing 
cyclic nucleotide antibodies of higher avidity or higher titre, enabling 
dilution to remove any non -specific effects. 
In January 1977, I was able to spend a period of three weeks at work 
in Dr Steiner's laboratory (University of North Carolina, U.S.A.) to 
evaluate different antibodies for immunofluorescent localization of 
cyclic nucleotides in rat cerebellum. 
A number of specific rabbit cyclic AMP antibodies, raised against 
succinyl cyclic AMP- keyhole limpet hemocyanin, were screened, and 
several showed specific cyclic AMP immunofluorescence at high dilution, 
clearly distinct from sections treated in parallel with non -immune 
immunoglobulin. Since the immunoglobulin concentration of antibodies 
from different sources may vary, it was essential to compare each 
specific cyclic nucleotide antibody with non -immune immunoglobulin at 
the same protein concentration. This is an important point, since not 
only may pre-immune sera have lower concentrations of imffu.n lobulin than 
immune sera (279), but pre-immune sera may not always be collected and 
therefore available for comparison. 
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I was also able to examine a variety of specific rabbit cyclic GMP 
antibodies raised against succcinyl cyclic GMP -KLH inmunogen, 
produced by Dr Steiner's group. Out of the antibodies tested,three 
showed positive staining distributed along fibres, whilst'one 
antibody also showed staining of capillary walls; with all these 
antibodies, staining was observed at high dilution and could be 
clearly distinguished from staining with non -immune imm noglobulin. 
The cyclic nucleotide antibodies selected were among those employed 
by Steiner's group for the localization of cyclic AMP and cyclic GMP 
in tissues such as liver,, intestine and testis (305), 
My visit to Dr Steinerts laboratory demonstrated that not only 
cyclic AMP, but also cyclic GMP could be localized in cerebellum 
with contrasting distribution. Being able to select positive staining 
antibodies which could be employed at high dilution,eliminated 
problems of non -specific immunofluorescence. Experiments carried out 
with these cyclic nucleotide antibodies are considered in greater 
detail in subsequent chapters. 
Returning to Edinburgh, positive staining was confirmed in the laboratory 
with samples of Dr Steiner's antibodies which had been selected, and an 
-immunization programme was initiated in ten rabbits with succinyl 
cyclic GMP- protein immnnogen, in the hope of producing successful 
antibodies fcr immunofluorescence. It was decided to concentrate on 
producing cyclic GMP antibodies, and monitor the bleeds from each 
rabbit during immunization with radioimmnnological techniques,to 
determine which of the characteristics (titre, avidity or cross -reactivity), 
were required for successful localization of cyclic GMP in C.N.S. tissue 
sections. 
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PRODUCTION OF ANTIBODIES TO CYCLIC NUCLEOTIDES AND 
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1. FACTORS AFFECTING ANTIBODY PRODUCTION 
1.1. Species 
Rabbits and guinea -pigs are generally used for production of antibodies, 
although many other species have been used including horse, goat, 
sheep, chicken and mouse (280). Certain strains of animals may 
sometimes be superior to others e.g. New Zealand white rabbits 
are recommended (212), and inbred strains with a restricted gene 
pool may be particularly successful (281). In general, a large 
number of animals are immunized in the hope of obtaining one or two 
antisera with high titre, avidity and specificity. In this respect 
small animals are preferable in that a large number may be used in 
one experiment, although large animals naturally produce greater 
volumes of antisera. 
1.2. Adjuvant 
Not all macromolecules are equally effective in eliciting a good 
immune response. Various local irritants and other 'adjuvants' have 
been introduced which overcome this difficulty to some extent (282). 
The adjuvants probably act by boosting the immune system and inducing 
local inflammation with proliferation of macrophages, which brings 
them into contact with antigen. Adjuvants also cause a local 
granulomatous lesion, which may act as a focus for antibody production 
(282). The adjuvant enables the antigen to be present in long -lasting 
form at the site of injection, helping to prevent rapid degradation 
and any direct physiological effect of the imm nogen itself, on the 
animal. Adjuvants are generally made from mineral oils and mycobact.eria 
which are then emulsified with antigen, although antigen adsorbed 
onto alum has been used (283). The most common adjuvant is Freund's 
mineral oil either 'complete' (containing killed, dried mycobacterium 
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tuberculosis) or incomplete' (without mycobacteria), both forms 
being commercially available and employed as water -in -oil 
emulsions (284). 
The physical form of antigens which do not require adjuvants may 
also be important for eliciting a good immune response e.g. bovine ( 
globulin is a good -immunogen in mice in the aggregated form, but 
when ultra- centrifuged to be freed from aggregates, it is ineffective 
(193). 
1.3. Route of immunization 
It is arguable which route is best for successful immunization, although 
it is genmally agreed that the intra- venous route is not effective 
(212). Commonly, oily adjuvant- immunogen emulsions are injected 
intra- dermally, sub -cutaneously or intra- muscularly. The first two 
procedures have the advantage that whilst small abscesses usually 
form and ulcerate at the site of injection (usually the upper region 
of the back), the animals do not seem unduly troubled by this. Foot- 
pad injection, despite its reported efficacy, should be avoided since 
animals are obviously in considerable pain with swollen, tender feet 
(285). 
The multiple intra- dermal injection procedure of Vaitukaitis et al 
(286) is a simple technique reported to be successful in producing 
near maximal response after a single injection at approximately 40 
sites on the animals back. Whilst animals develop extensive skin 
ulceration, they are reported to remain comfortable and in good 
condition with this procedure. 
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1.4. Dosing regimen 
After the first injection the antiserum titre rises slowly and 
forms a plateau after about 4 - 6 weeks, from which time a 
variable slow decline occurs (212). The secondary immune response 
produced by a series of booster injections may, or may not, 
increase the titre. The avidity of antiserum generally increases 
with time, although it may fall off or increase suddenly,during a 
series of boosters. There is evidence that high avidity is favoured 
by spacing boosters widely, and good avidity has been shown to return 
when an animal has been rested for periods of several months, after a 
series of shorter -spaced injections (212). 
Small doses of imm nogen,rather than large doses, are used for injection. 
Large doses have the capacity to induce tolerance in cells which 
contain, and potentially secrete, high avidity antibodies, which could 
prevent the cells from further proliferation (287). 
The primary antibody response produces antibody of the IgM type, 
whilst long term immunization with booster injections gives antibody 
almost entirely of the IgG type (282). 
Peak IgG antibody response occurs 10 - 14 days after booster injections 
of oily emulsions, and animal bleeds are therefore harvested at this 
time (285). 
2. PRODUCTION OF ANTIBODIES TO HAPTENS 
Whilst molecules of low molecular weight are generally not 
immunogenic, the classical immunochemical experiments of Landsteiner 
(288) showed that specific antibodies could be raised to well -defined 
small molecules when coupled to proteins, and used as antigens. He 
defined these small molecules as haptens, tspecific protein -free substances 
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Figure 15 Mechanism for coupling hapten and protein 
using carbodiimide 
which, although reactive'in vitro', induced none or only slight, 
antibody response.' 
Haptens are covalently coupled to high molecular weight 'carriers' 
e.g. serum albumin (molecular weight 69,000, keyhole limpet 
hemocyanin (molecular weight--,- 2.7 x 10 
6 
), for immunization. Common 
methods of coupling form peptide or C =N bonds. 
Carbodiimide coupling is shown in figure 15, and is a widely 
used condensation reaction generating a peptide linkage between protein 
and carboxyl groups of the hapten (289). 
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3. PRODUCTION OF SPECIFIC ANTIBODIES TO CYCLIC AMP AND 
. CYCLIC GMP - METHODOLOGY 
3.1. Preparation of hasten- protein conjugates. 
Cyclic nucleotides were rendered iurogenic by coupling their 
succinylated derivatives to a high molecular weight protein 
carrier, the coupling procedure being carried out directly 
according to Steiner et al (230). 
Keyhole limpet hemocyanin was found to be insoluble, proving difficult 
to work with as a dark -grey powder, and therefore human serum albumin 
was employed for all coupling experiments. 
Figure 16 Coupling of succinyl cyclic nucleotides to 
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The reaction was carried out in glass vials, as used for scintillation 
counting. 
i) 30mg of human serum album i r (crystallized form, Sigma Chemical Co.) 
were dissolved in 3101 of distilled water. 
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ii) 15mg of succinyl cyclic AMP or succinyl cyclic CMP (supplied as 
the free acids from Boehringer Mannheim, Sussex) were added, the pH 
then being adjusted to 5.5. 
iii) 15mg of 1- ethyl -3 ( 3, dimethyl- aaninopropyl)- carbodiimide 
hydrochloride, ETC (Sigma Chemical Co.),were dissolved in the 
solution and the pH was rapidly re- adjusted to 5.5. 
iv) The vial was stoppered,wrapped in aluminium foil to prevent 
access of light, and incubated for approximately 18 hours at room 
temperature. 
v) The solution was transferred to Visking 10mm width dialysis 
tubing (Gallenkamp, Glasgow) which had been previously boiled in 
distilled water to remove traces of glycerin. Dialysis was carried 
out for 4 days at 4 °C,aga-inst 5 litres of phosphate- buffered saline 
(see appendix 2) agitated with a magnetic stirrer; the buffer was 
changed twice daily. 
vi) The contents of the dialysis tubing were removed,and lyophilized 
in a Leybold Heraeus GT2 freeze drier (Germany). Extensive dialysis 
ensured removal of unreacted succinyl cyclic nucleotide and EDC, 
whilst retaining the high molecular weight complex of nucleotide and 
protein within the dialysis tubing. 
vii) A sample of lyophilized conjugate was diluted in PBS to a 
concentration of 0.5mg /m1, and examined in an ultra- violet 
spectrophotometer (Pye Unicam, SP500), scanning from 190 -350nm against 
PBS, and against ESA at the same concentration, to confirm formation 
of the conjugate (see figure 17). Succinyl cyclic GMP -HSA conjugate 
exhibited maximum absorbance at 255nm whilst succinyl cyclic AMP-ESA 
conjugate showed a maximum at 257nm. Unconjugated ESA huwever, showed 
maximum absorbance at 280nm, whilst ETC showed no absorption maxima in these 
regions. Steiner et al (230) have calculated that 5 -6 succinyl cyclic 
nucleotide molecules couple to each albumin molecule,with this procedure. 
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10 
Fib e 17 Spectrophotometer 
trace for succinyl cyclic 
GMP -HSA conjugate and for 
HSA. 
235 255 278 Wavelength nm 330 
A - 0.5mg /m1 succinyl cyclic GMP -HSA conjugate vs. PBS 
B - 0.5mg /m1 HSA vs. PBS 
C - 0.5mg /ml succinyl cyclic GMP -HSA conjugate vs. 0.5mg /m1 ESA 
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3.2. Immunization of rabbits. 
Immunization was carried out according to Steiner et al (230),with 
the exception that footpad injections were not given,on the grounds 
that they had been reported to be painful to rabbits. 
White, male, New Zealand rabbits weighing approximately 2Kg,were 
stored in separate cages in the rabbit room of the Pharmacology 
Animal House, University of Edinburgh. A period of at least four 
weeks was allowed for the animals to settle -down in their housing, 
after arriving from the Bush Estate Animal Breeding Station, Penicuik, 
Scotland. Their food consisted of oxoid SG1 pellets and green 
vegetables or carrots,with water available 'ad libitum'. A check 
was constantly maintained on the weight and overall condition of the 
animals. Each rabbit was labelled by a tattooed number on the ear; all 
the experimental. procedures were carried out in the animal house,with 
the assistance of an animal technician. 
Blood was taken from each rabbit before starting immunization,to serve 
as pre -immune control. 
3.2.A. Bleeding procedure. 
Animals were placed in a wooden restraining box and allowed to settle - 
down for several minutes. Initially, cotton wool wadding was used inside 
the box to prevent the rabbits moving, but this resulted in the 
death of two rabbits,due to rapid twisting of the head which caused 
breakage of the neck. A plastic restraining box with adjustable sides 
(Forth Tech, Scotland) was subsequently employed, which ensured that 
the rabbits were unable to move whilst being bled. Fur was plucked 
from the upper side of one of the rabbits ears, and the marginal ear 
vein was located. Petroleum jelly (Chesebrough -Ponds Ltd, London) 
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was smeared onto the edge of the ear to prevent clotting of drawn 
blood on the fur. The remainder of the ear was dabbed with cotton 
wool soaked in xylene,to cause local irritation and dilatation 
of the vein. Care was taken to ensure that the xyleie.did not come 
into contact with the area to be cut. An artery clip was placed 
posterior to the site of incision to cause a 'build -up' of blood. 
A sterile scalpel blade (No. 11 Swann- Morton) was used to make a 
small incision in the exposed ear vein, and blood was allowed to 
trickle into a glass collection tube. Accidental incision of the 
underlying artery, which sometimes occurred, was not serious and 
helped to quicken the collection of blood; approximately 30m1 of 
blood were drawn from each rabbit. When bleeding was almost complete 
the artery clip was removed and placed on the other side of the 
incision to help stop the blood flow. On completion, the clip was 
placed on a small piece of cotton wool covering the incision, to 
assist clotting and healing. After a few minutes the clip was removed 
and the rabbit was returned to its cage. 
After collecting blood from each rabbit, the collection tubes were 
sealed with 'parafilm' and removed to the laboratory. Clotting was 
facilitated by either allowing the blood to stand for one hour at room 
temperature, or leaving undisturbed overnight at 4 °C. It was important 
not to exceed these clotting times, to prevent haemolysis. Fibrous 
clots were removed or loosened from the sides of the collection tubes. 
Serum was separated from corpuscles by centrifugation at 2,500 r.p.m. 
for 30 minutes at 4 °C (MBE Mistral 21, centrifuge). A Pasteur pipette 
was used to remove serum from each tube, which was then transferred 
to clean, labelled tubes. Approximately 15ml of serum were obtained 
from 30m1 of blood. 5ml of serum were stored frozen in the deep- freeze 
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at -25 °C, whilst the remaining 10m1 were used directly for preparation 
of the immunoglobulin fraction (see page 129) 
3.2.B. Injection procedure. 
The immanogen, lyophilized succinyl cyclic nucleotide -human serum 
albumin conjugate, was dissolved in PBS and added to Freund's 
adjuvant, in a small glass beaker. The mixture was vigorously mixed 
for 4 - 5 minutes using a Polytron mixer (Northern Medical Supply 
Ltd, Great Britain) until a thick white emulsion formed. The beaker 
was kept constantly cool with a damp cloth during this procedure. 
It was essential to add the immunogen to the oily adjuvant, rather 
than the other way around, in order to form a stable emulsion (212). 
The stability was checked by ensuring that the emulsion remained in a 
single phase when stored overnight at 4 °C. An immunogen-adjuvant 
ratio of 1 :1 was initially used, but produced a very thick emulsion 
which proved difficult to pack into the syringe for injection; ratios 
of 1 :2 and 1 :3 were subsequently found to be more satisfactory (285). 
Approximately double the quantity of emulsion required was made, since 
regardless of the immunogen-adjuvant ratio, it proved impossible to 
transfer all the emulsion from beaker to syringe. 
Rabbits were firmly held on a flat table, ensuring that they were not 
allowed to move during injection. For the primary injection, immunogen 
was injected in Freund's 'complete' adjuvant (Miles Laboratories, Slough, 
Buckinghamshire). The emulsion was injected intra-dermally into 
approximately ten sites in the upper shaved region of the animals back. 
A glass 1ml syringe was found preferable to the plastic disposable type 
for injection. Approximately 0.3ml of emulsion were injected at each 
site, a total of 3ml being injected per rabbit. Disposable 21 guage 
needles were used for injection. 
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Sub- cutaneous booster injections in Freur_d's 'incomplete' adjuvant 
were given at two-or-three sites in the shaved regions of the animals 
back, using a glass 1ml syringe with disposable 25 guage needles. 
Approximately 0.5ml of emulsion were given at each site, forming 
small blisters under the skin. Animals were returned to their cages 
after injection. 
Tables 1 and 2 summarize the immunization schedules used for 
production of antibodies to cyclic nucleotides. Individual bleeds 
are labelled, since they are referred to individually later in the 
text. 
In schedule I (Table 1), rabbits 4 and 7 died, due to their necks 
breaking during bleeding, whilst in schedule II (Table 2 ), rabbits 
3 and 4 developed ear infections, probably as a result of the routine 
syringing procedure, and were destroyed on humane grounds. All the 
other rabbits remained in good health during the course of immunization. 
In schedule I (Table 1) , the first injection employed an immunogen- adjuvant 
ratio of 1:1 whilst booster injections used a ratio of 1:3. In 
schedule II (Table 2), the first injection used a ratio of 1:2 whilst for 
booster injections the ratio was 1:1. 
In schedule I (Table 1) rabbits were rested for four months between the 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.3. Preparation of imm noglobulin fraction from serum 
Immunoglobulin fractions were prepared from sera not only to 
concentrate the antibody- containing fraction, but also to remove 
cyclic nucleotide phosphodiesterase activity present in serum, 
which might destroy the cyclic nucleotides in tissue sections, or 
during the radioimmunological techniques for estimation of 
antibodies. Free circulating cyclic nucleotides would also be 
removed from serum by this fractionation procedure (see page 169). 
Ammonium sulphate fractionation of serum at 40% concentration is a 
simple and effective means of preparing a crude immunoglobulin 
fraction from pre -immune and immune sera,and is often employed prior 
to chromatographic preparation of highly purified IgG from serum (265). 
Method: 400g of ammonium sulphate(especially low in heavy metals) 
were dissolved in 500m1 of distilled water with constant stirring at 
70 -80 °C. The solution was stirred for about 20 minutes, covered, and 
allowed to cool to room temperature, whilst needle -like crystals 
formed at the bottom of the beaker. After cooling, the saturated 
supernatant was decanted into another beaker,and the pH adjusted to 
7.4 with ammonium hydroxi-e(28%) and sulphuric acid (50%). The 
solution was stored at 4 °C, and filtered prior to use. 
The (salting -outs procedure of imm noglobulin from serum (carried out 
according to Nairn, reference 194) was performed'on icé in the 
laboratory, after pre -cooling all the reagents. 
Saturated ammonium sulphate solution equal to 3 of the serum volume, was 
added at the rate of approximately one drop per second, in a glass 
test tube. The mixture was stirred gently with a glass rod,as a thick 
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white precipitate formed. Stirring was continued for a short time 
before allowing the mixture to stand'on ice'for 30 minutes to obtain 
maximum precipitation. The mixture was centrifuged at 2,500r.p.m. for 
30 minutes at 4 °C (MBE Mistral 2L centrifuge). The resulting 
supernatant was discarded and the precipitate dissolved in PBS to 
give a total volume equal to half the original serum volume. 
The immunoglobulin fraction, dissolved in PBS,was dialyzed against this 
buffer for three days at 4 °C with two changes of buffer per day (see page 121). 
On completion of dialysis, one drop of 1M barium chloride was added to 
one drop of the immunoglobulin fraction to test for 5042 ions. A 
white turbid solution, clearing on acidification with hydrochloric 
acid, would have indicated the presence of sulphate ions, and therefore 
incomplete dialysis. Complete removal of ammonium sulphate was 
always found with this dialysis technique however. 
The immunoglobulin fraction was clarified by centrifugation at 13,000g 
for three minutes (Eppendorf centrifuge), divided into aliquots and 
stored frozen at -25 °C. Aliquoting prevented constant freeze -thawing 
which can result in aggregate formation, a possible cause of non- 
specificity in immunofluorescence (235). 
To confirm that the fractionation technique resulted in an enrichment of 
IgG in the crude immunoglobulin fraction, the percentage of protein 
representing IgG in the immunoglobulin fraction was calculated. IgG 
values were obtained using a Miles radial immnnodiffusion kit for 
rabbit IgG (Miles Laboratories, Slough, Buckinghamshire), and protein 
values were determined by the method of Lower et al (see appendix 5). 
Pre -immunization bleeds and antiserum A7B2 were found to contain 
approximately 12% of total protein as IgG, whereas crude immunoglobulin 
fractions of these and selected other bleeds (also from Dr Steiner's 
laboratory), contained approximately 50% of protein as IgG. 
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4. DETERMINATION OF TEE CHARACTERISTICS OF CYCLIC NUCLEOTIDE 
ANTIBODIES USING RADIOIMMUNOLOGICAL TECHNIQUES. 
4.1. Introduction 
As already noted in chapter II, only certain cyclic nucleotide 
antibodies appear to be suitable for use in the immunfluorescent 
localization of cyclic AMP and cyclic GMP in C.N.S. tissue 
sections. A number of characteristics of these antibodies may 
contribute to their usefulness. High titre antibodies might be 
of importance, so that a high concentration of antibody would be 
available for binding on a tissue section. Alternatively, high 
avidity antibodies, by binding ?tightly' to cyclic nucleotides in 
the tissue, could be essential since they would not be easily 
removed during the buffer washing procedures. Finally, the 
specificity of cyclic nucleotide antibodies might be a critical 
factor, a positive staining antibody possibly being highly selective 
for one nucleotide, and showing minimal cross -reactivity to closely 
related molecules in the tissue. 
In order to study these characteristics, with a view to selection of 
antibodies as immunohistochpmical reagents, high sensitivity 
radioiunlogical techniques were employed to study the binding of 
antibody to nucleotide in solution. Prior to starting my work in 
Edinburgh, cyclic nucleotide antibodies had been produced in the 
laboratory by Mr T Attree and screened for titre in binding assays 
employing [3H] cyclic nucleotide tracers. Whilst Steiner et al (230, 231) 
had employed 251] tyrosine methyl esters of succinyl cyclic nucleotides as 
high specific activity tracers, cyclic nucleotides with tritium 
incorporated directly into the molecule have recently become 
commercially available,at high specific activity. Whilst these tracers 
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still have lower specific activity than 
1251] 
tracers, direct 
labelling on the nucleotide rather than iodination of a 
derivative produces a molecule with higher affinity for antibody 
(see page140)2'ritiated tracers also offer several practical 
advantages over iodinated tracers(290); they are more stable over 
long periods of time,-and therefore do not require periodic 
synthesis as do iodinated compounds. Being 'soft' em.ittors, 
-tsi_tiateitracers are also safer to handle than iodinated compounds 
which emit e radiation. 
The existing binding assay was initially employed to measure the 
titre of cyclic AMP and cyclic GMP antibodies prepared according to 
immunization schedule I (1976). The assay technique and results, 
employing 'second antibody' precipitation to separate antibody -bound 
and free cyclic nucleotide, are discussed, followed by modification 
for measurement of not only titre,but also avidity and cross -reactivity 
of cyclic GMP antibodies prepared by immunization schedule II (1977). 
4.2. Binding of [ EE] cyclic AMP and cyclic GMP by dilutions of 
cyclic nucleotide antibodies prepared according to immunization 
schedule I - 'second antibody' technique. 
All operations in the laboratory were carried out 'on ice' in 1.3ml 
plastic ' Eppendorf' tubes. Automatic ' Eppendorf' pipettes were used 
to dispense reagents. 
i) 0.05M sodium acetate, pH 6.2, was employed as the assay buffer. 
The buffer was stored at 4 °C for not more than a few days, since 
longer storage resulted in cloudiness due to bacterial formation. 
ii) Rabbit immunoglobulin fractions of cyclic nucleotide antisera 
were diluted with buffer in. dilutions from 1:10 to 1:100, and 
centrifuged at 13,000g for 3 minutes (Eppendorf centrifuge) to remove 
any aggregates. 2001 of centrifuged supernatant were placed in 
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Eppendorf tubes. Duplicates were made for each dilution of 
antibody. 
iii) yi1 of[3H]cyclic AMP or [3H] cyclic GMP was diluted with 2.5ml 
of buffer. Labelled cyclic nucleotides were obtained from the 
Radiochemical Centre (RCC), Amersham, Buckinghamshire ; TRK 304 
[ 
8_3Hladenosine 3',5'- cyclic phosphate, ammonium salt, specific 
activity of free acid -27.5Cí /m mole, concentration 1mCi /mi. 
TRK 392 [83H]guanosine 3',5'- cyclic phosphate, ammonium salt, 
specific activity of free acid -21.0 Ci /m mole, concentration 1mCi /m1. 
Labelled cyclic nucleotides were received from RCC in 50% ethanol, 
and stored at -25 °C as recommended, being diluted with buffer prior 
to use. 
50/1 of either diluted [3H] cyclic nucleotide were added to the 
antibody in the Eppendorf tubes, briefly vortex mixed , and incubated 
for four hours at 4 °C. 
iv) An appropriate dilution of high titre donkey anti- rabbit serum 
(code no. RD.17, Lot no. K1953B, Wellcome Laboratories, Beckenham, 
Kent) was added in a volume of 50/21. The reaction tubes were briefly 
vortex mixed, and incubated at 4 °C for a further 18 -20 hours in order 
to precipitate rabbit antibody. 
v) The reaction tubes were centrifuged in batches of twelve at 
13,000g,for three minutes. 
vi) The supernatants were carefully removed and transferred to glass 
scintillation vials in preparation for radioactivity 'counting' . 
vii) 200/1 of buffer were added to the tubes followed by vortex 
mixing to wash the precipitates. Centrifugation was then repeated 
nor a further six minutes. 
viii) The resulting supernatants were transferred to scintillation 
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vials in preparation for radioactivity counting. 
ix) The remaining precipitates were dissolved by adding 1001 
of 9% formic acid, vortex mixing, and allowing to stand at room 
temperature for 30 minutes. 100l of distilled water were then 
added to dilute the acid. After mixing, the solubilized precipitates 
were transferred to scintillation vials,in preparation for 
radioactivity counting. 
x) 10m1 of NE 260 micellar liquid scintillation cocktail (Nuclear 
Enterprises, Edinburgh) were added to each of the vials, which were 
then stoppered and thoroughly mixed. A period of one hour was 
allowed to reduce any chemilirminescence,prior to counting of 
radioactivity (291). Samples were counted for four minutes each 
using an automatic Nuclear Chicago scintillation counter. Machine 
'background'was calculated by counting a 2001 buffer sample with 
scintillant; this value was substracted from each reading. Counting 
efficiency for tritium was calculated at 40%. 
The percentage of total radioactivity bound by each dilution of 
antibody was calculated according to the formula: 
C 
% radioactivity bound = 
where: 
A+B+C 
A = number of counts from supernatants fraction 
B = number of counts from 'wash' fraction 
C = number of counts from precipitate 
Non -specific binding was calculated as the percentage radioactivity 
bound from the immunoglobulin fraction taken from t,nimmunized 
rabbits. 
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4.2.A. Notes on assay 
The labelled cyclic nucleotides chosen,had the highest specific 
activity commercially available,when these experiments were 
carried out. 0.73 p moles of [3H] cyclic AMP and 0.95pmoles of 
[3H]cyclic GMP were added per assay tube (approximately 17,000 
and 13,000 counts /minute respectively). Samples were counted for 
four minutes each to reduce statistical counting errors and were 
discarded if duplicate variation exceeded 5 %. 
Experiments were carried out to determine the quantity of 'second 
antibody' required to precipitate the maximum amount of radioactivity, 
for different dilutions of cyclic nucleotide antibodies (see figure 18). 
At low dilutions of cyclic nucleotide antibody, increasing amounts of 
'second antibody' were required for maximal precipitation. It was 
important to adjust 'second antibody' concentrations for each dilution, 
since decreased binding would result using levels above or below the 
optimum. 
4.2.B. Results 
Tables 3 and 4 show the effect of dilution of immunoglobulin fractions, 
on percentage radioactivity bound, by bleeds taken from rabbits 
3 and 5 (immunized with succinyl cyclic AMP -HSA), and rabbits 6 and 8 
(immunized with succinyl cyclic GMP-HSA). Non- specific binding 
of [3H] cyclic nucleotides by non -immune immunoglobulins at a 
dilution of 1:50,was found to be approximately 1.0%. 
Antibodies with similar titre were found in four rabbits injected 
with succinyl cyclic AMP -HSA and succinyl cyclic AMP -KLH, and 
three rabbits injected with succinyl cyclic GMP -HSA conjugate, 
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Table 3 Percentage of[3B]cyclic AMP bound by immunoglobulin 
fractions of bleeds taken from rabbits 3 and 5 during 
the course of immunization with succinyl cyclic AMP -HSA 
conjugate - 'second antibody' method. 
RABBIT 3 
DILUTION OF IMMUNOGLOBULTN FRACTION 
1:10 1:50 1:100 
BLEED 1 3.0 2.5 1.5 
BTFFD 2 20.0 3.3 1.9 
BT, ;D 3 7.7 2.3 1.8 
BT,;D 4 6.3 2.1 
BURT) 5 56.9 24.7 10.7 
RABBIT 5 
DILUTION OF INIr2UN0GL0BULIN FRACTION 
1:10 1:50 1:100 
BU:F;D 1 2.5 1.7 1.6 
BT,F'FD 2 9.7 2.2 2.3 
BuND 3 39.4 6.0 2.7 
BLEED 4 48.8 4.1 4.4 
BUIE]) 5 48-.3 7.7 
158- 
Table 4 Percentage of [N cyclic GMP bound by iramunoglobulin 
fractions of bleeds taken from rabbits 6 and 8 during 
the course of immunization with succinyl cyclic GMP -HSA 
conjugate - 'second antibody' method 
RABBIT e DILUTION OF fl MNOGLOBULIN FRACTION 
1:10 1:50 1:100 
BLFTFD 1 14.5 3.7 2.2 
BLEED 2 2.9 1.9 1.9 
BLEED 3 44.3 12.6 5.5 
BLEED 4 57.6 35.4 16.3 
BLEED 5 61.8 41.9 21.1 
RABBIT B DILUTION OF I UNOGLOBULIN FRACTION 
1:10 1:50 1:100 
BT TRD 1 30.4 5.8 2.6 
BT,FTF;D 2 30.9 6.2 3.3 
BLEED 3 29.9 5.2 2.9 
BLEED 4 65.8 29.0 14.0 
BUTP1D 5 56.9 26.3 12.9 
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This pilot study demonstrated that antibodies to cyclic AMP and 
cyclic GMP could be produced in rabbits with variations in titre 
not only between different animals, but also between different bleeds 
from the same animal, with a general increase on repeated boosting. 
In an attempt to produce antibodies of higher titre, and to carry out 
a study of variations in titre, avidity and specificity during 
immunization, a complete study was initiated using ten rabbits 
immunized with succinyl cyclic GMP -HSA conjugate. 
4.2.0 Discussion 
A number of factors suggested that the binding assay should be 
modified before the more extensive studies were performed on the 
antibodies from the ten rabbits injected according to immunization 
schedule II. The requirement for 2001.1 of cyclic nucleotide 
antibody consumed large amounts of antibody in the binding studies. 
Secondly, 50íl undiluted 'second antibody' were 
assay tube for maximal precipitation of radioactivity with low 
titre antibody, which proved expensive for large numbers of tubes. 
Finally, 0.95 p moles of[3H]cyclic GMP were used per assay tube, 
which would require the assay to be significantly scaled -down for 
development of a radioimmunoassay to approach the sensitivity to that 
reported by Steiner et al i.e. 0.01 p moles (231). 
The announcement of a specific and sensitive radioimmunoassay kit for 
cyclic GMP by the Radiochemical Centre, Amersham, Buckinghamshire 
(333),formed the basis for a modified binding assay to measure the 
titre of cyclic GMP antibodies produced in the laboratory. The kit 
employed 50x-1 of diluted specific cyclic GMP antiserum in a total 
incubation volume of 200p1. The most important development was the 
- 140 
use of an ammonium sulphate step for precipitation of antibody -bound 
antigen, rather than 'second antibody' precipitation. The salt 
precipitation technique is cheap and rapid, preventing the lengthy 
18 -20 hour second incubation step. Cyclic nucleotides and other 
small molecules e.g. peptides,lend themselves particularly well to 
fractional precipitation techniques (e.g. ammonium sulphate and 
ethanol), being soluble at concentrations of precipitant, at which 
immnnoglobulins are completely insoluble (282). Steiner et al (231) 
have also adopted the ammonium sulphate technique for their iodinated 
radioiunoassay, reporting similar results between this technique 
and the 'second antibody' method,for separating bound and free 
nucleotides. 
The Radiochemical Centre method was adapted for use with immunoglobulin 
fractions of antisera, and also higher specific activity [3H] cyclic 
GMP (31Ci /m mole) labelled on the ribose sugar. The sensitivity of 
the cyclic GMP kit and modificl technique are close to that found with 
iodinated radioimmunoassay, although the specific activity of the 
tritiated cyclic GMP is still more than five times lower than that of 
the iodinated tracer. This is probably due to cyclic GMP being more 
effective in competing with and displacing[3H]cyclic GMP from specific 
antibody, than in displacing an iodinated tyrosine methyl ester 
derivative (292). 
The modified technique is described in detail for the measurement of 
titre, and subsequently avidity and specificity, of cyclic GMP 
antibodies prepared according to immunization schedule II. 
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4.3. Binding of [3H] cyclic GMP by dilutions of antibodies 
prepared according to immunization schedule II - 
'ammonium sulphate' technique. 
Method: 
All operations in the laboratory were carried out 'on ice' in 
1.3ml plastic Eppendorf tubes. 
i). 0.05M TRIS + 4mM EDTA, pH 7.5, was employed as the assay buffer. 
ii) High specific activity radiolabelled cyclic GMP (31 Ci /m mole) 
was obtained from the Radiochemical Centre, Amersham, Buckinghamshire(ROC). 
tl of [ribose_5_3H]cyclic GMP (TRK 499) was diluted with 8ml of 
assay buffer. 50r1 aliquots were added to Eppendorf tubes to give 
a total of approximately 22,000 counts /4 minutes (approximately 0.2 p moles), 
per tube. [3H]cyclic GMP was received from RCC in 50% ethanol and 
stored as recommended at -25 °C, being diluted with buffer prior to 
use. 
iii) 5(?-1 of 'carrier' rabbit ;mmi oglobulin (Dakopatts, Denmark; 
supplied by Mercia. Diagnostics, Watford, bland). 
iv) 50/1 of buffer were added to each tube. 
v) 501 of diluted antibody were added to each tube, to give a total 
incubation volume of 2001. Tubes were stoppered and briefly vortex 
mixed. Duplicate determinations were carried out at each antibody 
dilution. 
vi) Tubes were incubated 'on ice' for 12 hours at 4 °C. 
vii) 1m1 of ice -cold 60% saturated ammonium sulphate (58.5g of the 
salt, low in heavy metals, dissolved in 150m1 of distilled water) 
was added to each tube; the tubes were then allowed to stand 'on ice' 
for five minutes. 
viii) Tubes were centrifuged in batches of 12 for 3'minutes at 13,000g, 
using an Eppendorf centrifuge. After replacing the tubes 'on ice' 
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supernatants were carefully removed by suction and discarded. 
ix) 1.1m1 of distilled water were added to each tube, and left for 
at least five minutes,to dissolve the pellet. 
x) Tubes were thoroughly vortex mixed. A 1ml sample was removed 
from each tube and transferred to glass scintillation vials, in 
preparation for radioactivity counting. 
xi) 10m1 of NE 260 micellar scintillation cocktail were added to 
each of the vials, which were then stoppered and thoroughly mixed. 
Samples were counted for four minutes each, as previously described 
(see page 134) . 
xii) Machine 'background' was calculated by counting a 1ml sample of 
distilled water with scintillant; this value was subtracted from each 
reading. The percentage of 
L3Hicyclic 
GMP bound by antibody was 
calculated as the (number of counts bound) divided by the (total 
number of counts per assaytube)the product being multiplied by 100. 
Total counts were obtained by counting two tubes with 50-1 of [3H] 
cyclic GMP + 1ml of distilled water + 10m1 of scintillant. The mean 
number of total counts were divided by 1.1 to obtain counts per 
assay tube. 
The percentage of radioactivity bound by dilutions of non -immune 
immunoglobulin was also calculated. 
4.3.A Notes on assay 
i) Separation of bound and free radioactivity. 
Very low precipitation of radioactivity was found in initial 
experiments using [3H] cyclic GMP and rabbit anti -cyclic GMP 
immunoglobulin. Experiments were therefore carried out with 
different amounts of non -immune rabbit immunoglobulin to act as 
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'carrier' (212),and aid precipitation of antibody -bound tracer. 
The effect of carrier concentration was examined on precipitation 
of [3H] cyclic GMP in two experiments (see figure 19). In one, a 
low titre antibody (8 B 5) was examined in dilutions of 1:10- 1:50,whilst 
in the- other a high titre antibody (A7 B5) was employed at 1:100- 1:500. 
A quantity of 500pg of carrier was selected as giving maximal 
precipitation at all dilutions, with both types of antibody. 
To ensure that the ammonium sulphate separation step was as efficient 
as the 'second antibody' technique previously employed, the percentage 
radioactivity bound with ammonium sulphate (and 500pg of carrier), 
was compared with that obtained using 'second antibody' at similar 
(final) dilutions to those employed in section 4.2 (see page 136). 
The results, shown below, demonstrate that ammonium sulphate 
separation is equal to,or more effective than,'second antibody' 
separation,in this study: 
A7 B5 (ANTIBODY DILUTION: 1:300) 
a) Ammonium sulphate separation 
( -I- 500pg carrier) 
b) Second antibody, final dilution 1/20 
c) Second antibody, final dilution 1/10 
d) Second antibody, final dilution 1/4 





Note: Reaction incubated for 12 hours at 4 °C prior to addition of 
'second antibody' (high titre donkey anti- rabbit serum, Wellcome 
Laboratories, Beckenham, Kent). Reaction time for'second antibody step: 





































































































































































































































ii) Antibody selection 
For selection of antibodies with highest titre produced from the 
ten rabbits ionized with succinyl cyclic GMP -ESA, a 1:100 
dilution of unfractioned antiserum (1:50 and 1:100 dilution of 
bleed 1) was tested for binding, from each bleed of each rabbit. 
The high dilution was employed to minimize any phosphodiesterase 
activity present in the serum. This rapid procedure énabled antisera 
to be 'screened' in order to select those showing maximum binding of 
[3cyciic GMP. Selected antisera (those underlined in table 5) were 
fractioned with ammonium sulphate, to obtain the immùnoglobulin 
fractions, which were subsequently used for more extensive binding studies 
in the following section, and also assessed for immunofluorescence. 
Table 5 Selection of cyclic GMP antisera (produced according to 
immunization schedule II) on the basis of titre, for subsequent 
preparation of imm noglobulin fractions. 
Values represent %H]cyclic GRIP bound in assay. 
RABBIT 
BLEED 1 BLF.F;TI 2 LURED 3 BT,TED 4 BLEED 5 
Antiserum diir! Antiserum 
1 : 
dilution 
100 1:50 1:100 
Al 4.5 12.4 13.0 20.7 
A2 4.1 5.0 10.5 14.3 
A3 
A4 16.2 11.0 11.1 30.1 
A5 2.4 2.9 2.7 3.1 
A6 2.3 2.1 4.4 3.7 
A7 9.4 8.0 8.5 14.9 20.7 57.5 
AS 2.8 1.2 2.3 1.7 
A9 3.1 5.9 6.4 8.3 




The binding of [3H]cyclic GMP by 1:10 and 1 :50 dilutions of 
immnnoglobulin fractions from non - immune rabbit sera was found to 
be approximately 1.0%. 
Selected antisera shown in table 5, were fractioned with ammonium sulphate. 
Graphs were constructed for each cyclic GMP antibody, of percentage 
radioactivity bound (ordinate)vs the dilution of immunoglobulin fraction 
(abscissa).Titre was selected as the dilution of antibody (undiluted 
protein concentration, 20mg /m1) added in 50f-1, to bind 30% of 
added[3H]cyclic GMP. In order to compare the titre of antibodies from 
different rabbits during the course of immunization, a graph was drawn 
of log inverse titre (ordinate) vs number of bleed (abscissa) for 
rabbits showing bleeds with titre greater than 1 :15 (see figure 20). 
A logarithmic rather than linear scale was used, since titre is in 
general distributed logarithmically (282). The graph shows the wide 
variation in response, but with a general trend for titre to increase 
during the course of immunization, but to vary in its time ,f onset. 
Rabbits A7 and A10 were given 5 booster injections in comparison to the 
other rabbits which received 4; it is interesting to note the different 
responses in titre which the last injection elicited.. Rabbits A5 , A6, 
and A8, although boosted on four occasions, failed to produce 
antibody of significant titre. Steiner et al (231) have similarly 
reported that only 50'%o of rabbits showed significant binding of 
antiserum IgG fractions to [3H]cyclic GMP, after immunization with 



































































































































































































































































































4.4. Construction of radioi munassay standard curves 
for comparison of avidity of cyclic GMP antibodies. 
The titre of an antibody measures the dilution required to bind a 
fixed quantity of labelled antigen, and principally represents the 
'amount' of specific antibody in an antiserum. Avidity is a measure 
of the binding energy of antibody for antigen (282); this term is often 
confused in the literature with affinity, which strictly relates to 
the property of the antigen, whilst avidity relates to the properties 
of the antibody. Whilst avidity depends in part on affinity, it 
can also involve other factors such as antibody and antigen valency, 
which are associated with binding. Avidity is often expressed in 
terms of the ability of an antibody to effect a biological antigen - 
binding function. The distinction may be clarified by considering 
that an antibody of constant avidity can react with a large number of 
different, but related, antigens of different affinity. 
In RIA, the sensitivity of an antiserum is primárily dependent upon. its 
avidity (282). Standard RIA curves have therefore been constructed 
for cyclic GMP antibodies in order to compare sensitivity. All other 
factors which may influence sensitivity e.g. assay volume and 
equilibration time (212), have been kept constant. In the following 
discussion, therefore, sensitivity may be regarded as synonomous 
with avidity. The quantity of tracer has been selected to be as low 
as possible without introducing statistical counting errors due to 
too few counts. For comparison of standard curves,the dilution of each 
antibody(undiluted protein concentration. adjusted to 20mg /m1)was selected whici 
bound 30% of[3HJcyclic GMP (0.2 p moles per assay tube), in the absence 
of unlabelled cyclic GMP. Standard amounts of unlabelled cyclic GMP 
were then added to displace this 'zero binding' from ," 6,000 counts /4 minutes 
-149- 
toL^1600 counts /4 minutes. Zero binding was converted to 100% to 
eliminate the slight variations around 30% binding by the different 
antibodies, and the relative percentage binding was calculated for 
each antibody with different amounts of unlabelled Graphs 
were then constructed of relative percentage binding of 
L3H1cyclic 
GMP (ordinate) vs. amount of unlabelled cyclic GMP (abscissa, log 
scale). For example see figure 21, showing standard curves for 
4 bleeds taken from rabbit A10. Samples were discarded if duplicate 
variation was greater than 5 %. A zero binding level of 30% tracer 
was chosen to reduce the amounts of low titre antibody required for 
binding. An added advantage of low zero binding compared with (say) 
a 50% level, is that sensitivity or detection limit is increased; 
cross- reactivity to related antigens may also be decreased with a 
lower zero binding level (293). Reduction to very low levels however, 
limits the precision of the standard curve since the gradient is 
reduced (212). 
A number of techniques have been used for comparing the sensitivity 
of antisera during immunization, from RIA standard curves (referred to 
in reference 282) e.g: 
i) by comparison of the detection limits from the standard curves 
i.e. the amount of unlabelled antigen causing a statistical reduction 
in zero binding, 
ii) by comparing the amount of unlabelled antigen required to reduce 
zero binding by different percentages, 
iii) by reduction in zero binding of different antisera, using an 
arbitrarily selected quantity of unlabelled antigen. 
Using the latter method Hurn and Landon, for example, compared the 































































































































































































- 151 - 
percentage reduction of zero binding(40%),from approximately 23% 
with low sensitivity antisera to 71% with high sensitivity 
antisera. 
In the present study the quantity of unlabelled cyclic GMP per 
50/1 required to reduce relative binding to 50% for each antibody, 
was calculated from the graphs - this was termed the R50 value. 
A high sensitivity antibody will require a small amount of 
unlabelled cyclic GMP and therefore have a low R50 value, whereas 
a low sensitivity antibody will require a larger amount of 
unlabelled cyclic GNP to cause equivalent displacement of[3H]cyclic 
GMP, and therefore have a high R50 value. 
To graphically compare the sensitivity of different antibodies during 
the course of immunization, the reciprocal of the R50 values were 
taken for each antibody, and plotted logarithmically vs. number of 
bleed. A logarithmic scale was used since unlabelled antigen 
concentrations are generally expressed in this manner for plotting 
RIA standard curves. Figure 22 shows the variation in sensitivity with 
different bleeds from different rabbits immunized according to schedule II. 
Wide variationwas observed not only between different rabbits, but also 
between different bleeds, sensitivity appearing to fall during early 
immunization and increase later. 
Comparison of figures 20 and 22 shows that there is no general 
correlation between titre and sensitivity during the course of 














































































































































































































































































































4.5. Measurement of affinity constants and indices of affinity 
heterogeneity,of selected cyclic GMP antibodies. 
i) Derivation of formulae. 
The previous section compared the sensitivity, and therefore avidity, 
of a large number of cyclic GMP antibodies obtained from rabbits 
during the course of immunization. For calculation of affinity 
constants of antibodies, the technique of Nisonoff and Pressman (294) 
was used, enabling calculation of not only mean affinity constants, 
but also deviation of affinity constants of antibodies from this value - 
heterogeneity index of affinity (see also reference 193). 
The quantitative relationship of the interaction of antigen and 
antibody at equilibrium is represented by the equation: 
where: 
Ab + Ag 
k 
a . k 
d 
AbAg 
Ab, represents free antibody 
Ag, represents free antigen 
Ab Ag,represents antibody - antigen complex 
ka, kd represent rates of association 
and dissociation respectively 








represents molar concentration 
ka 
K = k [Ab] 
where: K = equilibrium constant or affinity constant (units,M 1) 
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1 +K [Ag] 
where: n = number of antbody binding sites, valency 
This may be alternatively expressed as: 
b 
717-Alb 
where: b = bound antigen concentration [Ab Ag] 
If isolation and purification of the antibody are not possible for 
determining antibody concentration, K may be calculated from this 
equation with respect to total antibody binding sites [Ab] rather 
than [Ab] and n. The equation may therefore be expressed as: 
Fb.j 1+K EA,g] 
1 r 
1 1 ñ Ab K 1 Ab C t 
[Ab]ma be determined experimentally by extrapolation of the straight 
line plot resulting from 
b 





Due to the heterogeneity of antibody affinity however, the theoretical 
straight line plot may deviate from linearity. The value of K is 
therefore calculated from a plot of the logarithmic transformation of 
the Sips equation (see reference 295): 
a 
K 
1 +K Ag° 
Thus: 
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log n r r = a log K -}- a log[Ag] x x x 
where: r = moles of antigen bound per mole of antibody 
a = heterogeneity index of affinity 









n - r 
since [Ab]= n{Ab] 
Ab 







Therefore in a plot of log Abt-- b vs. log [Ag] (seexxx), 
when: 
b 
log Abt-- b =0, K= 
2 
The heterogeneity index, a, is given by the slope of this plot. As 
the slope approaches 1, the antibody population approaches 
homogeneity with respect to association constants. 
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ii) Experimental procedure - determination of [N, 1, a and K. 
Four antibodies showing different results by immunofluorescence, 
were examined in detail. Dilutions of antibodies binding approximately 
30% of tracer in the binding assay were incubated under the same 
conditions, but with varying quantities of[3H]cyclic GMP,from 0.08 - 
0.53 p moles per assay tube. Calculation of percentage tracer bound 
at each concentration, enabled the quantity of[3H]cyclic GMP bound 
and free, to be calculated in p moles. The amount of [3]E] cyclic GMP 
bound by non-immune serum was calculated for each concentration of 
tracer and subtracted. All experimental-. determinations were carried 
out in duplicate. The data is summarised in table 6. 
[Abtiwas calculated from the plots of b 
vs 
f 
as the intercept on 
the ordinate, when 
1 
= 0. [Abt] values for each antibody were 
subsequently used for calculation of a and K from the plot of 
log 
b 
vs. log f. Results shown in table 7 were calculated 
[Abil -b 
from lines of best fit, using an Olivetti programmable calculator. 
Since values are generally expressed as dissociation constants, Kd 
values were calculated for the cyclic GNP antibodies, and ranged 
from 2 x 10 -10 to 2 x 10 -9 11. 
Kd values of between 1.5 and 4.1 x 109M have been found by a similar 
method for cyclic GMP antisera (296) and Wood and Marks (297) have also 
calculated Kd values for three cyclic GMP antisera of 3.1 x 109M, 
1 x 109M and 1.8 x 10 -8M. 
The heterogeneity index of the four cyclic GMP antibodies examined was 
close to 1.0, indicating that the population of antibody molecules were 
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Table 7 Mean dissociation constants and heterogeneity 










A10 B5 1.0 0.21p mole /200/1 1.1x10 -9M 
A7 B2 1.0 0.40p mole /2001 2.0x10 9M 
AMERSHAM 1.0 0.19p mole /2001 1.0x10 -9M 
STEINER G17 1.5x10 -9M 
7/15/74 
1.0 0.30p mole /200x1 
STEINER G28 0.9 0.042p mole /2001 2.0x10 1 °M 
Total assay volume = 200x1 
I 
4.6. Measurement of cross -reactivity of selected cyclic GMP 
antibodies with closely related nucleotides. 
4.6.A. Determination of complete cross -reactivity data for selected 
cyclic GMP antibodies. 
Cyclic GPI and related nucleotides were compared in a RIA system 
for their capacity to displace[ 3H] cyclic GNP from three antibodies, 
which showed different results by i mm nofluorescence. An antibody 
with high specificity for cyclic GMP would be expected to require 
large amounts of other nucleotides to compete with, and displace 
[3H]cyclic GNP; a low specificity antibody however, being unable 
to clearly distinguish cyclic GMP from related nucleotides, would 
only requke small amounts of these compounds to displace an 
equivalent quantity of [3H]cyclic GMP. It was hoped that examination 
of cross -reactivity data would help to determine the sites, or 
determinants, on the cyclic GMP molecule,conferring specificity 
of binding. 
The cyclic GMP antibodies were tested against cyclic GMP and 14 
related purine, and one pyrimidine, nucleotides (Sigma Chemical Co.). 
Standard cyclic GMP RIA curves were constructed for each antibody as 
previously described, with 0.2p moles of [3H] cyclic GMP, a zero binding 
level of 30%,and 10 -7 - 10 15 moles of related nucleotide in a volume 
of 50r1,in place of unlabelled cyclic GMP. Figure 23 shows cross - 
reactivity curves for A10 B5 antibody. 
A cross -reactivity index was calculated for each nucleotide, as the 
ratio of the amount of nucleotide to the amount of cyclic GMP, required 
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Table 8 Cross -reactivity of selected cyclic GMP 
antibodies to related nucleotides. 
Cross -reactivity index was calculated 
as the quantity of nucleotide relative 
to cyclic GMP to reduce relative binding 
of [3H4 cyclic GMP to 50% (cyclic GMP = 1) 
0.2p moles of [ H] cyclic GMP per assay tube. 
NUCLEOTIDE 
CROSS - REACTIVITY INDEX 






3',5'- cyclic GMP 1 1 1 
31,5'- cyclic IMP 21 270 8.3 
31,51- cyclic AMP 4,300, 24,700 15,000 
31,5' -cyclic UMP 4,000 65,000 23,600 
21,31- cyclic GMP 200,000 200,000 47,000 
21,3' -cyclic AMP > 250,000 > 290,000 > 280,000 
GMP > 250,000 - > 290,000 > 280,000 
GDP > 250,000 > 290,000 > 280,000 
GTP > 250,000 > 290,000 > 280,000 
AMP > 250,000 > 290,000 > 280,000 
ADP > 250,000 > 290,000 > 280,000 
ATP > 250,000 > 290,000 > 280,000 
2'0- monobutyryl 
31,51 -cyclic GMP 0.9 1.4 0.9 
N1monobutyryl 
3',51- cyclic GMP 380 1,000 360 
2'0- succinyl 
3',5'- cyclic GMP 
0.009 0.016 0.011 
2'0- succinyl 
3',5'- cyclic AMP 
100 
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4.6.B. Discussion 
i) The three antibodies showed similar cross -reactivity, although 
A10 B5 was slightly more specific. The data is similar to that 
reported for other cyclic GMP antibodies (231, 297). 
ii) Synthetic succinyl cyclic GMP showed approximately 100 -fold 
higher affinity for the three antibodies, compared with the 
naturally occurring cyclic GMP. This may be explained since the 
immunogen was succinyl cyclic GMP -HSA. This increased affinity has 
been exploited by Cailla et al (233, 234) using succinylated samples 
and standards, to increase the sensitivity of cyclic nucleotide RIA 
to the femtomolar level (see also-page305for acetylation of cyclic nucleotides) 
iii) A prime determinant for specificity appeared to be the 3',5' 
phosphodiester bond, since adenosine and guanosine mono, di, and tri- 
phosphate nucleotides showed very low cross -reactivity (>250,000). 
This is of particular value since ATP, for example, occurs at high 
concentrations in the cell (231), and might interfere with measurement 
of cyclic GMP levels by RIA. 
Even when the phosphate group is linked between the 2' and 3'positions 
on the ribose moiety (cyclic 27,31 - monophosphates), cross -reactivity 
was very low, stressing the importance of the 31,5' determinant. 
It is interesting that whilst 3',5' and 2',3' derivatives all showed -parallel 
RIA curves suggesting competition at the same site on the cyclic 
GMP antibody, this was not observed with non -cyclic nucleotides, 
suggesting that binding was occurring at different sites. 
-163- 
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Figure 24 Comparison of structures of cyclic nucleotides. 
Cyclic IMP cross -reacted with cyclic GMP to the greatest extent 
in comparison with the other cyclic nucleotides tested. Examination 
of the structures of the cyclic nucleotides (see figure 24 above) 
explains these observations,on the basis of molecular similarities. 
The importance of the 3',5' group in determining specificity relative 
to nucleotides without this cyclic structure, may be related to the 
3',5' bond altering the plane of the ribose moiety in cyclic 
nucleotides (as demonstrated in reference 298). 
Substitution of a butyryl group on the 2Lposition of the ribose sugar, 
had very little effect on affinity relative to cyclic GNP, whilst 
substitution of this uncharged group on the 112 position on the purine 
moiety, caused a modest decrease in affinity. 
These studies show that a prime antigenic determinant on the cyclic GMP 
molecule is the 31,5' cyclic structure, with substituents on the purine 
moiety conferring additional specificity. 
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4.6.C. Determination of cross -reactivity of cyclic GMP antibodies 
to cyclic AMP, taken from two rabbits during progressive 
immunization. 
Your bleeds from rabbits A7 and A10 were examined in one experiment 
for cross -reactivity to cyclic AMP (see table 9 below). Cyclic AMP 
was studied since it is naturally occurring, and usually present in 
tissues at higher concentrations than cyclic GMP. 
Table 9 Cross -reactivity of cyclic GMP antibodies,from bleeds 




A7 HUMID 2 4,000 
A7 BLEED 3 2,125 
A7 BLEED 4 6,786 
_47 BLF:FD 5 11,250 
A10 BLEED 2 27,660 
A10 BT,FF;D 3 11,406 
A10 BLRED 4 9,066 
A10 BT,FF;D 5 23,235 
Comparison of the data in table 9 with that in figure 22, shows a 
correlation in sensitivity and cross -reactivity (to cyclic AMP, 
during the course of immunization. This correlation is to be 
. . c,,-L 
expected (250), since a high avidity antibody to cyclic GMP with 
I. 
i'11- t 
binding sites 'tailored' to cyclic GMP, would not be expected to 
recognize and bind cyclic AMP as effectively. 
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5. COMPARISON OF CHARACTERISTICS OF CYCLIC GMP ANTIBODIES AS 
MEASURED USING RADIOIMMUNOLOGICAL TECHNIQUES, WITH ABILITY 
TO SHOW POSITIVE IMMUNOFLUORESCENT STAINING. 
To determine whether the binding of antibodies to nucleotide in a 
RIA system could be used to predict their usefulness in detecting 
tissue -bound nucleotide for immunofluorescence studies, cyclic GMP 
antibodies from immunization schedule II, Dr Steiner's laboratory 
and the Radiochemical Centre, were ranked according to their binding 
characteristics (titre, avidity and specificity), and compared with 
results by ;mmnnofluorescence. 
5.1. Immunofluorescence ranking of cyclic GMP antibodies. 
6rm rat cerebellar sections were incubated overnight, in an attempt to 
maximize specific staining (see page 105)with a range of dilutions of 
cyclic GMP antibodies, and equivalent concentrations of immunoglobulin 
from un;mmun-ized rabbits. It was found that whilst the majority showed 
no difference in staining in comparison:with non -immune immunoglobulins, 
and were therefore classed as negative, positive staining antibodies 
could be classified as localizing FIBRES or CAPILLARIES in cerebellar 
sections (for example, see figures 39, 49, and 50). The characterization 
of the positive staining structures is discussed in chapter IV. Three 
bleeds tested from one of Dr Steiner's rabbits, G17 (raised against 
succinyl cyclic GMP -KLH iunogen), showed particularly bright fibre 
staining, but surprisingly,whilst the three bleeds all specifically 
localized this component, one bleed in addition, showed capillary 
staining..( Rabbit G17 was boosted with immunogen between each bleed): 
STEIFER G17 7/15/74 STAINING (e.g.Fig JULY 1974 BUED FIBRE 49) 
STEINER G17 10/31/74 OCT 1974 BT,EF;D _K U RE STAINING 
STEINER G17 12/2/74 FIBRE AND CAPILLARY DEC 1974 BLEED 
STAINING (e.g.Fig 50) 
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Positive staining antibodies were ranked on the basis of intensity 
of specific staining relative to' background' (see page 188). 
Non -specific staining of cerebellar tissue sections could be clearly 
observed with concentrations of non -immune immunoglobulin (prepared 
by ammonium sulphate fractionation) in excess of approximately 
1mg protein /ml, the intensity increasing with concentration. 
The positive staining described in this thesis with cyclic AMP and 
cyclic GMP antibodies: G17, A10 B5, G28, #-7 and TEX cyclic AMP, 
was in the range of 0.2 - 0.8mg protein/61; A4 B2 and A7 B2 cyclic 
GMP antibodies were employed at 1mg protein /ml. With these latter- 
antibodies, brightly staining fibres could be clearly distinguished 
against the background non -specific staining of the Purkinje cells 
and structures in the granule layer, which probably represent the 
glomeruli (see figure 25 and also figures 53 and 58). 
Specific cyclic nucleotide antibodies were screened under identical 
conditions to non -immune immunoglobulin from the same animal, at 
the same concentration, for each brain area and tissue studied. It 
was often helpful to also employ higher concentrations of non -immune 
immunoglobulin, in order to maximize non -specific staining structures, 
as suggested by Hartman (257). 
5.2. Comparison of ranking of cyclic GMP antibodies using radio - 
immunological and immunofluorescence techniques. 
Examination of table 10 demonstrates that there is no binding 
characteristics) that either distinguishes positive or negative 
staining antibodies on immunofluorescence, or predicts iunofluorescent 
ranking. Furthermore, the extensive cross -reactivity studies carried 
out in section 4.6, were unable to show any significant differences 
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Figure 25 Immunofluorescent localization of cyclic GNP in 
rat cerebellum using antibodies A7 B2, Steiner G28 
and non -immune immunoglobulin. 
a) A7 B2 antibody 
b) Steiner G28 antibody 
5 Calibration bar = 50 
c) Non- immune immunoglobulin 
P - Purkinje cell body 
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Table 10 Ranking of cyclic GNP antibodies according to titre, 
sensitivity and cross -reactivity, and ability to show 

















A7B2 * A2R3 A7B4 G28 
A2B3 AlOB3 AlOB4 G17't11/14. 
AlOB5 * A2B4 A7B5 G17'hs/t 
A7B3 A4B2 * AlOB3 
A4B2 * A4B3 A10B5 * 
A10B2 G17042414.* A10B2 
A1B3 A7B4 
A9R4 Al OB2 
A7B4 Al B3 
G17 7/1s/74 * A7B2 * 
Al B2 G17'Íis/74* 
A10B4 AMFRS'FTAM 
A4B3 A1B2 
G17 '1/2/74- * Al 0B5 * 
A7B5 A7B5 
G28 * G28 * 
4 
AM AMER SH
NOTE: i) ARROWS show direction of increasing titre, sensitivity, specificity 
and intensity of specific immunofluorescent staining (relative to 
background). 
ii) ASTERISKS show positions of positive staining antibodies in ranking 
of titre,sensitivity and specificity. 
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between a fibre staining antibody (A7 B2), a capillary staining 
antibody (A10 B5), and one that is negative by immunofluorescence 
(Amersham). These three antibodies together with Steiner G17 12/2/74 
and G28, were also shown to be homogeneous with respect to affinity 
constants; this demonstrates that the positive antibodies do not 
contain, for example, a small population of molecules with very high 
affinity for cyclic GMP in the assay, which might be responsible for 
the positive staining patterns. 
5.3. To determine whether cyclic GNP antibodies might have binding 
sites masked by endogenous nucleotide. 
Since both cyclic AMP and cyclic GMP are found circulating in the 
plasma of u immunized animals (299), it was possible that production 
of antibodies in the plasma on repeated immunization could bind the 
circulating nucleotides, thereby masking some,or all,of the cyclic 
nucleotide antibody binding sites. In the case of low avidity antibodies, 
bound nucleotide is probably removed when the serum is fractioned with 
ammonium sulphate and the immunoglobulin fraction is extensively 
dialyzed. For the high avidity population, however, this procedure may 
not be sufficient to unmask all the binding sites. There exists the 
possibility, therefore, that the reason for the small number of antibodies 
showing positive immunofluorescence is due to this 'masking' effect. 
Steiner et al (215) have demonstrated that endogenous cyclic nucleotides 
can be removed from antibody under mild conditions which cleave the 
antibody -antigen bond, exposing binding sites which may prove useful in 
immunofluorescence. Following their methodology, three antibodies 
and a non -immune control were selected,and dialyzed with constant 
stirring (see page121) vs. 0.1M glycine -HC1 buffer at pH 2.2,overnight 
at 4 °C, followed by dialysis vs. PBS for an additional 3 days at 4 °C, 
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with three changes of buffer. The antibodies were then centrifuged 
at 15,000g for 15 minutes at 4°C ( Burkard 'Koolspin' centrifuge), 
to remove the slight cloudiness which resulted from this procedure. 
'Untreated' antibodies were compared with' treated' antibodies, using 
overnight incubation periods on frozen sections of rat cerebellum. 
The three antibodies were originally selected since one demonstrated 
fibre staining (A7 B2), one capillary staining (A10 B5), and one 
was negative on immunofluorescence (Amersham). After treatment there 
was no change, however, in these staining patterns, although there 
was increased non -specific fluorescence with the immune and non -immune 
immunoglobulin fractions. Similar effects were observed by Steiner 
et al (215), with certain antibodies, and may be attributed to 
irreversible damage caused to the immunoglobulin during the denaturation 
and renaturation dialysis steps. 
6. GENERAL DISCUSSION 
The characteristics of a large number of cyclic antibodies have 
been examined using radioiunological methods, in order to select 
antibodies for immunofluorescence on the basis of their titre, avidity 
or specificity. If the successful characteristic could be found, 
screening of antibodies for imrunohistochemistry would be rapid, and 
specific animals might be selected for a continta1 immunization programme. 
The development of these three antibody characteristics was monitored 
during progressive immunization of 10 rabbits with succinyl cyclic 
GMP -HSA immunogen. The results showed that not only do individual 
rabbits show varying immunological responses, but also that wide 
variation occurs between different bleeds. 
1(1 
The results also showed that antibodies demonstrating positive 
immunofluorescent staining could not be distinguished by the binding 
characteristics studied. Since slightly different staining patterns 
were observed with the positive immunohistochemical antibodies for 
cyclic GNP, a further object of the radioimmunological screening was 
to determine whether any of the binding characteristics were 
responsible. Again, neither titre, avidity nor specificity appeared 
to correlate with immunohistochemical staining patterns.Similar results 
were also obtained with cyclic GMP antibodies produced in Dr Steiner's 
laboratory and the Radiochemical Centre, which were tested in this 
study. The results suggest, therefore, that a larger pool of rabbits 
with selection using immnnohistochemical rather than radioimmunological 
criteria, should be employed in future studies. 
Although these experiments are, to my knowledge, the only detailed 
examination of radioimmunological techniques as potential screening 
methods for antibodies for use in immunohistochPmistry, a number of 
isolated reports have shown similar results. Swaab and Pool (300) for 
example, have stated that during progressive immunization, the ability 
of an antiserum to show positive i mm nofluorescence, decreased to such a 
point that it could not be used, whereas the titre by RIA remained high. 
An antiserum of low avidity by RIA has been shown to produce good results 
for immunohistochemistry (217), whilst another report showed a high 
specificity antiserum by RIA to have low specificity for imm nofluorescence 
(301). 
To explain these discrepancies, the following differences between 
Immunohistochemistry and RIA as techniques for detecting antigen should 
112 
be considered. 
i) RIA detects antigen by competition with tracer for specific 
binding sites on the antibody. RIA will therefore only monitor 
those antibody molecules that bind tracer. This contrasts with 
immunohistochemistry,where all antibody .molecules can bind and 
potentially localize their respective antigens,if present in the 
tissue section (302,303). The consequence of this difference is 
that the specificity controls differ for each procedure. By RIA 
the three cyclic GMP antibodies extensively examined for cross - 
reactivity with related nucleotides were highly specific. Specificity 
controls for immunohistochemistry are more rigorous, however, and 
require removal of the cyclic GMP antibody to correlate with removal 
of immunohistochemical.staining (302, 303). 
ii) RIA is an optimized, equilibrated assay system, which generally 
uses very high dilutions of primary antisera. In contrast, immuno- 
histochemistry generally uses primary antibody- at low dilution, 
for short incubation periodz (303). 
Discrepancies between equilibrium /non- equilibrium conditions in RIA and 
immunohistochemistry were eliminated in this study, however, using 
overnight incubation periods of tissue sections with cyclic GMP antibody 
Also, similar quantities of cyclic GMP antibodies were employed per tissue 
section and per assay tube, probably due to the relatively low titre of 
cyclic nucleotide antibodies in a tritiated radioimmunological system. 
iii) Perhaps the most important difference is that immunohistochemistry 
detects antigen which is bound in the tissue section causing its 
determinants to be modified or hidden, in contrast to RIA where the 
antigen is in solution with its determinants fully exposed. For example, 
it has been shown that antibodies generated against LH -RH conjugates 'see' 
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different portions of the molecule when bound in tissue sections 
for immunohistochemistry, whilst seeing the complete molecule in RIA (304). 
Since an antiserum contains a population of antibody molecules with 
different avidities for antigen, perhaps the reason for only certain 
cyclic GMP antibodies showing positive immunofluorescence, is that 
these antibodies contain a population of molecules with a higher 
avidity for cyclic GMP bound in a tissue section,thar free in solution. 
Different mechanisms of binding at different sites (as demonstrated for 
LH -RH, see reference 304) might also explain the different staining 
patterns with different cyclic GMP antibodies, as suggested by Steiner 
et al (215) and Dr E Rosenberg (personal communication). 
This concept is discussed more fully in chapter 4. 
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CHAPTaR IV 
CHARACTERIZATION AND VALIDATION OF CYCLIC 
NUCT,FOTIDE IMMONOFLUORESCENTT STAINING IN TEE C.N.S. 
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1. CYCLIC AMP IMMIINOHISTOCHMMISTRY 
1.1. Rat cerebellum and brain stem 
Employing antibodies Steiner# 7 and Steiner #8 from rabbits immunized 
with succinyl cyclic AMP -KLH conjugate,positive staining was observed 
predominantly in the granule layer of the rat cerebellum, with 
minimal reactivity in the molecular layer and white matter (see figure 26). 
The diffuse granule layer staining was similar to that obtained with 
non-immune ;mmunoglobulin, but could be clearly distinguished from 
non -specific staining on the basis of immunoglobulin concentration (see p.166). 
To determine whether the post -mortem elevation of cyclic AMP could be 
localized by immunofluorescence, sections were processed identically 
with Steiner #.7 antibody from rats whose cerebella were frozen within 
30 seconds,or 22 minutes after decapitation. Difficulty was found 
however, in removing the cerebella intact and immersing in the 
isopentane- liquid nitrogen freezing mixture within 30 seconds. Only 
after practise was it possible to freeze the tissue within this time, 
and this was inevitably accompanied by a certain amouitof damage to the 
cerebellum. In confirmation of the work of Bloom et al (236), the 
post -mortem rise in cyclic AMP was localized as increased staining in the 
Purkinje cell bodies, with no significant change in the other cell types 
(see figure 26); cerebella from three rats frozen at each time 
interval,were used in this study. 
Positive staining for cyclic AMP was also observed in the cytoplasm of 
selected large neurones in the brain stem, underlying the cerebellum. 
Positive staining neurones shown in figure 27 correspond to the 
mesencephalic trigemini nucleus, as judged by conventional histological 
localization of serially cut sections(toluidine blue staining, see appendix 4). 
- 178 - 
Figure 26 Immunofluorescent localization of cyclic AMP 
in rat cerebellum frozen in isopentane - 
liquid nitrogen within 30 seconds or 22 mins 
after decapitation - antibody#7. 
a) 30 seconds 
Calibration bar 
b) 22 minutes 
Calibration bar 





after decapitation. Low magnification. 
= 100ím 
after decapitation. Low magnification. 
= 100f -m 
after decapitation. High magnification. 
= 50km 
- granule layer 
molecular layer 
- Purkinje cell body layer 
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Figure 27 Comparative immunofluorescent localization of 
cyclic AMP and cyclic GMP in the brain stem of 
the rat. 
a) Cyclic AMP antibody# 7 
b) Cyclic GNP antibody, Steiner G17 10/74 ) Calibration bar = 10Orm 
Antibodies used at the same immunoglobulin concentration. 
The large neurones prominent in a),and faintly visible in 
b), correspond to those of the meseneephalic trigemini nucleus 
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and reference to a neuroanatomical rat atlas (308). 
Recently, I was able to examine a further cyclic, AMP antibody for 
immunofluorescence supplied by Dr Steiner. The antibody, TEX cyclic AMP, 
was raised against a succinyl cyclic AMP -HSA conjugate, and had been 
shown to be highly specific by RIA,and to show immunofluorescence in 
rat liver sections with a distribution as reported previously (305). 
In rat cerebellum frozen 21 minutes after decapitation (see figure 28), 
strong staining was observed in the granule layer,where the discrete 
localization to the granule cell nuclei clearly resembled that shown by 
Bloom's group (236), in contrast to the more diffuse staining shown by 
Steiner# 7 antibody in this layer. (Note however, that in rabbit 
cerebellum, figure 43, diffuse staining in the granule layer was also 
found with TEX cyclic AMP antibody). Widespread staining was also 
observed with TEX cyclic AMP antibody in the molecular layer and white 
matter, the pattern of staining resembling that of the glial nuclei 
stained with toluid'.1-q blue. In further contrast to the report from 
Bloom's group (236), and the observations with Steiner#7 antibody, 
only occasional Purkinje cell fluorescence was observed in rat cerebellum, 
which was frozen 22 minutes after decapitation. 
Ln the brain stem underlying the cerebellum, widespread staining of 
structures resembling the glial nuclei was observed with TEX cyclic AMP 
antibody, large neurones being unstained. 
Distinction between neurones and.glia might be studied using kainic acid, 
which selectively destroys neurones,whilst leaving glia intact and causing 
proliferation (309) , prior to cyclic AMP immunofluorescence. 
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Figure 28 Immunofluorescent localization of cyclic AMP in 
rat cerebellum using TEX cyclic AMP antibody. 
a) Granule and molecular layers 
b) Granule layer and white matter 
Calibration bar = 50rín 
g/G - granule layer 
m - molecular layer 
P - Purkinje cell body 
W - white matter 
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1.2. Rat substantia nigra 
Cyclic AMP immunofluorescence was performed with Steiner#7 and 
TEX cyclic AMP antibodies in the substantia nigra, a region of the 
brain known to contain neurotransmitter -sensitive adenylate cyclase 
(30'6) 
Dissection of area B in figure 29, containing the substantia nigra, 
was performed from two rat brains, using a pair of long metal blades 
moistened with ice -cold physiological saline, as described in 
reference 307. The dissected wedge of tissue was placed on a cork mat 
and frozen in isopentane- liquid nitrogen (see page 86), approximately 
5 minutes after decapitation. 6r'm coronal sections were cut in the 
cryostat, and the substantia nigra was located using toluidine blue 
histology and reference to a neuroanatomical rat atlas (308); serial 
sections were then processed for cyclic AMP immunofluorescence. No 
staining was observed in the substantia.nigra or surrounding areas with 
Steiner# 7 antibody, whereas TEX cyclic AMP antibody revealed widespread 
staining resembling that of glial nuclei stained using toluidine blue; 
the large neurones in the substantia nigra were unstained (see figure 30). 
1.3. Discussion 
Extensive studies on the localization of cyclic AMP, have been severely 
limited by the availability of positive staining cyclic AMP antibodies. 
The studies reported here, however, have suggested that different 
antibodies may have different abilities for localizing cyclic AMP, 
perhaps as a result of slightly different binding characteristics at 
different sites; this theme has been pursued more vigorously for cyclic 
GMP in this thesis. 
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Figure 29 Diagram showing ventral aspect of the rat brain, 
and regions dissected for immunohistochpm; cal 
experiments. 
Region kwas wa dissected for studies on the corpus 
striatum. 
Region B was dissected for studies on the substantia 
nigra and choroid fissure. 
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Figure 30 Immunofluorescent localization of cyclic AMP 
in rat substantia nigra using antibody TEX 
cyclic AMP. 
Toluidine blue staining to show substantia nigra and 
the choroid fissure. Low magnification. Calibration bar = 500r`m. 
b) Toluidine blue staining to show the large neurones in 
the substantia nigra. High magnification. Calibration bar = 100rm. 
c) Cyclic AMP im unofluorescence in the region of the 
substantia nigra. High magnification. Calibration bar = 100rn. 
SN /sn - substantia nigra. 
cf - choroid fissure. 
a) 
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2. CYCLIC GMP IMMUNOHISTOCHENIISTRY - 
OPTIMIZING CONDITIONS FOR POSITIVE 
IMlUNOFLUORESCENT STAINING 
Certain aspects of the technique were exami_ned,in order to maximize 
intensity of specific staining relative totbackgroundt immunofluorescence, 
using Steiner G17 cyclic GMP antibody. 
2.1. Section thickness 
10 - 14)11-m sections were originally used by Bloom et al for 
immunofluorescent localization of cyclic AMP in cerebellum, whereas 
tissue sections for routine immunofluorescence are now cut in Dr Steiner's 
laboratory at 2 - 6r`m. The effect of section thickness (4 - 12r'm) on 
cyclic GMP immunofluorescence was examined. It was found that 
thinner sections produced clearer fibre staining than thick sections. 
The minimal thickness, however, is limited by the efficiency and 
temperature of the cryostat (275), and whilst 4r`m sections could be cut, 
difficulty was often experienced at this thickness. Since serial 
sectioning was an important requisite, section thickness was routinely 
set at 6r'm,to ensure successful sectioning. 
Since immunofluorescence is dependent upon access of antibody to 
antigen in cells which have been cut open, reduction in section 
thickness would be expected to increase availability of antigen,and 
therefore improve staining. 
2.2. Antibody incubation time and dilution 
Modifications to the standard 30 minute incubation of first antibody 
e.g. increased temperature and increased incubation time, have been 
reported (318, 311). Positive immunofluorescence is dependent upon 
binding of specific antibody to tissue bound antigen. Daring a 
short 30 minute incubation period, we might expect all antibody 
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molecules to be available for binding to antigen, regardless of 
avidity, since the antigen -antibody interaction under these 
conditions, has probably not reached equilibrium. Increasing 
temperature and incubation time, however, will allow specific 
antigen -antibody interaction to reach equilibrium. Under these 
conditions, as for RIA, highest avidity antibody molecules will be 
bound to antigen. 
Steiner et al (215) have found similar staining patterns of cyclic 
nucleotide immunicfluorescence,using incubation times of first antibody, 
from minutes to many hours. These results suggest that the same 
molecules are involved for staining under non - equilibrium and 
equilibrium conditions. However, increasing incubation times allowed 
antibody dilutions to be markedly increased, reducing any non- specific 
effects and conserving valuable antibody. Experiments using Steiner 
G17 7/15/74 antibody incubated overnight (15 hours) on 6f'm rat 
cerebellar sections at room temperature, showed that antibody dilution 
could be increased 2 - 4 fold, and that whilst specific staining 
structures were the same as those observed at 30 minutes of incubation, 
non -specific background staining was reduced and specific staining was 
tsharper' (see figure 31). The results may be interpreted as the 
reduction of non -specific staining being due to the decreased immunoglobulin 
concentration,and the 'sharper' specific fluorescence being due to 
increased amounts of cyclic GXP antibody bound,under equilibrium 
conditions. 
Overnight incubation (15 hours) of first antibody was subsequently 
adopted,not only for cyclic GNP antibodies,but also for antibodies to 
other antigens. In all cases, extended incubation times showed clearer 
-187- 
Figure 31 Immunofluorescent localization of cyclic GMP in 
rat cerebellum - comparison of incubation times 
and cyclic GMP antibody dilution. 
a) Section incubated with Steiner G17 7/15/74 antibody 
(0.4mg protein /ml) for 30 minutes at room temperature. 
b) Section incubated with Steiner G17 7/15/74 antibody 
(0.2mg protein /ml) for 15 hours at room teperature. 
Photographs show granule layer of cerebellum. 
Calibration bar = 50fm 
- 188 - 
localization of positive staining structures,relative to background 
i.e. non -specific immunofluorescence. Increasing staining time above 
15 hours was not adopted,as it was occasionally found to cause loss of 
tissue sections from the 'coated' glass slides. 
Increased staining times allow localization of histochpmical charges 
in cyclic nucleotides (310), demonstrating that 'stimulated' 
nucleotides are still detected under these conditions. No advantage 
was found in increasing the incubation time or dilution of the second 
antibody (fluorescent conjugate), however. 
The working dilution, or immnnofluorescent 'titre', must be established 
for each antibody in each tissue, but may be interpreted differently 
amongst different workers. For example, one may aim for ma -ritual 
specific fluorescence by using a low working dilution, and be prepared 
to accept a degree of 'background' fluorescence. Others may a .im,however,for 
a lower intensity of specific fluorescence with complete absence of 
'background',by using a high working dilution of antibody. In the studies 
reported here however, dilutions of immune and non-immune immunoglobulin 
have been assessed in parallel on tissue sections, to obtain maximal 
contrast of specific fluorescence relative to background. 
2.3. Fixation 
Cyclic nucleotide immunohistochamistry is usually performed on unfixed 
frozen tissue sections, presumably since the pool of nucleotide that 
is localized is tightly bound in the tissue section (215). In many 
immunohistochemical techniques, however, fixation is essential to 
ensure localization, often by aldehyde perfusion for localization of 
antigens in the C.N.S. (see reference 311, for example). The effect 
of various chemical fixatives on cyclic GMP immunohistochemistry is 
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discussed in more detail in chapter VI, but the results showed that 
unfixed frozen sections were most suitable, also being quick and 
simple for tissue processing. Tissue freeze- drying coupled with 
wax embedding, which increases tissue preservation and prevents any 
possible diffusion of antigen in the tissue water whilst preparing 
frozen sections (275), has not been attempted,since it has been 
shown to reduce the amount of glial fibrillary acidic protein 
antigen available to antibody, in comparison with that available in 
frozen tissue sections; this resulted in decreased inmiunohistochemical 
sensitivity (312). 
CYCLIC GIP IMMONOHISTOCHENIISTRY - CHARACTERIZATION OF POSITIVE; 
STAINING IN THE C.N.S. 
3.1. Adult rat 
Antibodies generated against succinyl cyclic GMP -HSA or -KLH conjugates 
showing. positive staining,were classified on page165as staining fibres, 
capillaries or both components, in rat cerebellar sections. The following 
experiments were carried out to characterize these positive staining 
structures. 
3.1.A. Fibre staining 
Fibres were stained in all layers of the rat cerebellum, but were 
particularly marked in the molecular layer where long parallel fibres 
were observed, frequently running in groups'(figure 32), sometimes 
with a tortuous course (figure 33), and terminating at the external glia 
limitans at the centre of each folium. This distribution is observed 
with processes from the Bergmann glial cells whose cell bodies(which 
were unstained),surround the Purkinje cells (313). In cross -section, 
the fibres have the appearance of dots (see figure 34, for example). 
Membranes were observed in many areas surrounding small blood vessels, 
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a distribution characteristic of glial elements (313). 
Characterization of the stained processes as originating from 
astrocytes was achieved by comparative immunofluorescent studies 
with an antiserum to the glial fibrillary acidic protein (GFAP), 
generated in rabbits by Dr A Bignami (314). GFAP is a non -species 
specific nervous system protein,which has been extensively used as 
a selective marker for astrocytes in the C.N.S.(313, 314, 315), 
essentially for the fibrous type,which have long slender processes 
and differ from protoplasmic astrocytes, which have multiply ramified 
short processes (316). 
Sections of unfixed frozen tissue were processed for immnnofluorescence 
with either Steiner G17 7/15/74 antibody, or GFAP and non -immune sera 
at a dilution of 1:120, using overnight incubation periods. Identical 
areas of tissue were then compared and photographed. The results 
(figures 32, 33, 34, 49) clearly demonstrate the similarity of specific 
staining, suggesting that the cyclic GMP- positive fibres originate from 
astrocytes,rather than neurones or other types of neuroglia. 
The localization of cyclic GMP- positive fibres and GFAP may be contrasted 
with that of the glial marker protein S -100 which, for example, is found 
in the perikaryon of the Bergmann glial cell, in addition to the processes 
(313). 
Sections processed from other regions of the C.N.S. (brain stem, 
substantia nigra and striatum, figures 27, 35 and 36) showed similar 
localization of cyclic GMP and GFAP positive fibres, often as glial 
membranes surrounding small blood vessels (see figure 36). A more 
widespread distribution of staining was observed in white matter areas 
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Figure 32 Comparative Tmmunofluorescent localization of 
cyclic GMP and GFAP positive fibres in the 
molecular layer of the rat cerebellum. 
a) Steiner G17 7/15/74 cyclic Q1P antibody 
b) GFAP antiserum 
c) Steiner G17 7/15/74 cyclic GMP antibody 
d) GFAP antiserum 
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Figure 32 (Continued) 
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Figure 33 Immunofluorescent localization of cyclic GMP - 
positive fibres in the molecular layer of the 
rat cerebellum to demonstrate the tortuous 
course of the Bergmann glial fibres. 
Steiner G17 7/15/74 antibody used for immunofluorescent localization 
Calibration bar = 50p2 
Figure 34 Immunofluorescent localization of GFAP in rat cerebellum. 
Low magnification. Calibration bar = 100f`'m. 
gr - granule layer 
mol - molecular layer 
w - white matter 
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in the brain as would be expected, since fibrous astrocytes 
are predominantly foundin the white rather than the:grey' 
matter:. (316) . 
Figure 35 clearly shows the processes of a fibrous astrocyte 
stained with Steiner G17 7/15/74 cyclic GMP antibody, wrapping 
around a capillary as the specializedtend -foots (316), which attaches 
to the basement membrane. 
Although identical areas were photographed from several sections 
processed with both antibodies, it is clearly impossible to state 
categorically that every cyclic GMP positive fibre in a highly complex 
network such as the cerebellar granule layer or white matter, derives from 
a fibrous astrocyte. In this situation a tdouble- labellingt technique 
(194)would be beneficial to stain for cyclic GMP and GFAP on the same 
section with fluorescent anti- species conjugates of different colour; 
antisera from different species were not available to attempt this, 
however. 
With regard to the distinction of fibrous and protoplasmic astrocytes (313), 
staining in areas classically considered to contain the protoplasmic 
type e.g. grey matter of the striatum, has been observed in glial 
membranes surrounding blood vessels. 
Stab -wound injury to the frontal cerebral cortex of rats has been shown 
to tswitch -ont protoplasmic astrocytes to production of GFAP,and show 
strong GFAP- positive immmnofluorescent staining in these previously 
unstained glia (317). Stab -wound injury is therefore suggested as a 
future experiment tc determine whether cyclic GMP is involved in this 
induction of GFAP synthesis in protoplasmic astrocytes. 
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Figure 35 Immunofluorescent localization of cyclic GMP 
in the brain stem of the rat. 
Steiner G17 7/15/74 antibody used for immunofluorescent localization 
Calibration bar = 25/ni 
- 
Figure 36 Immunofluorescent localization of cyclic GMP 
in the substantia nigra and corpus striatum 
of the rat. 
a) Steiner G17 7/15/74 antibody used for localization of cyclic 
GMP in tissue section containing substantia nigra. Low 
magnification. Calibration bar = 1001`"ín 
b) Non-immune control for cyclic GNP antibody employed in a). 
Low magnification. Calibration bar = 100ím 
c) Steiner G17 7/15/74 antibody used for localization of cyclic 
GMP in the corpus striatum. High magnification. 
Calibration bar = 5011m 
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Future experiments might also examine the ultra -structural 
localization of cyclic GNP in astrocytes using PAP immunohistochPmistry, 
which may be of higher sensitivity (see page 61 ), to determine the 
relation of positive staining structures, to the intermediate size GFAP- 
positive glial filaments, as visualized by electron microscopy (318). 
Having made the distinction between fibre and capillary staining antibodies 
in rat cerebellum, it was also noted that in one structure in the rat 
C.N.S., namely the choroid plexus, cyclic GMP staining with 'fibre - 
staining' antibodies was found with a cytoplasmic distribution in the 
choroid epithelium (see figure 37). This is a specialized form of 
epithelium which resembles that of the ependymal (non- nervous) cells 
whip border on the ventricles (316). Comparison with figure 38 showed 
that these ependymal cells did not stain for cyclic (. Note, 
however, that the sub- ependymal glial network (313) formed from basal 
processes of the ependymal cells, showed positive cyclic ( -fibre 
staining. Non- ecific immunofluorescence was particularly noticeable 
as bright 'dots' at the apex of the ependymal cells, as described in 
reference 319. 
3.1.B. Capillary staining 
Capillary wall staining was observed with Steiner G17 12A2/74 and 
A10 B5 cyclic GMP antibodies in cerebellar tissue sections. Occasionally, 
bright 'dots' were observed in the capillary walls, probably representing 
the nuclei of endothelial cells (316) - see figure 39. 
Capillary staining was uniformly distributed in all layers of the 
cerebellum, and was also found in all brain areas studied, from all 
species examined in this thesis. 
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piaure 37 Tmmmnofluorescent localization of cyclic GMP in 
the choroid plexus. 
a) Steiner G17 7/15/74 cyclic GMP antibody. Arrow demonstrates 
positive cytoplasmic staining of an epithelial cell. 
b) Non-immune control for cyclic GMP antibody employed in a). 
Note non -specific staining at apex of epithelial cells. 
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Figure 38 Immunofluorescent localization of cyclic GMP 
to the sub- ependymal glial fibre network. 
a Steiner G17 7/15/74 cyclic GMP antibody. Low magn. Calibration bar= 100r`m 
b Toluidi:ne blue - ependymal cells. High magn. Calibration bar= 50í"m 
c Steiner G17 7/15/74 cyclic GMP antibody.High magn. Calibration bar= 50N 
-sí 
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Figure 39 Immunofluorescent localization of cyclic GNP in 
capillaries to show staining of endothelial cell 
nuclei. 
a) Steiner G17 12/2/74 antibody. Capillaries in cerebellar 
white matter of the rat. 
b) A10 B5 antibody. Capillaries in granule and molecular layers 
of the rat cerebellum. 
Calibration bar = 50rm 
G - granule layer 




- 201 - 
3.2. 10 day old rat. 
It was considered of particular interest to study the localization of 
cyclic GMP during development, since cerebellar levels of the 
nucleotide are 25 -30 fold lower in young rats (less than 12 days old) 
compared with the adult (180). Developing rat cerebellum is also a 
good model for studying astrocytic proliferation and therefore comparing 
distribution of cyclic GMP positive fibres with the GFAP antigen. 
Six,10 day old male rats (birth = day 1), from the Bush Estate Animal 
Breeding Station, Penicuik, Scotland, were employed in these studies. 
At this stage of post -natal development, rats are without body hair and 
their eyes are still closed. 
Animals were killed by cervical dislocation. Frozen 61"m sections of 
cerebellum from the young rats,required fixation in 2% freshly de- 
polymerized paraformaldehyde (see appendix 3),followed by buffer washes 
prior to application of antibody for immunofluorescence processing, to 
prevent loss of tissue sections from microscope slides. 
The peak of astrocytic proliferation occurs during the first post -natal 
week, after which time the granule layer, as found in the adult cerebellum, 
forms from migration of the abundant granule cells from the external to 
the internal granule layer (320, 321). Figure 40 shows the arrangement 
of cell layers in the cerebellum of a 10 day old rat using toluidine blue 
histology; this may be contrasted with that of the adult rat cerebellum, 
as shown in figure 9. 
Comparative immunofluorescent localization of cyclic GMP and GFAP 
positive fibres, showed. similar staining patterns in the cerebellum, 
although important differences were observed. GFAP staining was bright 
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Figure 40 Comparative irnofluorescent localization of cyclic 
GMP and GFAP in the cerebellum of a 10 day old rat. 
a) 
b) 
Toluidine blue staining to show arrangement of cell layers 
in 10 day old rat cerebellar cortex. Low magnification. 
Calibration bar = 100//'m 
GFAP antiserum. Low magnification. 
Calibration bar = 100rm 
c) Steiner G17 7/15/74 cyclic GMP antibody. Low magnification. 
d) GFAP antiserum. High magnification. 
Calibration bar = 50pm 
Note intense staining of Bergmann glial fibres in the 
molecular layer. 
e) Steiner G17 7/15/74 cyclic GMP antibody. High magnification. 
Calibration bar = 5Otm 
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Figure 40 (Continued) 
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Figure 41 Comparative immunofluorescent localization of cyclic 
GMP and GF.P in the brain stem of a 10 day old rat. 
a) GF.P antiserum 
b) Steiner G17 7/15/74 cyclic GMP antibody 
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in all layers, whilst cyclic GMP staining was most pronounced 
in the white matter (see figure 40). The Bergmann glial fibres, 
for example, showed strong positive staining for GFAP, but were only 
weakly stained with cyclic GMP antibody. In the brain stem underlying 
the cerebellum, similar staining was once again observed, although 
GFAP was more intense and slightly more widespread (see figure 41). 
3.3. Adult mouse and rabbit 
In view of the variability in response of rat cerebellar slices 
in vitro?, as described in the following chapter, biochemical studies 
were initiated on cerebellar slices from another laboratory animal, 
namely the mouse. During the course of parallel biochemical and 
immunohistochemical studies, it was found that cyclic GMP- positive 
fibres could not be observed in mouse cerebellum,with antibodies showing 
clear positive fibre staining in rat cerebellum (see figure 52). 
Antibodies showing capillary localization in the rat however, showed 
similar localization of these structures in the mouse. 
To determine whether astrocytic fibres were present in mouse cerebellum 
sections were stained with GFAP antiserum, which confirmed the presence 
of these fibres (see figure 42). 
In view of the differential localization of positive staining structures 
in the rat and mouse cerebellum, sections from two rabbit cerebella 
(as prepared on page 291) were also processed for immunofluorescence 
using Steiner G17 7/15/74 cyclic GMP antibody,which showed fibre 
staining in the rat, but not mouse cerebellum. In the rabbit,fibre 
staining was observed with a similar localization to that found in the 
rat; figure 43 contrasts the localization of cyclic GMP and cyclic 
AMP in rabbit cerebellum. Table 1.1 summarizes the immunofluorescent 
localization in rat', mouse and rabbit -CATS with. different..cyclic GMP antibodies 
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Figure 42 Immunofluorescent localization of GFAP in mouse 
cerebellar white matter. 
Section incubated with GFAP antiserum. 
Calibration bar = 50fm 
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Figure 43 Comparative immunofluorescent localization of cyclic 
AMP and cyclic GNP in rabbit cerebellum. 
a) TEX cyclic .AMP antibody. (White dot on photograph represents artefact). 
b) Steiner Gil 7/15/74 cyclic GMP antibody. Granule layer. 
Calibration bar = 5Orn 
G - granule layer 
m - molecular layer 
P - Purk;nje cell body 
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Table 11 Summary of im mrofluorescent localization of cyclic GMP 
in rat, mouse and rabbit C.N.S. tissue sections,using 
four different cyclic GMP antibodies. 
4. CYCLIC GMP IMM NOHISTOCHEMISTRY - COMPARATIVE; STUDIES WITH 
CYCLIC NUCLFOTIDE ANTIBODIES IN THE LIVER. 
It was considered important to determine whether the differences in 
immunofluorescent localization of cyclic GMP by different antibodies, 
might be confined to the C.N.S., or observed as a general phenomenon 
in other tissues. To examine this, immunofluorescence was performed on 
6,"m frozen sections of rat liver using overnight incubation periods of 
the cyclic GMP antibodies, at the same dilutions as those employed for 
localization in cerebellum. 
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A small piece of liver was removed from a rat and frozen in 
isopentane - liquid nitrogen approximately 2z minutes after 
decapitation. Using identical processing for immunofluorescence, 
similar staining patterns were observed with Steiner G17 antibodies 
(bleeds 7/15/74 and 1202/74) and 17 B2; see figure 44. Whilst 
hepatocyte membrane staining was observed, as previously reported 
in the literature for localization of cyclic GMP (215, 305), the 
intensity of staining was not particularly high, the clearest 
localization being observed with A7 B2 antibody. This was probably 
due to the fact that liver tissue required a lower 'working dilution' 
of antibody for optimal localization of the nucleotide, compared with 
C.N.S. tissue sections. 
Positive staining with cyclic GMP antibodies was not observed in nuclei, 
althoughthis was previously described by Steiner's group with certain 
antibodies; weak nuclear membrane fluorescence could be observed with 
A7 B2 antibody,however. The staining pattern with,I'itibody A10 B5 
showed a different localization from the other cyclic GMP antibodies, 
staining being confined to the endothelial lining of the sinusoids. 
Immunofluorescence was also performed with GFAP antiserum which essentially 
demonstrated no positive staining, although occasional fibres were 
visible. This observation suggested that the association of cyclic GMT 
and GFAP is confined to the C.N.S. and that the nucleotide is associated 
with fibrous astrocytes, rather than specifically with the marker protein. 
Positive staining with cyclic AMP antibody.# 7 along the sinusoids, 
confirmed that demonstrated in the literature (215, 305). 
These results in liver, demonstrate that differences in localization with 
cyclic GMP antibodies,may not be confined to the C.N.S. 
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Figure 44 Immunofluorescent localization with cyclic nucleotide 
antibodies in rat liver. 
Steiner G17 7/15/74 cyclic GMP antibody. 
Steiner G17 12/2/74 cyclic GMP antibody. 
A7 B2 cyclic GMP antibody - nuclear membrane arrowed. 
A10 B5 cyclic GMP antibody. 
e) #7 cyclic AMP antibody. 
Non-immune ;mmnnoglobulin. 
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5. CYCLIC GMP I MUNOHISTOCHEMIISTRY - SPECIFICITY. 
Specific i n nofluorescent staining is prirnarily dependent upon 
the defined Immunological reaction between the first antibody and 
the tissue antigen, in the indirect technique (194) . Whilst 
non -specific fluorescence due to non-immunological reactions 
has already been considered in detail, it is necessary to 
demonstrate that removal of either specific antibody, or specific 
antigen from the tissue section, results in elimination of staining 
(302, 303). The following discussion considers methods used for 
testing this immunological specificity. Stringent tests are required 
for cyclic nucleotide antibodies, since only a small number show 
positive imrmunofluorescence, and even these may show different 
staining patterns. 
5.1. To demonstrate that positive staining was due to antibodies 
generated against the immunizing conjugate. 
Staining patterns in cerebellar tissue sections were examined with 
immunoglobulin fractions of pre-immune sera and sera taken during the 
course of immunization, from a number of rabbits. The lack of positive 
staining with pre-immune immunoglobulins, demonstrated that circulating 
rabbit anti -tissue antibodies prior to immunization, were not 
responsible for staining. Specific staining structures were only 
localized with certain bleeds from rabbits, obtained after repeated 
booster injections of immunogen. Furthermore,imm nization of a large 
number of rabbits with cyclic 9HF, cyclic GMP kinase or catalytic 
sub -unit immunogens in the same species of rabbit, by an identical 
procedure, failed to show the positive staining structures found with 
cyclic GMP antibodies (see chapter VI). 
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5.2. To demonstrate that positive immunofluorescent staining was 
not a result of antibodies raised against the carrier 
protein employed for immunization. 
In cyclic nucleotide RIA, only the population of antibody molecules 
that binds tracer is under investigation, whereas for cyclic 
nucleotide immunohistochsmistry, the population of antibodies 
directed towards the carrier protein could also bind this protein, 
or cross -reacting antigens, in the tissue section. 
To demonstrate that immunization of rabbits with hapten- protein 
conjugates results in antibodies raised against not only the hapten, 
but also the protein, antibody A7 B2 which had been shown by RIA to 
have high specificity antibodies against cyclic (3P, was tested for 
antibodies against the carrier molecule, human serum albumin (HSA), 
and the related protein,bovine serum albumin (BSA). Agarose 
immunodiffusion plates were obtained from Miles Laboratories, Slough, 
Buckinghamshire (code no. 64 -275). 20/1 of undiluted antibody 
(imrmunoglobulin fraction) were placed in the centre well, and varying 
concentrations of the two proteins (in PBS) were placed in the six 
outer wells, in the same sample volume. After 72 hours at room 
temperature, the plates were viewed. With a concentration of HSA 
as low as 0.06mg /m1, a white line was observed between the centre hole 
and peripheral hole, demonstrating the presence of antibody. Using BSA, 
however, no line was observed with protein concentration as high as 
10mg /m1, the highest concentration tested in this experiment. These 
results demonstrate the specificity of the antibodies generated against 
the carrier protein. 
The possibility that antibodies against the carrier protein were 
responsible for immunofluorescent staining in tissue sections, was 
considered unlikely, since fibre and capillary staining was observed 
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with antibodies coupled to either HSA or KLH, demonstrating that 
the conjugation procedure did not effect staining pattern. However, 
antibodies A7 B2 and A10 B5 were incubated overnight with 10mg /ml 
HSA at 4 °C, to cause precipitation of the antibody -carrier complex 
(311). After centrifugation at 13,000g for 3 minutes (Eppendorf 
centrifuge), thefabsorbedt antibodies were compared with 'unabsorbed' 
antibodies, diluted in PBS at the same inm noglobulin concentration; 
no significant effect was observed on specific staining. As a further 
control, sections were incubated with a range of dilutions of commencial 
rabbit antisera to HSA (supplied by Nordic Immunologicals, Maidenhead, 
Berkshire); no staining was observed in tissue sections. 
5.3. To demonstrate that positive staining was due to cyclic GMP 
in the tissue section. 
Antibodies raised against succinyl cyclic AMP -HSA showed entirely 
contrasting patterns to those observed against succinyl cyclic GMP -HSA. 
This demonstrates that a non- specific antibody has not been raised 
against a component of the nucleotide- carrier linkage, causing positive 
imrmunofluorescent staining. This suggests that the cyclic GMP portion 
of the immunogen, in particular the purine determinants, are responsible 
for specific staining and the contrasting localization of cyclic AMP 
with cyclic GMP. 
RIA cross -reactivity data has demonstrated that the cyclic GMP antibodies 
used for immunofluorescence are specific, and do not show any appreciable 
cross -reactivity to related nucleotides. The following sections, however, 
consider methods of removing cyclic GMP antibody to satisfy the more precise 
inmiunohistochpmical criteria of specificity (302, 303). 
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5.3.A. 'Liquid- phase'blocking test. 
This test is often used to demonstrate specificity in immunohistochemistry 
(194). Antigen is added to antibody in solution, and in cases where 
the antigen- antibody complex precipitates e.g. protein antigens, 
complex may be removed by centrifugation, and the resulting 
supernatants,free from specific antibody, used to demonstrate removal 
of specific ;mmunofluorescence. This technique has been used for 
cyclic nucleotide imm nohistochemìstry with precipitating antibodies 
that are raised in goats (310). In cases where immune complexes are 
soluble e.g. rabbit cyclic nucleotide antibodies (215), specific 
antibody is not removed, but remains blocked by exce ?s antigen, and 
application of this blocked antibody to the tissue section should 
prevent specific staining. 
Steiner et al (215) have carried out'liquid- phase' blocking experiments 
in tissues such as liver with cyclic nucleotide antibodies, and reported 
that low concentrations (1/'ß'M) of the specific cyclic nucleotide 
could prevent staining, whereas higher concentrations of related 
nucleotides failed to prevent staining. 
Similar experiments have been performed in the laboratory using A7 B2, 
A10 B5 and Steiner G17 antibodies, incubated with concentrations of cyclic 
GMP as high as 1m M (of the sodium salt and the free acid), without 
producing any effects on specific staining in cerebellum or liver, however, 
using 30 minute or overnight incubation periods. 
To confirm that cyclic GMP antibody was effectively blocked after 
15 hour incubation at o 4 C with excess antigen, the binding capacity 
of antibodies were measured,.as described on page 141 The results 
in table 12 demonstrate that as little as 1/111 cyclic GMP used for 
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pre -incubation caused almost complete loss of binding forl3H] 
cyclic GMP, indicating that available cyclic GMP sites were blocked 
by this procedure. 
Table 12 Effect of pre -incubation of cyclic GMP antibodies 
(15 hours, 4°C) with concentrations of »niabelled 
cyclic GMP and cyclic AMP, on subsequent binding 










A10 B5 - 40.5 
10-311 cGMP 0.6 
10-411 cG1P 0.6 
10 
-6 
M cGMP 1.2 
10 -6M cAMP 39.9 
A7 B2 - 32.3 
10 o ' 
10-4M cGMP 0.7 
10 -6M cGMP 1.0 
10 
-6 




10 -3M cGMP 0.6 
10-4M cGMP 0 
10 -6M cGMP 0.7 
Percentage binding values shown in table, calculated after 
subtraction of non -specific binding(with non-immune immunoglobulin) 
Antibodies were also incubated in'liquid- phase'with 1 m M succinyl 
cyclic GMP and 1mg /ml of immunizing conjugate. Despite this, no 
reduction was found in the distribution or intensity of specific 
staining. 
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Incubation of Steiner G17 12/2/74 with 15 mM cyclic GMP under 
the same conditions, resulted in removal of capillary staining, 
whilst having no effect on fibre staining (see figure 45). Although 
this is a high concentration of cyclic GMP, and the specificity of 
this block must therefore be of question, incubation with 15 mm 
cyclic AMP had no effect on either capillarylor fibre staining, 
demonstrating a degree of immusxlagical specificity for the cyclic GMP 
block. To determine whether the capillary component of A10 B5 antibody 
showed blocking in a similar fashion with 15 mM cyclic GMP 
under these conditions, the experiment was repeated with this antibody; 
no effect was observed on capillary immunofluorescence, however. 
To ensure that staining,assumed to be due to cyclic GMP,could not be 
removed by incubating antibodies in 'liquid- phase' with related 
nucleotides,similar experiments were carried out by incubating Steiner 
G17,-A7 B2 and A10 B5 antibodies, with cyclic AMP, cyclic IMP, cyclic 
UMP and 5' GMP; no effect was found on immanofluorescent staining. 
The effect of increasing incubation time of antibodies with cyclic GMP 
was also observed,without effect, together with one hour incubation 
at 37 °C prior to overnight incubation. Similar results using 'liquid - 
phase' blocking to those previously described, were observed with#7 
and TEX cyclic AMP antibodies. 
The possibility was considered that staining was not being removed, 
since immune- complexes being applied to tissue sections in blocked 
antibodies, might be able to bind unoccupied cyclic GMP 'receptors' in 
the tissue, and therefore show positive staining; this effect has been 
observed with LH -RH immanohistochemistry (218). To examine this 
possibility, sections were incubated for 45 minutes at room temperature 
atizi=e Zel`*;a-t _af` ;icze.-;_imcú.im.-ti:on zrf Zti;-r,lar Z17 1L/2/'`74 aczer' ZEP ?arrtÿbh4y 1501 =c57tZic zrr 1516M 
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with 1 mM or 10 mM: cyclic GMP to saturate any unoccupied sites, 
followed by washing in buffer and immunofluorescence processing. 
No difference was found between sections pre -incubated with cyclic 
GMP or buffer (see figure 59). Similar results were also observed 
with TEX cyclic AMP antibody after pre -incution of sections with cyclic AMP. 
'Liquid -phase' blocking experiments, whilst widely used, have also 
been found by a number of workers to be unsuitable specificity controls 
for non -precipitating antibodies. For example, Swaab and Pool (300), 
have found pre -incubation ineffective and suggest that antibodies which 
are bound reversibly to free antigen during pre- incubation, 'prefer' 
the tissue -bound antigen,to the antigen in the medium. 
In studying cyclic nucleotide antibodies, Steiner et al (215) have 
reported that whilst some antibodies will block in 'liquid- phase', 
others will not, although all antibodies show the same staining patterns. 
This has also been observed by Rosenberg et al (personal communication). 
5.3.B. 'Solid- phase' blocking test. 
i) Introduction. 
An alternative approach to 'liquid- phase' blocking, is removal of specific 
antibody by absorption with antigen that is bound to an insoluble matrix 
(e.g. 215, 300). The technique of affinity chromatography enables 
antigen to be bound covalently in the form of a gel column; passage 
of antibody through the column enables specific antibody to bind, and 
be eluted under appropriate conditions of buffer strength and pH, which 
cleave the antigen -antibody bond. 'Solid -phase' techniques which are 
frequently used to prepare monospecific antibodies (280), might be 
expected to resemble imm?nohistochemical conditions, since antigen is 
immobilized in both cases. Purified antibodies, however, may be of low titre 
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Figure 46 Proposed mechanism for coupling primary 
amino groups to tactivatedt Sepharose. 
Redrawn from (323). 
Cyclic AMP and cyclic GMP possess a free amino group on the purine 
nucleus (N6 and N2 positions respectively), which is available for 
coupling to antactivated' form of Sepharose. Cyanogen bromide 
activation is most commonly employed, for coupling (see figure 46). 
The coupling procedure was attempted, as successfully employed by 
Fallon et al (324), for linking cyclic nucleotides to Sepharose. For 
small molecules linked covalently to Sepharose, 'spacer' groups are 
often substituted between the molecule and the gel. Six carbon 'spacers' 
are often used, and by increasing the distance of the molecule from the 
gel, increase the efficiency of antibody binding, by reducing steric 
hindrance (323). Affinity columns were therefore also constructed of 
cyclic nucleotides linked to activated Sepharose with a six carbon 'spacer'. 
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Cyclic nucleotide antibodies have also been purified using succinyl 
cyclic nucleotide -ESA, covalently linked to Sepharose (325, 326). 
This method of coupling was also attempted,to link the reactive amino 
groups of the protein carrier to the gel. In this way an effective 
'spacer' would be interposed between gel and cyclic nucleotide using 
the succinyl- protein link. A disadvantage of this column would be 
that 'carrier' antibody molecules would also be absorbed. 
The three coupling techniques were carried out under the conditions 
described below. The effectiveness of the columns was guaged by the 
binding capacity of high specificity cyclic (1P antibodies for [3HI 
cyclic Cam, eluted from 'control','cyclic AMP' and 'cyclic GNP' 
affinity columns. 
ii) Production of affinity columns. 
The following procedure (based on reference 324), describes the linking 
of cyclic AMP and cyclic GMP to'activated' Sepharose; identical 
procedures were carried out for production of the other affinity columns. 
Cyanogen bromide - 'activated' Sepharose 4B and'activated'ACH- Sepharose 4B 
(Sepharose with six carbon 'spacer'), were obtained from Sigma Chemical 
Company, Norbiton, Surrey. Pre -activated gels were used since cyanogen 
bromide activation is extremely hazardous. 
10g of the freeze -dried gel were suspended in 50m1 of 1 mM HC1, and 
stirred gently with a glass rod to remove any 'clumps' of gel. A 
glass sinter funnel(grade 3)was washed through several times with the 
acid. The suspended gel was transferred to the sinter, and washed through 
with 1 litre of 1 mM HC1, to ensure removal of dextran and lactose 
preservatives in the gel. 400m1 of distilled water were then passed 
through the gel, followed by 1 litre of 0.1M bicarbonate buffer, pH 9.0. 
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Three test tubes were each filled with 10m1 of gel (packed volume). 
1.5ml of a solution of either cyclic AMP, or cyclic GMP (50mg sodium 
salt, Sigma Chemical Co, dissolved in coupling buffer and adjusted to 
pH 9.0), or buffer, were added. Tubes were tightly stoppered, and 
shaken overnight at 4 °C on an automatic shaking machine (Luckham Ltd, 
England). After incubation, the contents of each tube were washed into 
three glass sinter funnels, with coupling buffer. Prior to use, the 
sinters had been thoroughly washed through with distilled water,and 
phosphate.- bufféred saline (see appendix 2). After washing, gels were 
stored in the buffer at 4 °C. Preservative was not added, since the 
gels were used, without recycling, within one week of preparation. 
In order to test the cyclic nucleotide -Sepharose columns, 1ml of each 
gel (packed volume) was placed in a disposable column. Colimmq were 
constructed from glass Pasteur pipettes containing a smalltplugt of 
cotton wool at the point where the pipette narrows, and a short 
length of polypropylene tubing, attached to the end of the narrow glass 
tube. Flow rates were made equivalent between columns, using small 
adjustable clips on the polypropylene tubing. Assembled columns were 
mounted on a rack and washed through with 5ml of PBS. 3001 of rabbit 
non -immune immunoglobulin (supplied by Mercia Diagnostics, and diluted 
1:10 with PBS) were then added to each column, followed by washing through 
with ,ml of buffer. Non -immune rabbit immnnoglobulin was used to block 
any non -specific reactive sites, which might have been present on the gel 
as a result of incomplete conjugation. 3001 of diluted cyclic T 
antibody were then layered onto each column, and washed through with buffer. 
Eluate was collected from each column after addition of specific antibody, 
together with ,lml of buffer washings to remove any loosely bound antibody. 
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Samples were dialyzed (as described on page 121 ) at 4 °C for 18 hours 
vs. distilled water. Dialyzed samples were then freeze -dried (Leybold- 
Heraeus GT2 freeze- dryer, Germany), and reconstituted with 300'1 of 
PBS. 5011 aliquots of each antibody were then assayed under identical 
conditions,for their ability to bind[3H]cyclic (p, as described on 
page141.Since some losses occurred during passage through Sepharose 
columns, binding of antibodies from 'control' columns. was compared 
with those from 'cyclic AMP' and 'cyclic G Pt columns. 
iii) Results. 
The results shown in table 13 demonstrate that whilst antibody to cyclic 
GMP is removed by passage through 'cyclic GNP affinity columns, 
significant amounts are also removed on passage through 'cyclic AMP' 
columns, although by RIA these antibodies show neglible cross -reactivity 
to cyclic AMP. In order to check that the cyclic nucleotide -Sepharose 
was neither saturated with antibody rumiing through the column, nor only 
partially accessible to antibody, aliquots of gel were incubated with 
antibody in Eppendorf tubes. After pre -blocking with non-immune 
immunoglobulin, gel was incubated with antibody for 30 minutes at room 
temperature, with frequent mixing. After incubation, gel was allowed to 
settle, and an aliquot of antibody tested for binding to[3H]cyclic GNP. 
Similar results were obtained as with the column procedure. 
iv) Discussion 
The results demonstrate that the affinity columns are not selectively 
removing a population of antibodies specifically directed towards cyclic 
GMP, when the purine amino group of the cyclic nucleotide is coupled to 
the matrix. Similar results were also obtained with linkage of the 
immunogen by the free amino groups of human serum albumin; it is assumed 
that the immunogen links via protein amino groups rather than the free 
purine amino group of the cyclic nucleotide. The low reactivity of this 
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Table 13 Binding of cyclic GMP antibodies to[3H]cyclic GMP 
after passage through cyclic nucleotide affinity 
columns. 
AFFINITY MEDIA 

























CONTROL - ACTIVATED 24.8 17.4 
SEPHAROSE 
cGMP - ACTIVATED 0 100 0 100 
SEPHAROSE 
cAMP - ACTIVATED 8.3 64.8 2.0 88.5 
SEPHAROSE 

















Percentage binding values shown in table, calculated after 
subtraction of non -specific binding with non -immune immunoglobulin 
in assay. 
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Figure 47 Two cyclic nucleotide derivatives that have been used 






N6- aminohexyl- amino -cAMP 
amino group on cyclic AMP, has been commented upon previously (327). 
Derivatives of cyclic AMP have been synthesized,and used to form a more 
highly reactive amino group for conjugation to Sepharose; for example, 
N6 - aminocaproyl cyclic AMP (327) and N6 - aminohexylamino cyclic AMP 
(328); see figure 47. 
Cyclic AMP has also been linked to Sepharose at the C -8 position (328, 329); 
linkage at this position makes possible the synthesis of any purine 
nucleotide - Sepharose conjugate. Recently, cyclic GMP has been immobilized 
for affinity chromatographÿ of cyclic GMP- dependent protein kinase (330), 
by synthesis of 8- (2- aminoethyl) -thio- cyclic GMP linked to Sepharose; see 
figure 47 above. 
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C8- nucleotide linked affinity columns might prove to be of higher 
specificity, and should therefore be considered for preparation in 
future studies. 
In these experiments cyclic AMP- linked Sepharose has been used to 
guage the selectivity of the cyclic GNP- affinity columns. Rosenberg 
et al (331) have shownthat passage of a cyclic AMP antibody through 
an agarose affinity column of N6- aminohexyl- aJnino- cyclic AMP, does 
not produce a specific cyclic AMP antibody, as judged by cross -reactivity 
of eluted antibodies to related adenaine nucleotides. 
To determine whether matrix -linked cyclic nucleotides prevented 
immunofluorescent staining by absorbed antibodies however, reconstituted 
antibody (A7 B2) from affinity columns of cyclic AMP- activated Sepharose, 
cyclic GMP- activated Sepharose, and control -activated Sepharose, as 
prepared on page 221 , were examined at equivalent rimmunoglobulin 
concentrations, by immunofluorescence on rat cerebellar sections. 
Figure 48 shows that there was no significant difference in 
immunofluorescent staining patterns with the column eluates, however. 
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Figure 48 Immunoflunrescent localization of cyclic GNP in the 
molecular layer of the rat cerebellum using A7 B2 
antibody, after passage through control and cyclic 
GNP affinity columns. 
a) Reconstituted antibody eluate from control Sepharose column. 
b) Reconstituted antibody eluate from cyclic GMP- Sepharose column. 
Calibration bar = 50N 
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6. GENERAL DISCUSSION 
Comparative immmmnofluorescent studies with fibre -staining cyclic 
GMP antibodies and the astrocytic marker protein, GFAP,revealed 
similar localization in adult rat C.N.S., and when applied to the 
cerebellum and underlying brain stem of the 10 day old rat. For 
similarities of GFAP and myosin immmmnofluorescence, which will be 
discussed in more detail in chapter VI,it has been reported (as found 
in these studies comparing GFAP and cyclic GMP), that both antigens 
show similar staining, although GFAP is 'sharper' (332). This has 
been attributed to myosin not being totally astrocyte -specific, and 
a similar argument may hold for comparison of cyclic GMF and GFAP 
fibre staining, since cyclic GMP imm,mnofluorescence is not restricted 
to the C.N.S.(e.g. localization in liver in these studies; see also 
reference 505). 
In one structure in the rat C.N.S. however, the choroid plexus 
epithelium, cyclic GMP fibre- staining antibodies showed a cytoplasmic 
localization, which was not found in the more unspecialized ependymal 
cells bordering the ventricles, perhaps suggesting a functional role in 
this structure (see chapter VI.). 
Having postulated that cyclic GMP antibodies contain populations of 
molecules with different avidities for tissue -bound nucleotide associated 
with different structures, a further degree of complexity is raised by 
the results in this chapter demonstrating that the fibre -staining 
component is observed in rat and rabbit C.N.S., but not in mouse C.N.S. This 
indicates that the particular configuration of tissue -bound cyclic GMP 
is either absent, or below the sensitivity of Lamunofluorescent detection 
in the mouse; further experiments will be required to determine whether 
this is a definite species, or perhaps strain effect. 
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Preliminary studies with a small number of cyclic AMP antibodies 
from Dr Steiner's laboratory have demonstrated that differences 
in binding of this nucleotide in the tissue section, may also cause 
differences in localization, in a similar way to cyclic GMP. The 
completely contrasting localization of the two nucleotides, however, 
emphasizes the degree of resolution that may be achieved by the 
technique, between structurally related nucleotides at different 
tissue sites. 
Proof of specificity of cyclic GMP immunofluorescence observed with a 
smell number of positive staining antibodies, is complicated by the 
failure of the classical tests of antibody removal to abolish 
iunofluorescent staining. Certain antibodies, for example, will 
specifically block staining when incubated with excess cyclic GMP in 
'liquid -phase', whereas others will not, although both types will 
demonstrate identical staining patterns (215). Similarly, certain cyclic 
GMP antibodies fail to block staining, even when passed through columns 
containing the nucleotide covalently linked to Sepharose gel. 
Applying the concept of stereo -specific differences in tissue -bound 
cyclic GMP, the population of antibodies useful for iunofluorescence, 
may have higher avidity for tissue -bound cyclic GMP than for nucleotide 
in solution, or even immobilized on a solid -phase matrix, under the 
conditions described in these experiments. 
RIA cross -reactivity studies have demonstrated that cyclic GMP antibodies 
showing positive immu ofluorescence,have high specificity for cyclic 
GMP in solution. Since the immnnohistochpmical specificity controls are 
incomplete, however, there exists the possibility that the antigen being 
localized in tissue sections may not be cyclic GMP. Future production 
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of rabbit cyclic nucleotide antibodies, must aim to select positive 
staining antibodies which are specifically blocked by'liquid'or'solid'- 
phase techniques. Of greater interest would be specific cyclic 
nucleotide affinity matrices, which could remove staining since they 
would indicate the configuration of bound nucleotide in the tissue 
section. Sub- cellular fractionation studies might also help to 
confirm immunofluorescent localization,and determine whether cyclic 
GMP is present in hitherto undetected sites (discussion on the bound 
pool of cyclic GMP in tissue sections is presented in chapter VI). 
A number of other observations suggest that cyclic GMP antibodies are 
localizing the tissue -bound nucleotide: 
i)Buffer- washed tissue sections,in which greater than 80% of cyclic 
GMP is lost (see chapter V), have a residual pool of cyclic GNP as 
detected by RSA of extracted tissue. 
ii) Initial observations using an enriched astrocytic fraction from 
8 day old rat cerebellum (321), have shown significant levels of cyclic ,AMT 
(approximately 10p moles/Mg of protein) compared with levels of 
approximately 2p mole /mg of protein, in a mixed cell population (personal 
communication, Dr J Garthwaite). Cyclic GMP has also been detected in 
vascular endothelial cell cultures from the intima of rabbit aorta (167). 
Since capillaries are tubes of endothelial cells surrounded by a thin 
basal lamina (316), this observation may be of significance. 
Attempts to alter tissue levels of cyclic GMP,to correlate with altered 
intensity or distribution of cyclic GMP immunofluorescence, are 
considered in the following chapter. 
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CHAPTER V 
ATTEMPTS TO CORRELATE BIOCHEMICAL 
CHANGES IN CYCLIC GNP TISSUE LEVELS 
IN THE CEREBELLUM, WITH IMMONOHISTOCHEMICAT, 
STUDTPS 
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1. MEASUREMENT OF TISSUE LEVELS OF CEREBELLAR CYCLIC GMP, 
USING RIA. 
In order to determine whether immunohistochemistry could localize 
biochemical changes in cyclic GMP to specific sites in the cerebellum, 
an assay was established for measuring tissue levels, based on the RIA 
technique previously described in chapter III. 
1.1. Preparation of tissue samples for assay 
Male, adult Wistar rats of approximately 200g, and male, adult albino CFI 
mice of approximately 35g, were obtained from the Bush Estate Animal 
Breeding Station, Penicuik, Scotland. 
For measurement of 'in vivo' cyclic GMP levels, approximately 
20mg. of cereIellar tissue were removed from the animal at a 
specified time after decapitation, washed briefly in'ice -cold' 
physiological saline,and homogenized with 2001 of 80% ethanol /water 
in 1.3ml plastic Eppendorf tubes using a Teflon pestle of 0.39" diameter 
(homogenizer,Gallenkamp, Glasgow). For 'in vitro' studies, slices were 
removed from the incubation medium and immediately homogenized. Following 
30 seconds of homogenization, 1ml of 8% ethanol /water was added to the 
tubes, which were then vortex mixed. It was important to ensure that 
homogenization was vigorous, but did not cause spillage of samples. 
Samples were allowed to stand for approximately one hour before being 
evaporated to dryness overnight on a 'Dri- Blocktat 60 °C (Grant 
Instruments, Cambridge). After complete drying, 2001 of RIA buffer 
(0.05M TRIS +4mM EDTA, pH 7.5) were added to each tube, followed by 
vigorous homogenization, until a 'milky' suspension was obtained. 1ml 
of assay buffer was added to each tube, followed by vortex mixing. A 
10 or 2011 aliquot was removed from the supernatants in each tube, for 
estimation of protein by the method of Lowry et al (374) - see appendix 5. 
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Tubes were centrifuged at 13,000g for 10 minutes (Eppendorf 
centrifuge) to ensure complete separation of supernatant from ' 
precipitated protein. An aliquot was taken from the supernatant 
from each tube,and appropriately diluted for cyclic GMP RIA; 
supernatant from each tube was stored at 4 °C,in case samples were 
required for re- assay. 
1.2. Cyclic GMP RIA 
The assay was carried out under similar conditions for construction 
of RIA standard curves,as discussed previously (see page 148). 
Standards from 0.06 to 2.0p moles cyclic GMP were employed in the 
assay. 50/1 of diluted sample were used in place of standards for 
measurement of cyclic GMP, one or two dilutions of each sample being 
assayed. Assays were conducted using duplicate samples; values 
showing greater than 5% variation between duplicates were discarded, 
and re- assayed. 
Prolonged storage of diluted antibody at 4 °C resulted in gradual 
reduction of zero binding level which, although not affecting the 
sensitivity of the assay adversely, could reduce precision if zero 
binding was lowered too far. Antibody was subsequently stored in 
frozen aliquots, which were thawed and diluted before use. Generally, 
no more than 60 assay tubes were processed in the one experiment 
(standards and samples in duplicate), standard curves being constructed 
for each assay performed. 
The majority of the cyclic GMP assays used the immunoglobulin fraction 
of a specific and sensitive antiserum supplied by the Radiochemical 
Centre, and employed in their cyclic GNP RIA kit (333). Due to the 
limited amounts of this antibody towards the latter part of my studies, 
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antibodies A7 B2 and A10 B5, whose specificity for cyclic GMP had 
been already established (see page161), were also employed for a 
number of assays. 
Dilution of assay samples was chosen to measure cyclic GMP in the 
range of 0.1 - 1.0p moles, where the standard curve has maximum 
slope and therefore greater precision (212), although detection limits 
(calculated as two standard deviations about zero binding) were 
calculated at approxiaaitly 0.03p mole in one experiment; the 
Radiochemical Centre cyclic GMP kit has a detection limit of 0.04p mole. 
The desired detection limit of an assay is dependent upon the tissue 
levels of the substance to be measured. The high levels of cyclic GMP 
in cerebellum did not require exquisitely sensitive techniques for 
measurement however. It should be considered though, that the higher 
dilution of a sample used in an assay, the less possibility there is of 
interference from cross -reacting molecules. 
1.3. Comparison of tissue levels of cyclic GMP measured with 
different antibodies. 
An experiment was carried out to determine the levels of cyclic GMP 
in incubated brain slices, using the immunoglobulin fractions of 
'Amersham' antibody, A7 B2, and A10 B5, and also the cyclic GMP RIA 
kit. The data is shown in table 14, and demonstrates that similar 
values were obtained with the different antibodies. 
1.4. Relation between sample dilution for RIA and cyclic GMP level. 
Table 15 shows the measurement of cyclic GMP (p moles /mg protein) using 
different dilutions of RIA sample, to demonstrate the close agreement 
between cyclic GMP level at differing dilutions of assay sample, measured 
using A7 B2 and A10 B5 antibodies. 
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Table 14 Comparison of tissue levels of cyclic CMP measured 
with different antibodies. 
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Table 15 Relation between sample dilution for RIA and cyclic Q level, using A10 B5 and A7 B2 antibodies. 
Values expressed as p moles cyclic GMP /mg protein 
DILUTION OF SAMPLE 
IN RIA A10 B5 A7 B2 
1/48 45.0 45.0 
1/72 43.6 40.5 
1/144 48.6 46.8 
1/288 46.8 45.0 
1/576 43.2 - 
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1.5. To determine whether the substance being measured 
by RIA is cyclic GMP. 
Cross -reactivity data (see page161) has shown that the antibodies 
employed for RIA are highly specific for cyclic GMP, showing minimal 
cross -reactivity with cyclic AMP, ATP and GTP, substances which might 
interfere in cyclic GMP tissue RIA. It is essential however, to 
demonstrate that specific removal of cyclic GMP from tissue extracts 
for assay, completely removes immuno- assayable material. There is a 
possibility that an unknown substance in the tissue extract could 
displace [3H1cyclic GMP from antibody, and therefore be falsely measured 
in the RIA. 
Cyclic GMP levels were therefore measured under normal and elevated 
conditions, in tissue extracts with, and without, the enzyme cyclic 3',5'- 
nucleotide phosphodiesterase. A small piece of cerebellum from a rat 
injected with either harmaline, a drug known to elevate cerebellar 
cyclic levels (see page 241 for experimental details), or saline control, 
was extracted with ethanol and homogenized in an Eppendorf tube with 2001 
of 1mM Tmidazole /1.6mM Mg SO4 buffer, pH 7.5. After complete 
homogenization, 1ml of this buffer was added to the tubes, which were then 
vortex mixed. 20/1 of the homogenate were removed for the estimation of 
protein by the method of Lowry et al (see appendix 5). After 10 minutes 
centrifugation at 13,000g (Eppendorf centrifuge),an aliquot of the 
supernatant was taken from each tube and appropriately diluted with buffer 
(' harmaline' sample 1 /144,'saline sample 1/24). 200-1 of each diluted 
sample were incubated with 101 of buffer containing 0.05 units of 
phosphodiesterase (Sigma Chemical Co), whilst a further 2001 of each 
sample were incubated as control, with 10/41 of buffer. Incubations were 
X Unit definition: one unit will convert 10 6moles of cyclic AMP to 
5' AMP per minute at pH 7.5, at 30°C, with no significant associated 
enzyme activities. 
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carried out for one hour in Eppendorf tubes at 37 °C in a water bath 
(Grant Instruments, Cambridge). Following the incubation, all 
samples were transferred to glass test tubes and heated for 10 minutes 
in a water bath at 100 °C, to destroy the enzyme. Two 50w1 aliquots 
from each tube were then assayed for cyclic (. 
Table 16 shows that phosphodiesterase has completely destroyed measurable 
cyclic GMP. 
Note: The discrepancy between the values in this table and table 17, 
showing the effect of harmaline on cerebellar cyclic GMP levels, may 
be due to samples -being homogenized in the Tmidazole/N!g 804 buffer 
(to optimize phosphodiesterase activity), but assayed in TRIS /EDTA RIA 
buffer. 
Additional support for the imm no- assayable compound being cyclic GMP 
comes from studies with incubated brain slices, where inhibition of 
cyclic 3',5'- nucleotide phosphodiesterase with the compound IBMX, 
produced large increases in measurable cyclic GMP (see table 24) 
Table 16 Effect of phosphodiesterase treatment on extracted 
cerebellar tissue samples, from two rats injected 
with saline control or harmaline, 30 minutes prior 
to sacrifice. 










Values expressed as p moles cyclic GMP /mg protein 
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1.6. Tissue deproteinization techniques for recovery of cyclic GMP. 
The most common tissue deproteinization techniques employ perchloric and 
trichloroacetic_ acids or aqueous ethanol, to precipitate protein and 
prevent further metabolism of cyclic nucleotides (333). The ethanol 
technique however,is simple,and has the advantage that it may be used 
to concentrate very low levels of substances for assay. 
An experiment was carried out to compare the recovery of endogenous 
cyclic GMP from rat cerebellum, using ethanol and trichloroacetic acid 
extraction. A small piece of cerebellum was removed from a rat, washed 
in ice -cold physiological saline, and divided into two equal parts. 
Ethanol precipitation of protein: 
One part of the tissue was thoroughly homogenized with 200w1 of sol% ethanol - 
water in an Eppendorf tube. 1m1 of the aqueous ethanol was then added 
and the tube was vortex mixed. After one hour, the contents of the tube 
were evaporated to dryness overnight at 60 °C on a 'Dri- Block'. When 
thoroughly dry, the sample was homogenized with 200`1 of RSA buffer, 
followed by addition of a further 1ml of buffer. After vortex mixing, 
a 20111 sample was removed from the homogenate for assay of protein. The 
tube was centrifuged for 10 minutes at 13,OOOg (Eppendorf centrifuge), 
an aliquot of the resulting supernatant being removed,and appropriately 
diluted for-assay. 
Trichloroacetic acid (TCA) precipitation of protein: 
The second part of the tissue sample was thoroughly homogenized by a 
colleague at the same time as the 'ethanol' sample, in 20Owl of'ice -cold' 
7% TCA in an Eppendorf tube. A further 1m1 of TCA was added,followed by 
vortex mixing;`le t-abewas then centrifuged for 15 minutes at 13,0O0g 
( Eppendorf centrifuge). The supernatant was removed to a 1Om1 glass test 
tube, and washed four times with three volumes of water -saturated ethyl ether, 
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to remove all traces of TCA. The contents of the tube were then dried 
under a stream of nitrogen gas from a cylinder. 1200/`"1 of assay 
buffer were then added to the tube followed by shaking to completely 
dissolve the contents. An aliquot of the solution was removed and 
appropriately diluted for assay. The precipitate obtained from the 
centrifugation of the Eppendorf tube was dissolved in 120014-1 of 
1W Na0H,anw7 20/1 were removed for assay of protein. 
Results: 
Tissue cyclic GMP- 10.8p moles cyclic GMP /mg protein 
ethanol extraction 
Tissue cyclic GMP- 9.0p moles cyclic GMP /mg protein 
TCA extraction 
Ethanol has also been shown to be more effective for cyclic AMP 
extraction, in comparison with TCA and perchloric acid (292). This is 
probably since the four wash -steps with ether are not required. 
To check the recovery of exogenous cyclic GMP, 50f1 of [3H] cyclic GMP 
were added to a mall piece of cerebellar tissue. Following homogenization, 
evaporation and reconstitution with buffer, 93% of the tracer was recovered. 
2. ATTEMPTS TO CORRELATE CHANGES IN CYCLIC GMP 'IN ViV0' WITH 
IMMDNOHISTOCHEMICAL CHANGES. 
2.1. Introduction. 
Experiments were carried out to determine whether immunohistochemistry 
could localize drug- induced changes in cyclic GMP to specific cell 
types or loci within cells, in rat cerebellum. 
It was initially important to ensure that cyclic GMP levels measured by 
direct homogenization of tissue samples after death, were equivalent 
to those in tissue that was frozen in the isopentane- liquid nitrogen 
mixture, in preparation for tissue sectioning for immunohistochemistry; 
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the possibility existed that freezing might in itself artefactually 
change cyclic GMP levels. 
Experiments were carried out to measure cyclic GMP levels in tissue 
homogenized or rapidly frozen, 2 minutes after decapitation. Cerebellar 
samples were compared from rats either injected with the tremorogenic.drug 
harmaline (40mg /Kg injected intra- peritoneally at 0.5mg /m1, using a 
25 guage needle, 30 minutes before sacrifice), or physiological saline 
as control. After 5 minutes, rats injected with harmaline displayed 
fine tremor which was maintained up to the time of sacrifice. This drug 
was chosen, since it has been reported to cause large biochemical 
changes in cerebellar cyclic GMP, independent of cyclic AMP, by a well - 
defined mechanism - activation of the climbing fibre input to cerebellum 
(172, 173). After 30 minutes, rats were decapitated and part of the 
cerebellum was removed. Tissue was briefly washed in'ice -cold' 
physiological saline and divided into two parts. One piece was homogenized 
in 80% ethanol /water, as described previously, whilst the other part was 
placed on a piece of labelled aluminium foil, which was attached to a 
metal frame and plunged into the isopentane- liquid nitrogen freezing 
mixture. With the assistance of a colleague, both these operations 
were carried out exactly 2 minutes after decapitation. 
The sample homogenized directly in aqueous ethanol was assayed for cyclic 
GMP and protein, as described previously. After 1 minute in the freezing 
mixture, the other sample was transferred to the cryostat (- 25 °C), 
and allowed to equilibrate for 30 minutes before being placed in a 
pre -cooled Eppendorf tube within the cryostat. 2001 of pre- cooled 8Cr/o 
ethanol /water were then added, ensuring that the tissue sample was 
covered. The tube was then removed from the cryostat and rapidly 
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homogenized, followed by addition of 1m1 of aqueous ethanol and vortex 
mixing. Cyclic GMP and protein were then assayed, as described previously. 
Table 17 shows that both direct homogenization, and freezing in isopentane- 
liquid nitrogen prior to homogenization gave similar levels of cyclic 
GMP, and confirm the elevation of cerebellar cyclic GMP levels by 
the drug harmaline (172, 173). 
Table 1 : Cerebellar cyclic GMP levels after saline or harmaline 
(40mg/Kg)injectiori 30 minutes prior to sacrifice - effect 
of direct homogenization,or freezing prior to homogenization. 
Values expressed as p moles.cyclic GMP/mg protein, 






SALINE 6.1 6.0 
5.5 6.3 
8.8 Mean = 6.2 
Mean = 6.8 
HARMALINE 27.0 44.1 
40mg/Kg 
i.p. 36.0 18.5 
34.1 39.6 
25.5 25.7 
Mean = 30.7 Mean = 32.0 
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2.2. Cyclic GMP immunohistochemistry applied to cerebella 
from rats injected with harmaline, to elevate cyclic 
GMP levels. 
6/Ina frozen sections were cut from 'saline' or 'harmaline' injected 
cerebella, and processed for cyclic GMP immunohistochemistry using 
three antibodies; Steiner G17 12AA/74, A7 B2 and A10 B5. Dilutions 
were chosen such that fluorescence with 'saline' injected sections 
was bright, but not maximal, in order to maximize any increases in 
intensity which might be observed with sections from'harmaline'cerebella, 
as a result of increased cyclic GMP levels. 'Saline' and 'harmaline' 
sections were examined on the same slide to eliminate any differences 
in slide processing. Positive staining was observed with the same 
distribution,and the same intensity,in 'saline' and 'harmaline' 
sections by visual comparison. For a more objective comparison, 
photographs were taken from different areas of 'saline' and 'harmaline' 
sections, using the same exposure times and identical development and 
printing conditions, (see figure 49). 
Comparison of prints taken from the molecular layer, granule layer and 
white matter areas of 'saline' and 'harmaline' sections showed no 
differences in distribution and /or intensity of cyclic GMP inmmnofluorescence; 
micro- dissection of mouse cerebella, however, had shown increased 
cyclic GNP biochemically, in the molecular latyer,after harmaline injection 
(169). 
These experiments have been carried out on a total of 8 rats injected 
with harmaline, and 8 saline- injected controls with identical results; 
they have also been independently confirmed by Y Koide of Dr Steiner's 
group (personal communication). Identical results were also obtained 
with 'saline' and 'harmaline' sections fixed by immersion in 'ice -cold' 
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Figure 49 Immunofluorescent localization of cyclic GMP in 
sections of cerebellum taken from rats injected 
with saline control or harmaline prior to decapitation, 
and the effect of buffer washing or fixation on 
;mmnnofluorescence, prior to application of antibody. 
All sections were processed identically using Steiner G17 
7/15/74 cyclic GMP antibody. 
a) Unfixed section from rat injected with saline control) 
b) Unfixed section from rat injected with harmaline: )Calibration 
bar =50iim 
c) Unfixed section from saline- injected rat, washed 
in buffer,prior to application of antibody ))Calibration bar =100Nm 
d) Unfixed section from harmaline- injected rat, washed 5 
in buffer,prior to application of antibody 
e) Section from saline- injected rat fixed in Lice -colds 
2% freshly depolymerized paraformaldehyde and washed 
in buffer, prior to application of antibody 
Calibration bar =5Orm 
f) Section from harmaline- injected rat fixed in lice - 
cold' 2% freshly depolymerized paraformaldehyde and 
washed in buffer,prior to application of antibody -granule layer 
M - molecular layer, P - Purkinje cell body, G - granule layer,W - white matter 
B 
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Figure 49 (Continued) 
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2% freshly depolymerized paraformaldehyde (see appendix 3), followed 
by 3 x 3 minute washes in PBS, prior to processing for immunofluorescence 
(see figure 49) . 
2.3. Cyclic GMP immunohistochemistry applied to cerebella from 
rats treated with either pentobarbitone or ethanol, to 
decrease cyclic GMP levels. 
Whilst harmaline elevates cerebellar cyclic GNP levels several -fold, 
cyclic GMP levels have been reported to be decreased by a number 
of drugs which act as C.N.S. 'depressants' (55) e.g. intra- peritoneal 
injection of pentobarbitone has been shown to decrease cerebellar 
cyclic GMP levels (334), whilst intra- gastric intubation of rats 
with ethanol causes a dose -dependent decrease in cyclic GMP, in rat 
cerebellum (335). 
Two groups of 3 rats were injected intra- peritoneally with either 40mg /Kg 
of pentobarbitone ('Sagital' -May & Baker Ltd, Dagenham, Essex) in 
physiological saline, or saline control. 5 minutes after injection rats 
were decapitated, followed by freezing of cerebella in isopentane- liquid 
nitrogen, 2 minutes later. 6/um sections were processed for cyclic 
GMP imrmunohistochemistry and photographed,as before. No differences 
were found between intensity and /or distribution of specific fluorescence. 
Ethanol was administered to a group of 4 rats by intra- gastric intubation 
as a 20% w.v. solution in water (335), water being given by the same 
method to 2 control animals. Rats were fasted prior to the experiment 
in order to clear their stomachs. By biting onto a clamped wooden 
stick drilled with a small hole, a narrow plastic tube, coated in 
liquid paraffin, was passed through the hole and fed into the stomach. 
It was important to ensure that the tube entered the oesophagus and not 
the trachea,passing completely into the stomach with minimum resistance. 
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Figure 50 Immunofluorescent localization of cyclic GMP 
in cerebellar sections taken from rats treated with 
either ethanol or water. 
Sections were processed identically using Steiner G17 
12/2/74 cyclic GMP antibody. 
a) Cerebellar section from rat treated with ethanol solution by 
intra- gastric intubation. 
b) Cerebellar section from rat treated with water (control) by 
intra-gast±ic intubation. 
Calibration bar = 5Orm 
Gr - granule layer 
Mol - molecular layer 
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Between 6 and 7ml of aqueous ethanol or water were slowly administered 
to each rat by means of a plastic tube and syringe. 
Rats given aqueous ethanol became very drowsy on being returned to 
their cages, remaining sedentary until sacrifice one hour later; 
the greatest decrease in cerebellar cyclic GNP levels (335) has been 
found to occur at this time, after oral administration of ethanol. 
After decapitation the cerebella were removed and frozen 2 minutes later. 
6f m frozen sections from 'control' or 'ethanol' cerebella showed no 
difference in intensity and /or distribution of specific cyclic GMP 
staining with Steiner G17 1202/74 antibody, on visual or photographic 
comparison (see figure 50). 
2.4. Conclusion. 
Several drug treatments have been selected, which cause the most 
significant increases or decreases reported in cerebellar cyclic GMP 
levels 'in vivo'. Employing visual and photographic semi -quantitative 
techniques on unfixed and fixed frozen sections, no changes have been 
found in the intensity and /or distribution of cyclic GMP immnnofluorescence 
with the three positive staining cyclic GMP antibodies examined. 
3. ATTEMPTS TO CORRELATE CHANGES IN CEREBELLAR CYCLIC GMP 
'IN VITRO' WITH IMMUNOHISTOCHENICAL CHANGES 
3.1. Introduction 
Since attempts to correlate tin vivo' biochemical changes with 
imrunohistochemical changes had been unsuccessful, it was decided to 
employ 'in vitro' techniques to attempt to localize, in particular, the 
large biochemical changes in cyclic GMP induced by depolarizing agents, 
as reported by Ferrendelli's group (149, 150, 151). 
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Tncubated respiring brain slices containing a heterogeneous cell 
population, have the advantage over !in vivo' studies that the 
extra -cellular environment of the tissue may be precisely defined and 
controlled, although they are not subject to effects that may occur 
in the intact brain. To illustrate this latter point, harmaline which 
is effective in elevating cerebellar cyclic GMP levels several -fold 
'in vivo' causes a slight decrease in levels 'in vitro' (169). This 
is because it exerts its effect 'in vivo' by stimulating the intact 
climbing fibre input to the cerebellum, thereby indirectly elevating 
cerebellar cyclic GMP levels (172, 173). 
Preliminary biochemical studies were carried out in incubated 
cerebellar slices to establish that significant elevations in cyclic 
GMP could be obtained by a number of agents, acting by different 
mechanisms. A method was developed for freezing incubated slices and 
cutting frozen sections, which could then be processed in the usual way 
for cyclic GMP immunohistochemistry. This technique had previously 
been used by Kebabian et al (239) for cyclic nucleotide localization 
in incubated slices of bovine superior cervical ganglion, and Kapoor 
and Krishna (336) for pancreatic slices, but represented the first 
application to 'in vitro! studies with C.N.S. tissue. 
3.2. Preparation and processing of incubated cerebellar slices. 
A Krebs- Ringer incubation buffer was continually gassed with 95% 02,5 %002 
(British Oxygen. Co. Ltd, London) from a cylinder, for 1 hour'on -ice; 
and used for preparation of tissue slices,as decribed below. The 
constituents of the buffer were: 120mM NaC1, 4.7mM KC1, 25mM NaHCO3, 
1.2mM KH2PO4, 2.401 MgSO4, 2mM CaC12 and 10mM glucose (149). 
Rats were stunned with a sharp blow, and decapitated; the cerebella and 
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underlying brain stem were removed. Mice were killed by cervical 
dislocation. Care was taken to ensure that cerebella were not . 
damaged during decapitation or during removal from the skull; 
cerebella were discarded if damaged in any way. Rat or mouse tissue 
was briefly washed in lice -cold' buffer, and transferred to a small 
piece of filter paper soaked in buffer,and resting on an 'ice -cold' 
Petri dish. Tissue from the brain stem was carefully removed, and 
the cerebellum was positioned on a drop of glycerol on a small filter 
paper circle, in a Mcllwain tissue chopper (Mickle Laboratories, Surrey; 
see reference 307). The cerebellum was orientated so that coronal 
sections could be cut. A small amount of glycerol was also placed on 
the sharp razor blade of the tissue chopper, and slices were then cut 
at either 350I`"ß or 75011m, at maximum cutting rate. The chopped tissue 
and filter paper were then immersed in.ice -cold buffer and slices 
were carefully teased apart with the aid of forceps. Possibly a more 
rigorous selection procedure was used for slices than would normally be 
employed by other workers in biochemical experiments, since 
immunohistochemistry was also to be performed on sections taken from 
these slices; rarely, therefore, were more than three or four slices 
obtained from each cerebellum. Selected slices were transferred to a 
vial containing fresh buffer which was sealed, and stored on ice. The 
procedure was repeated as rapidly as possible with remaining animals, 
slices being stored in the sealed vial. When all the slices had been 
obtained, they were washed several times with fresh buffer and 
transferred to 60mí of'ice -cold pre- gassed buffer in the pre -incubation 
vessel. This was incubated in a water bath (Grant Lnstruments,Cambridge) 
at 37 °C, pre -incubation .une commencing when the buffer attained this 
temperature. 
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In early experiments, slices were incubated with buffer in a beaker, 
the medium being replenished with fresh,pre- gassed buffer at 37°C, 
every 30 minutes. Comparison of this technique with one employing 
continuous gassing of the medium, revealed much lower levels than 
with the continuous gassing technique, however. This was probably due 
to inadequate oxygenation of incubated slices, and continuous gassing 
was therefore used for all future experiments. 
A length of polypropylene tubing sealed at one end was fixed down 
the side, and to the bottom, of a glass beaker where it formed a 
circle. Passage of gas down the tube and into the buffer through 
perforations in the walls of the tube enabled the medium to be 
continuously gassed, the bubbles gently agitating the incubated slices. 
At the end of the pre -incubation period, sliceswere lifted onto a metal 
holder and each rapidly transferred to a similar continuous gassing 
apparatus, for incubation with the test agent. After incubation, slices 
were individually removed :.sing the metal holder, and rapidly homogenized 
in 200f1 of 80'%o ethanol- water, in Eppendorf tubes. 1ml of the aqueous 
ethanol was added,vortex.mixed, and samples were assayed for cyclic GMP 
and protein. 
For immunohistochemistry, slices were placed on labelled cork mats in a 
metal frame and rapidly frozen in the isopentane- liquid nitrogen freezing 
mixture. After equilibration in the cryostat, 6Jm sections were cut 
and processed for cyclic OP immtunohistochemistry. With the help of 
a colleague slices could be homogenized or frozen at the same time after 
removal from the incubation medium;this period was standardized at 
30 seconds. 
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3.3. Experiments using incubated slices of rat cerebellum. 
A preliminary experiment demonstrated that incubated slices would have 
to be at least 750rM thick to enable sections to be cut for 
immnnohistochemistry, after freezing. 7501"m rat cerebellar slices 
were pre -incubated for'two hours, the period reported for stabilization 
of basal levels after the post -mortem decapitation increase in cyclic 
nucleotides (337). Cyclic GMP levels were then measured after 
additional incubation for 15 minutes in fresh Krebs- Ringer buffer, 
and after 15 minutes incubation with a depolarizing agent -'high 
potassium' Krebs- Ringer buffer. This buffer, as described in 
reference 149, substituted the 4.7mM KCl in the normal buffer with 
120 mM KCl. To maintain the overall ionic strength of the buffer, the 
NaC1 concentration was reduced from 120mM (normal buffer) to 5mM in the 
'high potassium' buffer. The results shown in table 18 demonstrate the 
appreciable variation in basal cyclic GMP levels in the rat cerebellar 
slices, and levels after 'high potassium! buffer. Two slices assayed 
from the same rat showed significant variation in basal levels, suggesting 
that the cause was not inter- animal variation. It was considered that 
the variation might be a result of the slice thickness used. 'In vitro' 
biochemical studies are generally carried out on slices not greater 
than 400rm, since this is the theoretical maximum for adequate oxygenation 
of the interior of a C.N.S. slice (307). 
Experiments were repeated using 350rm incubated slices. Table 18 shows 
that - similar results were obtained with wide variation in cyclic GNP 
levels between slices, even from the same animal, and lack of stimulation 
with !high potassium! buffer, indicating that the effect was not related 
to inadequate oxygenation. This variability and lack of stimulation, 
precluded the use of rat cerebellar slices for iunohistochemical studies. 
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Table 18 Cyclic GMP levels in individual rat cerebellar slices 
of 750ím and 350rm thickness, after incubation for 15 
minutes in normal Krebs- Ringer or 'high potassium'(120mM) 
buffer. 
2 hour pre -incubation in normal Krebs -Ringer buffer. 
Values expressed as p moles cyclic GMP /mg protein. 
15 minute incubation 
in normal Krebs- 
Ringer buffer 
.15 minute incubation 






THICKNESS 14.2 36.5 
34.8) 












26.4 1 21.6 ) Rat 2 
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These results differ from those of Schmidt et al (337) who showed 
that after two hours pre -incubation, 'high potassium' buffer caused 
a significant elevation in cyclic GMP levels in rat cerebellum. These 
workers used finely chopped tissue rather than uniform slices, however, 
which may account for the stimulation they reported. Rinscherf 
et al (149), although showing higher cyclic GMP levels than I have 
reported in these studies,have also demonstrated extreme variability 
in basal levels in machine cut 300- 3501"m slices from rat cerebellum, 
and small stimulation with thigh potassium' buffer, as compared with 
cerebellar slices from a number of other species. 
Incubation of adult rat cerebellar slices has been found to result 
in swelling and pyknosis of neural and glial cells by ultrastructural 
techniques (153). Tissue which has been hand -cut however, shows 
better preservation than that which has been machine- chopped as 
employed in these studies. The biochemical levels of cyclic GMP in 
hand- chopped rat cerebellar tissue have been found to be constant 
under basal conditions and to show large responses to depolarizing 
stimuli (personal communication, Dr J Garthwaite). 
3.4. Experiments using incubated slices of mouse cerebellum. 
In contrast to the variable basal levels of cyclic GMP in rat cerebellar 
slices, incubated slices of adult mouse cerebellum at 750rm . 
and 350/4m, showed relatively constant basal levels, after one hour 
pre -incubation, similar to those reported by Ferrendellits group (149, 
150, 151). Incubation for five minutes with 'high potassium' buffer 
elevated cyclic GMP levels approximately 5 -fold in slices of both 
thicknesses (see table 19). This increase, whilst significant, is 
considerably less than that reported by Ferrendelli et al (150,151), 
who demonstrated maximal increases of approximately 40 -fold with 
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Table 19 Cyclic GMP levels (p moles/mg protein) in individual 
750ím and 350í4m mouse cerebellar slices, after 
incubation in normal Krebs- Ringer or 'high potassium' 
(120mM) buffer. 
Bracketed values represent slices processed in same experiment. 
(1 hour pre -incubation in normal Krebs- Ringer buffer). 
Significant difference between incubation in normal and 'high potassium' 
Krebs- Ringer buffer -:pt0.01, Wilcoxan two -tailed rank test. 
Basal cyclic GMP levels 
after pre -incubation 
5 minute incubation 















Mean. = 4.9 Mean = 26.9 
Standard deviation Standard deviation 












Mean = 5.9 Mean = 29.9 
Standard deviation Standard deviation 
= 1.72 = 7.21 
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respect to basal levels after five minute stimulation in this 
buffer. Whilst differences in experimental technique might be 
partly responsible for the variation, strain differences between 
mice may be significant. This has been suggested by Saito (155), 
studying responses of cyclic GMP in incubated slices exposed to 
adenosine. 
Increasing the incubation time ìn'high potass im buffer above five minutes 
however,resulted in more variable responses between slices. 
To ensure that the stimulation of cyclic GMP was a result of the 
changed potassium concentration of the buffer, cyclic GMP levels were 
measured in 75O/m mouse slices after one hour pre -incubation in normal 
Krebs- Ringer buffer, and in slices transferred and incubated for either 
5, 10, 15 or 20 minutes in buffer of identical composition. The results 
in table 20 show that the process of transferring slices had no 
significant effect on cyclic GMP levels, and that basal levels were 
constant for at least 80 minutes of pre -incubation. 
Table 20 Cyclic GMP levels (p moles /mg protein) in individual 7501''m 
mouse cerebellar slices transferred after incubation, and 
incubated in identical buffer for different periods of time. 
BASAL CYCLIC GMP LEVELS MINUTES OF INCUBATION IN IDENTICAL BUFFER 
AFTER PRE -INCUBATION 
5 10 15 20 
5.3 8.5 7.5 4.0 6.6 
6.7 
6.8 
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120mM KC1 was employed as !high potassium! buffer, since this 
concentration was found by Ferrendelli et al (150, 151) to give 
ma-Time-1 elevation of cyclic GMP in mouse cerebellar slices. 
In one experiment 750ím slices were incubated in thigh potassium! 
buffer at 20mM and 60mM KC1; NaC1 concentration was altered accordingly 
to maintain ionic strength. The results shown in table 21 indicate 
that whilst 20mM KC1 only caused a slight elevation in cyclic GMP 
levels, 60mM KC1 produced similar results to incubation in 120mM KC1 
thigh potassium! buffer (compare with table 19). 
Table 21 Cyclic GMP levels (p moles /mg protein) in individual 
750p m mouse cerebellar slices, after 5 minutes incubation 
in 20mM KC1 or 60mM KC1. 
(n = number of slices) 
see table 19 
Basal cyclic GMP levels 
after pre -incubation 20mM KC1 60mM KC1 
Mean = 4.9 11.8 24.0 
(n = 12) 
8.8 42.0 
Standard deviation 




Mean = 8.6 Mean = 30.7 
Standard deviation Standard deviation 
=a311- = 7.09 
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The dependency of 'high potassium' stimulation of cyclic GMP on 
calcium ions, as previously reported (150, 151), was confirmed 
by pre -incubating 750rm mouse cerebellar slices in Krebs- Ringer 
buffer for 45 minutes, followed by incubation for 30 minutes in 
buffer without calcium ions, and with the addition of 1mM EGTA. 
Three slices were then incubated for either 5, 10 or 15 minutes in 
120mM 'high potassium' buffer without calcium ions,and with the 
addition of the chelating agent; elevation of cyclic GMP was 
blocked under these conditions (see table 22 below). 
Table 22 Cyclic GMP levels (p moles /mg protein) in individual 
750í`m mouse cerebellar slices, after incubation with 
'high potassium' (120mM) buffer, in the absence of 
calcium ions. 
Basal cyclic 
GMP levels after 
45 minutes 
pre -incubation 
Cyclic GMP levels 
after 30 minutes 
incubation in 
calcium -free 
Krebs- Ringer + 
1mM EGTA 
Minutes of incubation 
in'high potassium' 
(120 mM) buffer - calcium 
+ 1mM EGTA 
5 10 15 
5.7 4.7 
5.6 
4.0 9.0 9.0 
To determine whether inhibition of cyclic nucleotide phosphodiesterase 
would significantly elevate cyclic GMP levels in mouse cerebellar 
slices, after 1 hour pre -incubation in normal Krebs- Ringer buffer, 
three slices were incubated for either 5, 10 or 15 minutes in buffer 
containing 1mM 3- isobutyl 1- methyl xanthine (IBMX, Aldrich,'Gold Label'), 
a potent inhibitor of phosphodiesterase. The results show that cyclic 
GMP levels were elevated with respect to control (see table 23). 
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In the same experiment, three slices were incubated after pre - 
incubation, for either 5, 10 or 15 minutes in thigh potassium' 
buffer + 1mM IBMX. After 5 minutes incubation, the cyclic GP 
level was elevated approximately 10 -fold compared with control. 
These results, shown in table 23, suggest that thigh potassium! 
buffer elevates cyclic GMP due to an action on the synthesizing 
enzyme, rather than by inhibiting phophodiesterase. 
Table 23 Cyclic GMP levels (p moles /mg protein)in individual 
750JLm mouse cerebellar slices incubated in normal 
Krebs- Ringer or !high potassium! (120mM) buffer, in 
the presence of a phosphodiesterase inhibitor. 
(n = number of slices) 
Bee table 19 
Basal cyclic Minutes of incubation Minutes of incubation 
GMP levels after in Krebs- Ringer buffer in !high potassium! 
pre -incubation + 1mM IBNIX buffer + 1mM IBMX 
5 10 15 5 10 15 
Mean = 4.9 
(n = 12) 18.1 14.3 15.0 54.3 48.8 46.6 
In a further experiment, slices were pre -incubated for 1 hour in 
normal Krebs- Ringer buffer containing 1mM IBMK; greater than 16 -fold 
elevation in cyclic GMP levels was observed, compared with slices 
pre -incubated in normal buffer without the phosphodiesterase 
inhibitor. Subsequent incubation of three slices withthigh potassium! 
buffer, produced very large increases in cyclic GMP levels, demonstrating 
the capacity of the incubated mouse cerebellar slice for accumulating 
cyclic GMP (see table 24). 
The calcium- dependent effect of cyclic GMP stimulation with !high 
potassium buffer was presumably due to an indirect effect on the soluble 
guanylate cyclase, which requires calcium ions for activation (114). 
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Table 24 Cyclic GMP levels (p moles /mg protein) in individual 
750fin mouse cerebellar slices after 1 hour pre -incubation 
in normal Krebs- Ringer or Krebs- Ringer with addition of 
1mM IBMX, followed by incubation with thigh potassium' 
(120mM) buffer + 1mM IBMX. 
(n = number of slices) 
see table 19 
Basal cyclic GMP Cyclic GMP levels Time in minutes after 
levels after pre - after pre -incubation incubation in 'high 
incubation in in Krebs- Ringer + potassium' buffer + 
normal Krebs- Ringer 
buffer 
1mM IBMX buffer 1mM IBMX 
5 72 20 
Mean = 4.9 90.4 150.9 192.0 117.3 
(n = 12) 71.3 
78.4 
The particulate guanylate cyclase which is present in mouse cerebellum 
(338), is calcium -independent, and has been shown to be stimulated 
by sodium azide and other agents, elevating cyclic GMP levels in 
incubated slices of rat cerebellum and other tissues (339). To 
demonstrate whether similar elevations could be elicited in slices of 
mouse cerebellum, 750rm slices were pre -incubated for 1 hour in normal 
Krebs- Ringer buffer, followed by incubation with 1mM sodium azide. 
Cyclic GMP levels were elevated to a similar extent as for incubation 
with 'high potassium' buffer (table 25). In a similar experiment to 
that described previously (see table 22), sodium azide was found to 
elevate cyclic GMP in the absence of calcium ions, presumably due to 
activation of the calcium -independent guanylate cyclase. 
The effect of the neurotransmitter noradrenaline was also investigated 
on mouse cerebellar slices, since it has been found to elevate cyclic 
GMP levels in a glial cell line (165). Noradrenaline (L- ARTERENOL HCL, 
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Table 25 Cyclic GMP levels (p moles /mg protein) in individual 
750ím mouse cerebellar slices incubated with 1mM 
sodium azide in the presence or absence of calcium ions. 
Minutes of incubation 
in sodium azide + calcium ions 
5 72 10 122 15 
1mM sodium azide 
+ 2mM Ca 
(normal Krebs - 
Ringer buffer) 
14.8 31.5 25.7 29.6 30.3 
1mM sodium azide 
- Ca 
+ 1mM EGTA 
22.5 
32.8 
24.9 31.3 29.3 30.9 
48.5 
Table 26 Cyclic GMP levels (p moles /mg protein) in individual 
750/ím mouse cerebellar slices incubated with 1mM 
noradrenaline. 
Basal cyclic GMP 
levels after pre- 
incubation in 
Minutes of incubation in 
1mM noradrenaline 
normal Krebs- Ringer 5 10 15 
buffer 
5.7 10.9 12.7 3.5 
4.7 
5.6 
Sigma Chemical Co) was dissolved in buffer directly prior to the start 
of the experiment since oxidation rapidly occured,producing a pirk 
coloration of the medium. 
A, small increase was observed in cyclic GMP levels after incubation 
with the neurotransmitter (see table 26). 
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3.5. Cyclic GMP immunohistochemistry applied to mouse cerebellar 
slices. 
Mouse cerebellar slices were incubated under identical conditions to 
those used for biochemical estimations, for subsequent i unohisto- 
chemical processing. Slices were incubated with the following agents: 
1) 7 slices were pre -incubated for 1 hour in normal Krebs- Ringer 
buffer as control. 
2) 4 slices were pre -incubated for 1 hour in normal Krebs- Ringer 
buffer, followed by 5 minutes incubation in 'high potassium' (120mM) 
buffer. 
3) 3 slices were pre -incubated for 1 hour in normal Krebs -Ringer 
buffer, followed by 5 minutes incubation in 1mM sodium azide. 
4) 2 slices were pre -incubated for 1 hour in normal Krebs- Ringer 
buffer, followed by 5 minutes incubation in 1mM noradrenaline. 
5) 4 slices were incubated for 1 hour in Krebs- Ringer buffer 
containing 1mM IBMX. 
The process of freezing incubated slices was found to have no effect 
on cyclic GMP levels in comparison with biochemical assay after direct 
homogenization, observations comparable with those found for 'in vivo' 
studies (see table 17). 
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Although incubated slices were prepared at 750rm, some difficulty 
was:..experienced in cutting serial 6tm frozen sections for 
immnnofluorescence. Sometimes only small parts of sections could be 
obtained due to the frozen tissue slice being 'wrinkled'. Sections 
were only processed if visual examination of the frozen section clearly 
showed a number of cerebellar folia. 
Although 750í"m and 350Nm incubated slices responded in a similar way 
biochemically, it was possible that part of the slice might have been 
unresponsive due to dead cells or swelling of cells, and that cyclic 
GMP might be unevenly distributed through the slice. The outer layer 
of cut cells would,in particular, be damaged during the long incubation 
procedure. Frozen sections were therefore cut from a number of the 
incubated slices at different positions through the slice,to compensate 
for any variation. 
Cyclic GMP iunohistochemistry was performed on either unfixed frozen 
sections, or those fixed with 2% freshly depolymerized paraformaldehyde 
prior to application of the cyclic GMP antibody. A10 B5 and Steiner G17 
antibodies were both used,but as stated previously (see table 11) 
only bleed 12/2/74 of the latter antibody showed positive staining, 
and fibre staining was absent. 
Visual and photographic semi -quantitative techniques were unable to show 
any differences in distribution and /or intensity of specific staining, 
in any of the céll layers with any of the treatments or between 
sections from the same slice (see figures 51 and 52). Experiments 
were repeated several times, using antibody dilutions designed to give 
minimal specific fluorescence under basal conditions, in an attempt 
to maximise any differences between basal and stimulated slices. 
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Figure 51 Immunofluorescent localization of cyclic GMP in frozen 
sections,from mouse cerebellar slices incubated with 
120nM thighotassium' buffer or 1mM sodium azide,or under 
control conditions. 
Sections processed identically with A10 B5 cyclic GMP 
antibody. 
a) Slice incubated in normal Krebs- Ringer buffer. 
b) Slice incubated in 120mM 'high potassium' buffer. 
c) Slice incubated in Krebs- Ringer buffer containing 1MM sodium azide. 
Calibration bar = 5Orm 
g - granule layer 
m - molecular layer 
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Figure 51 (Continued) 
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Figure 52 Immunofluorescent localization of cyclic GMP in 
frozen sections from mouse cerebellar slices, 
incubated in the presence or absence of 1mM 
noradrenaline. 
Sections processed using Steiner G17 antibody 
(bleeds 7/15/74 and 12/2/74). 
a) Slice incubated in normal Krebs-Ringer buffer; section 
incubated with Steiner G17 antibody(bleed 7/15/74). 
b) Slice incubated in normal Krebs- Ringer buffer; serial 
section to that used in a) above, incubated with Steiner 
G17 antibody (bleed 12/2/74). 
c) Slice incubated in normal Krebs- Ringer buffer; section 
incubated with Steiner G17 antibody (bleed 12/2/74). 
High magnification. 
d) Slice incubated in Krebs- Ringer buffer containing 1mM 
noradrenaline; section incubated with Steiner G17 antibody 
(12/2/74). High magnification. 
Calibration bar for a) and b) = 100fí 
Calibration bar for c) and d) = 50/'m 
G - granule layer 
M - molecular layer 
P - Purkinje cell body layer 
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Using both 'in vivo' and 'in vitro' techniques, no changes have been 
observed in intensity and /or distribution of cyclic GMP immunofluorescence, 
under a variety of conditions in which cyclic GMP tissue levels have 
been shown to significantly change biochemically. 
The absence of correlation suggests that imm,unofluorescence might not 
be localizing 'stimulated' cyclic GMP, which might be lost on the 
tissue sections during immu ohistochemical processing, by either being 
soluble or loosely bound to the tissue; the experiments in the following 
section were designed to examine this possibility. 
4. CYCLIC NUCLEOTIDE LOSSES FROM CEREBELLAR TISSUE SECTIONS 
DURING PROCESSING FOR I MlONOHISTOCHEMISTRY. 
4.1. Introduction. 
in histochem; cal studies examining losses of enzymes from tissue-sections, 
Wachsmuth (340).has shown that whilst membrane -bound enzymes are not 
lost from unfixed buffer- washed tissue sections, soluble enzymes e.g. 
aldolase and lactate dehydrogenase, show significant losses from unfixed 
or acetone -fixed sections, on subsequent immerson in buffer. 
Steiner et al (215) have suggested that losses of the low molecular cyclic 
nucleotides may occur from tissue sections, and could be quantified by 
measuring cyclic nucleotides extracted from tissue sections, in the 
buffer washings. It seems likely that the reason why losses have not 
been measured experimentally by groups using cyclic nucleotide imm no- 
histochemistry, is that increases in fluorescence have paralleled the 
biochemical increase in levels in a number of tissues (e.g. see 
references 236 and 239) . 
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In experiments designed to measure cyclic GMP losses from rat 
cerebellar frozen sections, quantification in buffer washings was 
not attempted since levels would be extremely low, almost certainly 
prohibiting measurement. Cyclic GMP levels were therefore measured 
in frozen sections, before and after buffer -washings. Unwashed 
sections contain total nucleotide i.e. bound and free' cyclic GMP, 
whilst washed sections will contain only that pool of cyclic GMP 
which is tissue-bound i.e. the amount remaining, and therefore 
potentially able to be visualized, on the tissue section. 
Measurement of tissue levels of cyclic nucleotides in homogenates, 
are obtained by extraction of the nucleotides after protein denaturation. 
The levels obtained are total levels and do not give any information on 
whether the nucleotides are free or bound' i.e. to soluble or 
tissue -bound specific receptor proteins. Recently, the occupation of 
cyclic AMP- dependent kinase receptor protein, by cyclic AMP, has been 
measured under different conditions to estimate free and bound 
nucleotide (341). In the following experiments which are described, 
free and bound' refer to whether cyclic nucleotides are attached to 
insoluble tissue proteins; the''bound pool is that potentially 
available for immunohistochemical localization, since the possibility exists 
that !hidden' antigenic determinants on the tissue -bound nucleotide, 
could prevent access of total nucleotide in the bound pool, to 
specific antibody. 
4.2. Cyclic GMP losses from buffer- washed cerebellar sections 
taken from controlled rats. 
To determine the effect of buffer washing on tissue cyclic GMP,unfixed 
sections were assayed for cyclic and protein, and serial scc».icns 
were washed and agitated for 3 x 3 minutes in buffer prior to assay, 
to remove soluble or loosely bound nucleotide. 
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Preliminary experiments showed that approximately 30 x 10rm frozen 
sections would be required to accurately determine both protein and 
cyclic GMP levels, using the assay procedures already described. 
A total of 60 x 10pm frozen sections were cut from each of 10 
cerebella frozen 2 minutes after decapitation, at different positions 
throught the cerebella, to minimize any possible regional differences 
in cyclic GMP. Alternate sections were placed on two coated glass 
slides (appendix 1); the 30 sections were placed close together on 
each slide. After drying the slides in air for 30 minutes, one slide 
was labelled 'unwashed' and remained on the bench, whilst the other was 
placed in a metal staining rack, and washed three times for 3 minutes 
in 400m1 of PBS in a staining dish. On removal from the dish, 
both slides were dried under cool air from a hair- dryer, to evaporate 
buffer. Initial experiments showed that distilled water could be 
substituted for PBS as the third wash, without affecting biochemical 
measurementsor immunofluorescence; this prevented the white film of 
buffer salts forming on the 'washed' slide,after drying. 
For estimation of cyclic GMP and protein levels, sections were carefully 
scraped off each slide with a plastic pipette tip and 8% aqueous ethanol, 
and washed into Eppendorf tubes with a total of 1.2ml of the aqueous 
ethanol. The tubes were vortex mixed, and allowed to stand for 1 hour. 
After this time they were opened and placed in a 'Dri- Block' (Grant 
Instruments, Camb- ̂idge) overnight,at 60 °C. When dry, the contents of 
the tubes were homogenized in either 120r1 or 150rl of radioimm noassay 
buffer (0.05M TRIS /4mM EDTA), followed by centrifugation at 13,000g 
for 10 minutes (Eppendorf centrifuge). Duplicate 5orl samples were used 
directly in the RIA for measurement of cyclic GMP. The remaining 
supernatants were removed, and the precipitates re- suspended in 50`1 
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of distilled water. Aliquots of the suspension were appropriately 
diluted, duplicate samples of 20/1 being used for estimation of 
protein. 
The results shown in table 27 demonstrate the very large loss (greater 
that ac%) of cyclic GMP, after buffer -washing of tissue sections. 
The values are expressed as p moles cyclic GMP /mg protein, to correct 
for any variation in tissue quantity taken from the assay. Washing, 
however, causes a loss of soluble proteins to the buffer. If the 
results are expressed as p moles cyclic GMP in washed and unwashed 
sections, the percentage loss is even greater than shown in the table. 
This is important when comparing fluorescence in washed and unwashed 
tissue sections, since intensity is dependent upon quantity of cyclic 
GMP, rather than concentration. 
The large losses in cyclic GNP show that in cerebella taken from rats 
and frozen 2 minutes after decapitation, only a small fraction of cyclic 
GMP remains on the tissue section after buffer washing. Processing 
tissue during imm»nohistochPmistry requires either 6 or 7 buffer washes 
altogether, so it could be possible that the fraction of cyclic Q 
contributing to the fluorescent staining pattern could be even less 
than reported here, where three buffer washes have been employed. However, 
employing overnight washing of tissue sections in gently agitated PBS, 
prior to application of specific antibody, no significant difference 
was found in staining compared with sections processed after the 
standard procedure; this suggests that the tissue -bound pool 
visualized by immunofluorescence is constant after short buffer washing. 
It is possible to estimate the amount of cyclic GMP potentially 
available for immnnofluorescent staining in each section, from these results. 
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Table 2 Cyclic GMP levels (p moles /mg protein) in pooled 
10I`m rat cerebellar sections either unwashed,or 






% loss from 
unwashed 
sections 
1 2.30 0.30 87.0 
2 2.69 0.25 90.7 
3 3.23 0.22 93.2 
4 2.73 0.39 85.7 
5 2.34 0.28 88.0 
6 2.66 0.58 78.2 
7 1-.68 0.26 84.5 
8 2.02 0.40 80.2 
9 2.57 0.27 89.5 
10 1.92 0.38 80.2 
Mean = 2.41 Mean = 0.33 Mean = 85.7 
Standard Standard Standard 
deviation deviation deviation 
= 0.46 = 0.11 = 4.95 
Cyclic GMP levels in washed sections significantly different from 
unwashed sections, p40.01 Wilcoxan matched -pairs two- tailed rank 
test. 
Table 27 shows that a mean value of 0.33 p moles cyclic GMP/mg protein 
is bound on tissue sections after washing. Since 30 x 10 /m cerebellar 
sections contain approximately 0.7mg protein, it can be calculated that 
one 10Jm section contains approximately 7.7 x 10- 15moles of cyclic 
GMP. 
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4.3. Cyclic GMP losses from buffer- washed cerebellar sections 
taken from rats injected with either harmaline or saline 
control. 
To determine whether changes occurred in soluble or tissue -bound cyclic 
GMP, after elevation of Ivels induced by drugs, an experiment was 
carried out to determine the effect of prior administration of the 
drug harmaline on cyclic GMP levels in unwashed or washed rat cerebellar 
sections. 
Two groups of 7 rats were injected intra- peritoneally with either 
saline control or harmaline (40mg/Kg), injected 30 minutes prior to 
sacrifice; cerebella were frozen 2 minutes after decapitation. 
The results shown in table 28 demonstrate that whilst harmaline elevated 
cyclic GMP levels approximately 3 -fold in unwashed sections, it had 
no effect on levels in washed sections, with respect to saline- injected 
catrol. The results may be interpreted as showing that whilst harmaline 
elevates total cyclic GMP levels in cerebellum, the stimulated pool 
is either soluble or loobaly bound to the tissue, and therefore lost by 
buffer washing, whilst the bound pool remains constant. 
The process of sectioning and thawing tissue sections may account for 
the lower levels of cyclic GMP in frozen unwashed sections, as compared 
with cerebella similarly frozen, but homogenized and then assayed. To 
determine which factor was responsible, frozen sections might be pooled 
and extracted with ethanol in the cryostat at -25 °C, to prevent thawing 
of sections at room temperature. 
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Table 28 Cyclic GMP levels (p mole /mg protein) in pooled 10í`'m 
rat cerebellar sections either unwashed or after 3 x 3 
minute buffer washes, from rats injected with either 
saline control or harmaline, 30 minutes prior to sacrifice. 
SALINE Control HARMALI N E 40mg/Kg 













































Each pair of results (washed and unwashed) were obtained from the 
same animal; 7 rats were used in each group. 
Significant difference, p40.01 between saline unwashed and harmaline 
unwashed sections. No significant difference at the 5% level between 
saline washed and harmaline washed sections; Wilcoxan unpaired two- 
tailed rank tests. 
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Since no difference was observed in the intensity and /or distribution 
of cyclic GMP immunofluorescence, in sections taken from mouse 
cerebellar slices pre -insulated with a phosphodiesterase inhibitor 
prior to freezing compared to control (see page 263), if phosphodiesterase 
becomes active on thawing of sections to room temperature, it has no 
effect on cyclic GMP immunofluorescence. The similar staining patterns 
of cyclic nucleotide immunofluorescence at different times of antibody 
incubation (see page 185 and reference 215),suggest that phosphodiesterase 
is not active when processing air -dried tissue sections. 
Wachsmuth (340) has demonstrated that loss of the soluble enzyme 
aldolase from buffer- washed tissue sections, can be prevented during 
immunofluorescence by the aldolase antibody cross -linking the antigen. 
To test the possibility that cyclic GMP antibody might prevent cyclic 
GMP losses, tissue sections were either washed for 3 x 3 minutes in PBS 
prior to application of the cyclic GMP antibody, or processed as usual 
without this preliminary washing. No differences in distribution 
and /or intensity of specific staining were found. Figure 49 
indicates that antibody did not prevent losses of either basal or 
stimulated cyclic GMP, as localized by immunofluorescence. 
4.4. Cyclic AMP losses from buffer- washed sections taken from rat 
cerebella frozen within 30 seconds or at 2; minutes after 
decapitation. 
4.4.A Confirmation of post -mortem elevation of cyclic AMP levels 
in tissue homogenates. 
A small piece of cerebellum was taken from each of 5 rats frozen within 
30 seconds or 22 minutes after decapitation. After transfer from the 
isopentane- liquid nitrogen freezing mixture to the cryostat,and subsequent 
equilibration at -25 °C,samples were homogenized in 8% aqueous ethanol 
in Eppendorf tubes, followed by evaporation overnight at 60 °C. 
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Samples were assayed for cyclic AMP, using the assay kit supplied 
by the Radiochemical Centre, Amersham, Buckinghamshire (TRK 432; 
see also reference 342). The kit uses a binding protein instead 
of an antibody for measuring the competitive displacement of 
[3R] cyclic AMP by unlabelled cyclic AMP. Protein -bound cyclic AMP 
is separated from free cyclic AMP using charcoal adsorption. Levels 
of cyclic AMP were expressed as p moles cyclic AMP /mg protein. 
Table 29 Effect of post -mortem decapitation on rat cerebellar 
cyclic AMP (p moles /mg protein). 
RAT 1 87.6 
Cerebella frozen 
RAT 2 69.6 within 30 seconds 
after decapitation 
RAT 3 73.8 
RAT 4 181.1 Cerebella frozen 
at 22 minutes 
RAT 5 218.4 after decapitation 
The results confirm the post -mortem increase in biochemical tissue 
levels of cyclic AMP in rat cerebellum; this increase has been localized 
histochemically, as increased numbers of Purkinje cells fluorescing 
(see figure 26 and reference 236) . 
4.4.B. Cyclic AMP losses from buffer- washed tissue sections. 
In two experiments cyclic AMP was assayed in washed and unwashed 
10ím sections taken from rat cerebella frozen within 30 seconds,or at 
22 minutes after decapita +ion. The methodology was similar to that 
described previously for the cyclic GMP studies. 
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Table 30 Cyclic AMP levels (p moles /mg protein) in pooled 10ím 
sections from rat cerebella frozen within 30 seconds 
or at 2 minutes after decapitation;sections unwashed or 
after 3 x 3 minute buffer washes. 
CEREBELLA FROZEN WITHIN 
30 SECONDS AFTER 
DECAPITATION 


























Individual values from pooled 30 x 10rm sections,from individual 
cerebella. 
4.4.C. Discussion 
The results from the small sample shown in table 30 (above), indicate 
that bound levels of cyclic AMP are not significantly different in 
washed sections from rat cerebella decapitated at two different times, 
whilst immunofluorescence can detect charges due to the post -mortem 
increase. Increased fluorescence may occur, therefore, with a very 
small increase in bound cyclic AMP that has not been detected with 
these experiments. Alternatively, a redistribution of the nucleotide 
may occur on stimulation, causing increased levels at certain sites and 
therefore increased fluorescence, without a net change in bound cyclic 
AMP levels. It is also interesting that a signjToant,though smaller 
loss of cyclic AMP compared to cyclic CMP, has been found from the 
unfixed rat cerebellar sections. 
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An alternative method has been used to quantify the fraction of cyclic 
AMP utilized for imm nofluorescence (Dr T W Rall, personal communication). 
In these studies cyclic AMP levels in mouse cerebella frozen within 30 
seconds after decapitation were 20 -25 p moles /mg protein, as compared 
with 60 -85 p moles /mg protein, 2 minutes after decapitation. These 
values were obtained by homogenization and extraction of frozen tissue 
samples, and therefore represent total cyclic AMP. The amount of cyclic 
AMP extracted from rnfixed frozen tissue sections however with cyclic 
AMP antibody, was approximately 2 p moles /mg protein from animals 
decapitated at both time intervals. Similar cyclic AMP immunofluorescent 
staining patterns were observed between rat and mouse cerebella, and 
increased numbers of mouse Purkinje cells were seen to show specific 
fluorescence in the studies reported by Dr Rail. These results confirm 
that only a small fraction of the cyclic nucleotide content measured 
biochemically, contributes to the immunofluorescent staining patterns. 
5. GENERAL DISCUSSION 
An important aim of this work was to determine whether immunohistochemistry 
could localize changes in biochemical tissue levels of cyclic nucleotides, 
to particular cellular sites. The cerebellum was studied in detail 
for these studies, since as discussed in the introductory literature 
review, it contains high levels of both cyclic AMP and cyclic GNP, which 
suggests that both nucleotides may have an important function in this 
brain area. In applying cyclic nucleotide immunohistochemistry to the 
C.N.S, Bloom et al (236) were able to localize cyclic AMP in the 
cerebellum and demonstrate increased numbers of Purkinje cells 
fluorescing, when biochemical levels were increased after post- mortem 
decapitation. 
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These observations have been repeated, demonstrating that for studies 
on cyclic AMP, imm nohistochemistry may be a useful tool. However, 
the function of m1nolocalizable cyclic AMP in other cellular 
elements must be considered. If a Purkinje cell pool is responsive 
to noradrenaline, perhaps the other pools might respond to stimulation 
by other neurotransmitters. Siggins et al (237) have tested the 
effect of 5 putatative neurotransmitters ( noradrenaline, GABA, 
glycine,5- HT and histamine) by topical application,and shown that 
none have significant effects on the pools of cyclic AMP that are not 
associated with the Purkinje cells. That imm nohistochemistry may 
reveal different pools of cyclic .AMP in a tissue stimulated under 
different conditions, is demonstrated in studies in the human 
peripheral lymphocyte (215) : - 
In lymphocytes incubated with prostaglandin E 1, all of the cyclic AMP 
specific fluorescence was localized to the cytoplasm, with no staining 
in the nucleus. Cells incubated with phytohemagglutinin, however, 
showed a'patchy'fluorescence along the plasma membrane, whilst 
isoproterenol elicited staining throughout the entire cell. 
Biochemical studies on cyclic GMP in the cerebellum have been carried out 
not only to determine levels in tissue homogenates, but also in an 
attempt to determine the cellular localization of the nucleotide. 
Micro- dissection of mouse cerebella coupled with highly sensitive 
radioimmunoassay (169), demonstrated that cyclic GNP was concentrated in 
the molecular layer of the cerebellar cortex and that a variety of drugs 
and conditions known to elevate cerebellar cyclic GMP, increased the 
concentration of the nucleotide in this layer. 
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Studies with mutant mice with Purkinje cell deficiency, have also 
suggested that a pool of cyclic GMP may be associated with this 
cell type (170, 171). 
The cyclic GMP iunofluorescent studies reported in this chapter, 
however, have failed to correlate elevations in biochemical levels 
of the nucleotide with increased fluorescence in the positive 
staining structures (astrocytic fibres and capillaries), and it is 
important to note that fluorescence has neither been observed in Purkinje 
cells nor other neuronal elements. 
Since biochemical changes in tissue levels as great as 16 -fold 
have not been detected, whereas much smaller increases have been 
successfully localized by cyclic nucleotide immunofluorescence in 
other tissues (e.g. see references 239 and 336), the sensitivity 
of the technique would appear to be adequate. For precise measurement 
of fluorescence intensity rather than semi- vantification, micro - 
spectrophotofluorimetry coupled with interferometry,for measurement 
of section thickness,would be required (343). 
The possibility exists that the reason why increases in staining 
intensity with respect to control have not been observed under 
conditions where tissue levels of cyclic GMP are elevated, is that 
under basal conditions, binding sites are fully saturated with the 
nucleotide. To test this possibility ,immnnohistochemistry has been 
applied to cerebellar sections taken from animals where drug administration 
(pentobarbitone, ethanol) has been reported to cause a decrease in tissue 
cyclic GMP levels. The results confirmed that the pool of cyclic GMP 
localized in tissue sections did not change under conditions where total 
cyclic GMP levels as measured biochemically were not only increased, but 
also decreased. 
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Development of a technique to determine whether immunohistochemistry 
localized all, or only a fraction,of cyclic GMP present in a frozen 
tissue section,demonstrated greater than 80% loss during buffer - 
washing for iunofluorescence. Similar experiments with cyclic AMP 
suggested a smaller but significant loss,and demonstrated that total 
nucleotide was not being localized. 
It was of interest that the fraction of cyclic GMP remaining in the 
tissue after washing and therefore potentially localizable, was 
unchanged when sections were taken from the cerebella of rats injected 
with harmaline,in order to elevate total cyclic GMP levels. These 
results may explain why changes in cyclic GMP iunofluorescence 
were not observed in tissues with elevated levels of cyclic GMP, 
since stimulated cyclic GMP might be in a soluble or loosely bound 
pool and therefore lost during processing, 
It may be concluded,therefore,that 
when applied to the C.N.S. is an unsuccessful technique for localizing 
biochemical changes, since only a fraction of the total nucleotide is 
localized on the tissue section. 
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1. INTRODUCTION 
Cyclic nucleotide immunohistochemistry is successfully performed 
on TTnfixed frozen tissue sections, in contrast to the localization 
of many other antigens which require fixation in order to be visualized 
(for example,see reference 311). Since specific receptor proteins 
are found in tissues which bind cyclic AMP and cyclic GNP, and are 
assumed to function as intermediates in eliciting the physiological 
responses attributed to these molecules (34), it is reasonable to 
assume that as the receptor proteins have both a soluble and particulate 
cellular distribution (181, 344, 345),they may bind the cyclic 
nucleotides in tissue sections. 
Recently, antisera have become available to the cyclic nucleotide - 
dependent protein kinase holoenzymes, and their regulatory and 
catalytic sub -units. Steiner's group (247) have demonstrated that the 
receptor components may be localized in liver by immunofluorescence 
with these antisera, and that the histochemical distribution of these 
proteins may change under acute and chronic conditions. 
In March 1978 I was able to visit Dr Steiner's laboratory for a second 
time, to determine whether the receptor components could be localized 
by imm- unofluorescence in the C.N.S. 
2. CYCLIC GNP- DE:HM:1 T PROTEIN KINASE INIMUNOHISTOCHEMISTRY 
In cerebellum, cyclic GMP kinase has been inferred biochemically to 
have a similar distribution to cyclic GMP, from experiments employing 
mutant mice and lesion studies of the cerebellar climbing fibre input_ 
(184); these results are compatible with cyclic GMP binding,and 
activating,a specific protein kinase,to mediate its effect in a Purkinje 
cell pool. 
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Cyclic GMP kinase holoenzyme, prepared to apparent homogeneity 
from bovine lunglby affinity chromatography with 8 -(2 -amino ethyl) -thio- 
cyclic GMP- Sepharose (330), was used to immunize rabbits by injection 
in Freund's adjuvant; specificity was checked by Dr Steiner's group 
using Ouchterlony immunodiffusion tests (247). 
2.1. Rat C.N.S. 
Immunofluorescence on cerebellar sections from 2 rats was performed 
using overnight incubation periods and equivalent immunoglobulin 
concentrations (0.05mg protein /ml) of Steiner G&#5 specific cyclic 
GMP kinase antibody, and the i.mmunglobulin fraction of pre -1mmne serum 
from the same rabbit, to serve as control. Specific staining was found 
with a punctate appearance in the granule layer, and was uniformly 
distributed in the molecular layer, with white matter being almost 
completely devoid of staining (see figure 53). The nuclei and cytoplasm 
of occasional Purkinje cells showed positive staining. The fluorescent 
structures in the granule layer probably represent glomeruli, complexes 
of pre- and post -synaptic terminals between mossy fibres, granule cell 
dendrites and terminals of Golgi axons (346); a similar localization was 
found in the mouse cerebellum. 
Extending the study to -areas of the rat C.N.S. outside the cerebellum, 
very bright specific staining was observed between the mid -brain and 
the hemispheres, corresponding to the choroid fissure. Figure 54 shows a 
coronal section of rat brain at the level of the substantia nigra, 
demonstrating cyclic GMP kinase immunofluorescence in the fissure, presented 
in the form of a montage. Figure 55 shows in high magnification the 
plexus -like nature of the staining( which was not observed with cyclic 
GMP antibodies ),and probably derives from the pia mater. See also figures 
29 and 30. 
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Figure 53 Immunofluorescent localization of cyclic GMP- dependent 
protein kinase in rat and rabbit cerebellum. 
a) Rat cerebellum - pre -irone immunoglobulin control.) 
b) Rat cerebellum - Steiner G145 cyclic kinase ) 
Calibration bar = 50N 
antibody. 
c) Rat cerebellum - Steiner GK #5 cyclic GMP kinase 
antibody. High magnification. Calibration bar = 25ml. 
d) Rabbit cerebellum - Steiner Gg #5 cyclic GNP kinase 
antibody. Calibration bar = 50mm. 
g/G - granule layer 
m/M - molecular layer 
gl - glomerulus 
P - Purkinje cell body 
W - white matter 
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Figure 54 Photographic montage to show the immunofluorescent 
localization of cyclic GMP -dependent protein kinase 
in the choroid fissure of the rat brain, at the 
level of substantia nigra. 
Steiner GK #5 cyclic GMP kinase antibody. 
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Figure 55 linmunofluorescent localization of cyclic 
GMP- dependent protein kinase in the choroid 
fissure of the rat brain, at the level of 
substantia nigra - high magnification. 
a) Pre-immune e imm noglobulin control. 
) 
b) Steiner GK 5 cyclic GNP kinase antibody.) Calibration 
bar = 100 i 
White spots in a) represent artefacts. 
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2.2. Rabbit C.N.S. 
Experiments were carried out to determine the immunofluorescent 
localization of cyclic GMP and cyclic GMP kinase in the cerebellum 
and spinal cord of the rabbit. 
Two adult, New Zealand white rabbits, were stunned by a sharp blow 
and decapitated; the cerebellum was removed and a small portion of 
medial lobe was frozen in isopentane- liquid nitrogen freezing 
mixture within 5 - 10 minutes. Removal of a portion of lumbar spinal 
cord and freezing, was accomplished within 20 minutes of decapitation. 
6rm frozen sections of rabbit tissue were subsequently processed for 
immw ofluorescence. 
The distribution of cyclic GMP immunofluorescence in rabbit cerebellum 
was similar to that observed in the rat (see figure 43), but with 
antibody to cyclic T kinase, bright specific staining was observed 
in the Purkinje cells,which was not found with pre -immune immunoglobulin 
(see figure 53). 
In sections of spinal cord, cyclic:GMP fibre staining was observed 
with a similar distribution to that reported for GFAP antigen (347), 
the fibre 'mesh' being clearly Observed. around unstained large neurones 
"in the anterior horn (see figure 56). Once again, in contrast 
to the immunofluorescent localization of cyclic GMP, cyclic GMF kinase 
staining was observed in the cytoplasm of these large cells, with a 
'speckled' appearance (see figure 57). Less intense staining was also 
observed in a number of smaller cells in both the grey and white matter 
of the cord. 
It is interesting that a pool of cyclic GMP appears to be associated 
with large motor neurones of the spinal cord, from biochemical studies 
with normal mice and the 'wobble/0 mutant (348). 
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Figure 56 Immunofluorescent localization of cyclic GMP- positive 
fibres in rabbit spinal cord. 
Section processed with Steiner G17 7/15/74 antibody. 
The crosses represent large unstained neurones in the 
grey matter of the cord. 
Calibration bar = 50/m 
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p:i.gu.re 57 Immunofluorescent localization of cyclic GMP- dependent 
protein kinase in rabbit spinal cord. 
Steiner GK#5 cyclic GMP kinase antibody. 
a) Low magnification. Calibration bar = 100N. 
b) High magnification, showing brightly 
fluorescent cells in the grey matter. 
Calibration bar = 50r'm. 
G - grey matter 
W - white matter 
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2.3. Discussion 
These preliminary results on the localization of cyclic GMP kinase, 
are of particular interest in showing that it does not parallel 
that of cyclic GMP, as observed by imm,urofluorescence. The specificity 
of Steiner GK 5 cyclic GMP kinase antibody has been demonstrated by 
Steiner °s group using Ouchterlony immunodiffusion tests against 
related cyclic nucleotide receptor proteins,.but unfortunately the 
antigen was not available on my visit, for absorption tests to 
demonstrate complete specificity of the C.N.S. staining patterns. 
The strong staining of Purkinje cells in rabbit cerebellum may reflect 
increased amounts, or availibility to antibody, of the cyclic GMP 
kinase relative to the rat or mouse. The parallel localization of 
cyclic GMP kinase and cyclic AMP in the Purkinje cells by iuno- 
fluorescence, might represent a mechanism of cellular control, since 
cyclic AMP can compete with cyclic GMP,for its binding site on the 
kinase (349). Staining for cyclic GMP kinase in the choroid fissure 
is particularly surprising, and warrants further investigation. 
An important theoretical consideration is that antibody to cyclic GMP 
kinase might not recognize a complex of cyclic GMP /cyclic GMP kinase 
in a tissue section, due to blockade of antigenic determinants. This 
possibility seems unlikely however, since parallel localization has been 
observed with the two molecules in rat liver (personal communication 
Dr Steiner). 
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3. CYCLIC AMP -DEPENDENT PROTEIN KINASE IMMUNOHISTOCHENISTRY 
IN TEE C.N.S. 
3.1. Catalytic sub -unit. 
The catalytic sub -unit of cyclic AMP- dependent protein kinase, 
prepared to homogeneity from rabbit skeletal muscle (350),has 
been used by Steiner's group to prepare specific antibodies,which 
have been employed for imimunofluorescence. In liver for example 
(247), a reticular distribution in liver cell nuclei has been shown 
histochemically,.which changes after acute drug treatment. Applying the 
catalytic unit antiserum at a dilution of 1:160, together with 
pre-immune serum at the same dilution (using overnight incubation 
periods), a striking distribution of specific staining was found 
in the nuclei of cells in rat cerebellum (figure 58). 'Liquid - 
phase' absorption of catalytic unit antiserum with excess catalytic 
unit overnight at 4 °C (100"1 of antiserum 1:1 dilution + 10011 of 
0.8mg /m1 of catalytic unit antigen), and subsequent dilution to give 
original antibody dilution(1:160),completely removed nuclear stai ing. 
3.2. RII regulatory unit. 
An antiserum raised in a goat to the PII regulatory unit of cyclic AMP - 
dependent protein kinase was also used for immunofluorescence iR rat 
cerebellum, where the regulatory unit has been measured in both 
cytosol and membrane fractions (344). 
The antibody (Steiner RII# 9) was incubated overnight in a range of 
dilutions on 61 sections from a rat cerebellum, with equivalent 
concentrations of non -immune goat immunoglobulin. An FITC rabbit 
anti -goat serum IgG conjugate (Miles Laboratories, Indiana, U.S.A) was 
employed at a dilution of 1:30, in place of the usual second antibody. 
No difference could be found between immunofluorescent staining with 
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Fi e g Immunofluorescent localization of the catalytic 
sub -unit of cyclic AMP- dependent protein kinase 
in rat cerebellum. 
a) Catalytic sub -unit antiserum (Steiner t,11). 
b) Catalytic sub -unit antiserum incubated with excess 
catalytic sub -unit antigen in liquid -phase, as control. 
c) Cerebellar white matter - catalytic sub -unit antiserum. 






Purkinje cell body 
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immune and non-immune immunoglobulins, however. 
Other RII regulatory unit antibodies will need to be evaluated to 
determine whether this is a general observation or not, and further 
immunofluorescence and biochemical studies will be required to elucidate 
the relation of cyclic AMP to cyclic nucleotide receptor sub -units 
in the C.N.S., under 'control' and 'stimulated' conditions. 
4. EXPERIMENTS TO DETERMINE THE MECHAaISM OF BINDING OF 
CYCLIC GMP IN RAT CEREBELLAR SECTIONS. 
4.1. Effect of cyclic GMP and related nucleotides on tissue 
sections, prior to immunohistochemical processing. 
To determine whether 'receptors' for cyclic GMP ' in vitro', could 
bind exogeneous nucleotide, cyclic GMP at 10MM concentration 
was added to tissue sections and incubated for 2 hours at room 
temperature, followed by buffer washing and processing for cyclic 
GMP immunofluorescence. No change was observed in the intensity 
and /or distribution of specific staining (see figure 59), suggesting 
that 'receptors' were not able to bind,and show altered immunofluorescence 
of cyclic GMP, under these conditions. 
Pre -treatment with 10mM concentrations of AMP, ADP, ATP, GPI, GDP 
and GTP similarly had no effect on the intensity and /or distribution 
of specific cyclic GMP immunofluorescence. 
These observations contrast with those of Sternberger (218), who 
demonstrated increased immunofluorescent staining for LH -RH on pre - 
treating rat pituitary tissue sections with the peptide. Pre -treatment 
with certain analogues removed staining due to displacement of LH -RH 
from the tissue receptor. Receptors to other molecules have been 
similarly demonstrated in a number of tissues e.g. prolactin (351) 
and vasopressin (322). 
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Figure 59 Effect of pre -treatment of rat cerebellar tissue 
sections with PBS (control) or 10mM cyclic GMP, 
prior to immunonuorescent staining. 
Sections processed with Steiner G171a/ a/74 cyclic 
GMP antibody. 
a) Pre -treatment with PBS (control) for two hours at room temperature. 
b) Pre -treatment with 10mM cyclic GNP for two hours at room temperature. 
Calibration bar = 50 /m 
P - Purkiìije cell body. 
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To determine whether tissue sections might bind cyclic GMP but not 
show changes in immu ofluorescence, 6tm rat cerebellar sections 
on coated glass slides, were incubated with [3H] cyclic GMP or 
pre- washed overnight in PBS using a magnetic stirrer, to attempt 
to remove any bound cyclic GMP and expose binding sites, prior to 
application of the tracer. 0.3 p moles of [ribose_5_3H] cyclic 
GMP (TRK 499, Radiochemical Centre, Amersham, Buckinghamshire, 
specific activity :31Cí /m mole) were applied to tissue sections. in a 
volume of 70rl for 30 minutes or overnight (15 hours), at room 
temperature. After incubation,a 50J1 aliquot of tracer was carefully 
removed and counted for radioactivity (see page 134). For control, 
71'l of tracer were placed on an area of the glass slide without the 
tissue section, and after the specified incubation period, a 50f`1 
aliquot was removed for counting of radioactivity. 
The results shown in table 31, suggest that under the conditions 
employed, rat cerebellar tissue sections do not show significant uptake 
of exogeneous cyclic GMP. Two limitations of this method must be 
realised however: i) conditions of incubation of sections e.g. 
temperature, may be unsuitable for binding ii) the uptake of tritiated 
cyclic GMP may be minimal, and undetected using the quantity.of tracer 
employed in the experiment. 
Considered together with the 'in vivot and tin vitro! data in chapter V, 
where endogeneous cyclic GMP levels have been increased or decreased 
without alterations of imm nohistochemical cyclic GMP, thetboundt i.e. 
immunolocalizable pool of cyclic GMP,does not appear to be influenced 
by thc, soluble, or loosely -bound pool. 
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Table 31 To determine whether individual 6(ßm rat cerebellar 
sections show uptake of[3HJ cyclic (, after pre - 
incubation under a number of conditions - 0.3 p moles 
cyclic GMP incubated per tissue section. 
















50/1 [ H] cGMP 
CONTROL 21,440 21,928 20,797 
21,280 21,167 
50f1 PHi cGMP 
.AFTER .21,174 22,453 19,670 
INCUBATION 
WITH TISSUE 20,310 
SECTION 
4.2. Effect of cyclic nucleotide phosphodiesterase on tissue 
sections, prior to immunohistochemical processing. 
In tissue sections, the constant staining patterns of cyclic nucleotide 
immnofluorescence with incubation times from minutes to many hours 
(215), suggests that phosphodiesterase is not active, or is not present 
at the same sites as the nucleotides. To determine whether tissue 
cyclic GMP could be degraded by exogeneous phosphodiesterase however, 
sections of rat cerebellum were incubated with the enzyme prior to 
tissue processing for immunofluoresceñce. This technique would also 
function as a specificity cor_ crol,since the enzyme will only cleave 
3', 51 phosphodiester bonds and should only specifically 
remove 31,5' 
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cyclic nucleotide iunofluorescence (See also page 237). 
In one experiment,frozen sections were washed in buffer to remove the 
soluble pool of cyclic GMP,and individually incubated at room temperature 
for 5 hours, with 0.3 units of phosphodiesterase (Sigma Chemical Co) 
in a volume of 25/1, or buffer control. After PBS buffer washing 
(3 x 3 minutes), sections were processed for cyclic GMP immnnofluorescence 
using Steiner G17 7/15/74 antibody. 
In a second experiment, frozen sections were washed in buffer to remove 
the soluble pool of cyclic GMP,and individually incubated overnight 
at room temperature with 0.3 units of phosphodiesterase in a volume 
of 25íl, or buffer control. After PBS buffer washing (3 x 3 minutes), 
sections were fixed in 2% freshly depolymerized paraformaldehyde (see 
appendix 3). Following 3 x 3 minute PBS buffer washes, sections were 
processed for cyclic GMP imm nofluorescence using Steiner G17 12/2/74 
antibody. In both experiments carried out, a slight reduction was 
observed in the intensity and distribution of positive staining (see 
figure 60), although background staining was moderately increased. 
It is surprising that the large amount of enzyme employed in these 
experiments only produced a small effect on immunofluorescence. Similar 
difficulties have been experienced (331) with this approach to the use 
of the enzyme as a specificity control for cyclic nucleotide immunofluorescence. 
It seems likely that the 3t, 5, phosphodiester group of the bound cyclic 
GMP is protected from attack by the enzyme, as a result of its 
orientation in the tissue section. It should also be noted that cyclic 
AMP when complexed with cyclic AMP- dependent protein kinase, is resistant 
to attack by phosphodiesterase ( 39 ). It would be of interest to 
confirm the stability of the tissue -bound nucleotide to phosphodiesterase, 
by assaying cyclic GMP on tissue sections after pre -treatment with enzyme. 
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Figure 60 Effect of pre- treatment of rat cerebellar sections 
with cyclic nucleotide phosphodiesterase prior to 
immnnofluorescence. 
a) Section incubated with PBS for 5 hours, followed by processing 
with Steiner G17 7/15/74 cyclic GNP antibody. 
b) Section incubated with 0.3 units of phosphodiesterase for 5 
hours, followed by processing with Steiner G17 7/15/74 antibody. 
Calibration bar = 50Pm 
P - Purkinje cell body 
B t_ o 
4110 
NI,, . . 
; 
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4.3. Effect of fixation of tissue sections on immunohistochemistry. 
The effect of fixation on cyclic GMP immunohistochpmistry has been 
examined,prima.rily to determine whether the soluble pool of cyclic 
GMP could be prevented from being lost from tissue sections. 2% 
freshly depolymerized paraformaldehyde (see appendix 3) as employed 
by Wedner et al (235),before or after the cyclic GNP antibody, 
produced similar results to 'infixed rat cerebellar sections, under 
conditions where cyclic GNP levels were basal or stimulated (see 
figure 49). This fixative has been employed when section pre -treatment 
(e.g. with phosphodiesterase) has necessitated incubation with solutions 
in excess of 15 hours, or when soft tissues (e.g. from 10 day old rats) 
have been processed for immunofluorescence. Higher concentrations of 
the fixative have been reported to prevent localization of cyclic 
GMP in other tissues (215). 
Frozen sections of rat cerebellum treated with lice -cold' 8C0 ethanol - 
water, formalin or formaldehvde vapour, and washed in PBS prior to 
processing for cyclic GMP iunofluorescence, have abolished positive 
staining (see figure 61). Similarly,sections taken from the cerebellum 
of a rat perfused with cold 4% paraformaldehyde in 0.1 M phosphate 
buffer + 5% sucrose, have shown no specific staining for cyclic GMP. 
Similar results have been reported using gluteraldehyde, acetone or 
alcohol for cyclic nucleotide imm nofluorescence in other tissues 
(215). 
These fixation techniques may modify a protein associated with cyclic 
GMP in the tissue, causing release of the nucleotide, thereby preventing 
positive staining. It may be noted that 80% tithe -col -water has been 
used to extract cyclic GMP from buffer- washed tissue sections for assay. 
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Figure 61 Effect of ethanol fixation of rat cerebellar sections 
on cyclic GNP mm nofluorescence. 
a) Unfixed frozen tissue section processed with Steiner G17 
12/2/74 antibody. 
b) Frozen tissue section fixed with 810% ethanol -water prior 
to processing with Steiner G17 12/2/74 antibody. 
Photographs show cerebellar granule layer. 
Calibration bar = 506. 
B 
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Fixatives may modify the primary amino group on the purine moiety 
of cyclic GMP, preventing binding of specific antibody. 
4.4 Effect of acetylation on immunohistochemistry. 
Rosenberg et al (331) have shown that gas -phase acetylation of tissue 
sections,significantly increases the intensity of localization of 
cyclic AMP in rat liver by immunofluorescence, and that acetylation 
increases the avidity of cyclic nucleotide antibodies by RIA. This 
is to be expected, since cyclic nucleotide antibodies are raised 
against succinyl derivatives of the nucleotides, coupled to proteins. 
Whilst they have only shown a small effect for cyclic GMP, their 
experimental technique was carried out to determine whether acetylation 
affected fibre or capillary cyclic GMP staining components in rat 
cerebellum. 
6wm frozen cerebellar sections were incubated for 5 minutes at room 
temperature in a Coplin jar containing gauze soaked in triethylamrne, 
followed by 40 seconds in acetic anhydride vapour,using the Coplin jar 
arrangement. After washing sections for 3 minutes in PBS they were 
processed,together with controls,using overnight incubation with 
Steiner G17 12A2/74 antibody. After staining, neither fibre nor 
capillary component was enhanced, but background staining was slightly 
increased. Gas -phase acetylation of sections processed with non - 
immune immunoglobulin, showed a similar increase in non -specific 
background staining. 
4.5. Effect of divalent cations on tissue sections, prior to 
immunohistochemical processing. 
To determine whether divalent cations play an important part in the 
binding of cyclic GMP to tissue sections, rat cerebellar sections were 
treated with PBS containing 10 -310 -CaC12,10 -3M MgCl2 or 10-411 EDTA 
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for 30 minutes at room temperature, or 37 °C (Petri dish containing 
slide,incubated in an oven at this temperature), prior to processing 
for immunofluorescence with Steiner G17 12/2/74 antibody. In 
contrast to the results reported by Steiner et al (215) in liver, 
no differences were found in positive staining between sections 
pre -treated with the ions and chelating agents, compared with 
sections incubated with PBS as control. 
4.6. Discussion. 
The results of this series of experiments suggests that cyclic GMP 
is firmly bound in C.N.S. tissue sections, possibly to a protein, 
which protects the 3, 5' phosphodiester bond from cleavage; the 
mechanism of binding in C.N.S. sections shows differences compared 
with binding in liver sections. Since the distribution of the cyclic 
GMP kinase receptor protein does not parallel that of cyclic GMP, 
one must postulate a different binding mechanism in the C.N.S. 
Complex of cyclic GIP with phosphodiesterase would appear to be 
unlikely, since the molecules have a different histochemical 
distribution in the C.N.S. (see reference 248). In regenerating liver, 
there is a good correlation between cyclic GMP iunofluorescent 
distribution, and the quantity and activity of particulate guanylate 
cyclase, but not the soluble form (245). Since the pool of cyclic 
GMP localized by immunofluorescence is firmly bound to the tissue 
section, this correlation might suggest that it is synthesized and 
bound, perhaps in a molecular complex with the cyclase. In the testis, 
however, increased cyclic GMP immunofluorescence was found to correlate 
with the soluble guanylate cyclase and not the particulate form.(352). 
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5. GENERAL DISCUSSION 
Cyclic GMP and cyclic GMP- dependent protein kinase have been shown in 
these studies to have a completely contrasting distribution in the 
C.N.S. by immnnohistochemistry, suggesting that the nucleotide is not 
bound to the kinase holoenzyme in C.N.S. tissue sections. The 
localization observed with the kinase and catalytic sub -unit of 
cyclic AMP- dependent protein kinase is particularly interesting, 
and more extensive studies with more antisera,may be of more use for 
understanding cyclic nucleotide function in the C.N.S., than for 
studying the immunohistochem.ical localization of the individual 
nucleotides. 
The inmiunohistocheuwiòal localization. of cyclic GMP kinase, for example, 
may reflect sites where soluble neuronal cyclic GMP binds transiently, 
to affect a physiological response. In liver, cyclic GNP and cyclic 
GMP kinase have been found at the same sites (personal communication 
Dr Steiner ), and perhaps changes in cyclic GMP distribution in tissues 
will only be observed when there is parallel localization of cyclic 
GMP and receptor protein; studies on other tissues will confirm if this 
is a general phenomenom. 
A note of warning should be added at this point, however, and that is 
that analogous to the nucleotides themselves, immunohistochemistry 
will only localize the tissue -bound pool of the receptor proteins, and 
this may represent a fraction of the total. Future studies will have 
to ensure that total protein is localized and,if not,whether fixation 
can prove to be of use. 
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Assuming that cyclic GMP is not bound to cyclic GMP kinase in 
tissue sections, an alternative form of binding that is stable, 
modified by various fixatives and results in protection of the 3',5' 
group must be postulated. Since the cyclic nucleotide kinases are 
the only specific tissue receptor proteins for oylic AMP and cyclic 
GMP in the C.N.S., a more generalized form of binding may occur, 
presumably via the charged phosphate groups, or purine nucleus. 
It must be remembered,however,that the binding has specificity in 
that: i) cyclic AMP and cyclic G1lP show entirely different 
localization in the C.N.S. ii) species -specificity has been 
demonstrated for the cyclic GMP fibre -staining component. 
The immunofluorescent localization of cyclic GMP to astrocytes, 
capillaries and epithelial cells of the choroid plexus, has led to 
the consideration that the nucleotide may be bound to, or associated 
with, the proteins actin and myosin in C.N.S. tissue sections, since: 
i) In the rat C.N.S., smooth muscle actin and myosin have been 
localized by immunofluorescence to astrocytes, capillaries and blood 
vessel walls (353, 354). Similar localization has also been found 
between myosin and GFAP (332). 
ii) Actin and myosin -like filaments have been found in rat brain 
capillaries using electron microscopy (355, 356). Myosin has been 
found biochemically in a cloned rat glial cell strain from the C.N.S. 
(357). 
iii) In skeletal, cardiac and smooth muscle, cyclic GMP and myosin have 
beenlocalized by immunofluorescence at the same sites. Ong and Steiner 
(358) have suggested that cyclic GMP may interact with myosin in some 
manner, perhaps regulating divalent cation availability, and have a 
role to play in the contractile process. 
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iv) In renal cortex, the i mm nofluorescent localization of cyclic 
GNP has led to the suggestion that it may be involved in the 
contractile function of the mesangial cells (240). 
v) Actin is localized by immunofluorescence in choroid plexus 
epithelial cells (359). 
An attractive possibility is that the .cium- dependent binding 
protein, CDR, might be associated with cyclic GNP and myosin. 
This protein,which is an activator of cyclic nucleotide phosphodiesterase 
(44), is a sub -unit of myosin light -chain kinase (360); this kinase 
has recently been partially purified from bovine bri.n (361). Although 
CDR has not yet been localized in the C.N.S. by i mm nofluorescence, 
studies in culture have shown that it is associated with contractile 
elements in the cell (362). Perhaps CDR could confer calcium 
sensitivity on motile phenomena in muscle and non -muscle systems, 
regulated by myosin, and possibly GMP. 
In attempting to understand the reason for differences in cyclic C.MP 
localization at different tissue sites, an observation from Professor 
U Groschel- Stewart's laboratory (personal communication) is of particular 
interest. This group has found that antibodies to smooth muscle myosin 
from different rabbits, may also show contrasting patterns of 
immunofluorescent localization of the protein in rat C.N.S. Using one 
antibody, capillary and blood vessel wall staining was observed, whilst 
with another, localization was confined to pericytes and astrocytes. 
Perhaps different forms of myosin at different sites,are associated with 
cyclic Gam, eliciting stereospecific differences in the determinants 
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on the bound nucleotide. In this connection it may be noted that 
myosin exhibits antigenic polymorphism at different sites in 
cardiac muscle (363). 
An association of actin and myosin with cyclic GNP, might suggest 
a function of the bound nucleotide pool detected, by immunofluorescence. 
Astrocytes in culture, have been shown to change shape, be pulsatile 
and migratory (364), a.vd contractile responses of glia have been observed 
in brain slices (365). An actin -myosin contractile system might 
be involved in these processes, and could also possibly regulate 
the diameter of capillaries, to modulate blood flow. 
Cyclic GMP is localized to fibrous astrocytes in 10 day old rat 
cerebellum, and may regulate the movement of migrating neurones via 
an actin -myosin system e.g. the Bergmann glial fibres may aid the 
migration of cerebellar granule cells during development (367, 368). 
It is interesting that a 'glial maturation factor' from adult brain, 
which'triggers' astrocytic differentiation in fetal brains in culture, 
has recently been shown to elevate cyclic GMP levels in the culture 
(366). 
In the choroid plexus, positive iunofluorescent staining was 
observed for cyclic GMP in the specialised epithelial cells; since 
actin has also been found at this site by immnnofluorescence (359), 
it may be postulated that bound cyclic GNP functions in a contractile 
process involved in secretion or osmotic regulation in the choroid plexus, 
and perhaps also the astrocytes (369). It is of interest that cyclic GMP 
has recently been detected in isolated rabbit choroid plexus (370). 
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CHAPTER VII 
CONCLUSION 
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Even though an extensive amount of information is available on 
cyclic AMP and cyclic GMP in the C.N.S., it is apparent that the 
role of these molecules in cellular regulation is still not 
completely understood. The most obvious fact to emerge is that 
these two structurally related molecules have different roles to 
play in the C.N.S. Whilst biochemical studies have demonstrated 
quantitative changes under a plethora of different conditions, 
the cellular location and sub -cellular distribution of these 
changes are surprisingly poorly defined in the C.N.S., which 
contains a variety of cell types. In measuring a change of cyclic 
GMP levels in the cerebellum for example, it is essential to determine 
whether the nucleotide is being stimulated in one,or more,of the five 
neuronal cell types (see reference 346),glial, or even the vascular 
elements, if we are to determine its function 'in vivo'. 
The application of a specific and sensitive immunohistochemical 
technique enebTing localization of cyclic nucleotides in tissue sections, 
is an attempt to satisfy this vital gap in our knowledge of cyclic 
nucleotide function. 
The studies reported in this thesis have concentrated on the immuno- 
fluorescent localization of cyclic GMP in the C.N.S., and have demonstrated 
tro important concepts: 
i) Different antibodies differ in their ability to detect cyclic 
nucleotides in tissue sections, even at different sites and in different 
tissues, probably as a result of sterochemical differences between 
bound nucleotides. The binding of an antibody to nucleotide when free 
in solution, as studied in radicimmunological techniques, is not a 
suitable 'model' for studying binding to tissue -bound nucleotide. 
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ii) Immunohistochemistry only detects a tissue -bound pool, which 
is a fraction of total nucleotide in a C.N.S. tissue section, 
failing to localize 'stimulated' nucleotide which is probably 
present in a soluble or loosely -bound neuronal compartment, and 
therefore lost from the tissue section during processing (the concept 
of compartmentalization of cyclic nucleotide pools has recently 
been discussed; see reference 371). 
These results clearly limit the value of the immunohistochemical 
technique for studying cyclic nucleotide function in the C.N.S., and 
suggest a cautionary approach to studies in other tissues,and also 
with other antigens. The introductory studies employing antisera 
to the cyclic nucleotide receptor proteins, suggest that this approach 
at the cellular and ultra -structural level, might be more lucrative 
in order to determine where the nucleotides bind and function. 
The question remains, however, as to the function of a pool of cyclic 
GMP detected on tissue sections by immunofluorescence. Whilst functions 
have been postulated to account for the astrocytic, capillary and 
choroid plexus epithelium staining in the C.N.S., examination of larger 
numbers of positive staining antibodies as a result of an intensive 
immunization programme, must seek to satisfy the immunohistochemical 
criteria of specificity, and determine whether cyclic nucleotides 
might be tissue -bound at other loci, hitherto undetected. 
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Shortly before submission of this thesis, a paper was published 
by V Chan-Palay and S L Palay entitled: 
"T unocytochemical localization of cyclic GMP: light and electron 
microscope evidence for involvement of neuroglia" 
Proc. Natl. Acad. Sci, U.S.A. (March 1979) 1: 1485 -1488 
A brief summary of the paper is presented, for comparison with the 
results reported in this thesis: 
Antibodies to cyclic nucleotides were raised by Dr A Guidotti against 
2!- O- succinyl cyclic AMP /GMP coupled with keyhole limpet hemocyanin. 
Indirect immunofluorescence and PAP techniques were employed,on 
formaldehyde perfused -fixed rat cerebellar tissue. 
Positive cyclic GMP staining was found most prominently in the Bergmann 
glial cell bodies,and their fibres in the molecular layer, staining 
also being observed in other neuroglia, and some stellate and basket 
cell somata. Lmuno- electron microscopy revealed both membrane and 
cytoplasmic components which were immnno- reactive. 
Employing drugs known to affect biochemical cyclic GMP levels in the 
cerebellum, altered immunohistochemical staining intensity was Íound,in the 
neuroglial, stellate and basket cells, and neurones in the deep 
cerebellar nuclei. Whilst Purkinje cells were unstained with most 
treatments, superfusion of noradrenaline or glutamate over the 
cerebellar surface, induced staining of Purkinje cells and also granule 
cell somata. 
Positive cyclic GMP staining was removed by liquid -phase absorption 
with 1mM cyclic GMP. 
" A contrasting localization of cyclic AMP was found, distributed in Purkinje 
cells, granule cells, stellate and basket cells, Bergmann glial cells and 
their processes, and neurones in deep cerebellar nuclei. 
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.APPENDIX 
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1. 'COATING'SOLUTION FOR MICROSCOPE SLIDES (372) 
1g of gelatin was dissolved in 200m1 of distilled water by heating to 
approximately 60 °C, with constant stirring. 0.1g of chrome -alum 
(chromic potassium sulphate)were then dissolved in the solution. On 
cooling to room temperature, clean glass slides (76 x 26mm, supplied 
by Chance Proper Ltd) were immersed in the solution, removed and allowed 
to dry. Whilst the coating solution was unstable even when stored 
at 4 °C,'coated' slides could be stored permanently at this temperature. 
2. PHOSPHATE- BUFFERED SALINE (PBS) 
0.15M NaC1, 0.01M phosphate buffer,pH 7.2, was prepared by. dissolving the 
following reagents in 1 litre of distilled water: 8.5g NaC1, 1.34g 
Na2HPO4.aH2O and 0.39g NaH2PO4aH20. 
3. 2% FRESHLY DEPOLYMERIZED PAR.AFORMA?DEYDE FIXATIVE 
8g of paraformaldehyde were dissolved in 400m1 of PBS with constant 
stirring at 60 °C, in a fume cupboard. The resulting solution was 
allowed to cool, covered,and placed'on ice'; fixative was freshly 
prepared for each experiment. 
4. TOLUIDINE BLUE STAINING OF C.N.S. TISSUE SECTIONS (373) 
6rm frozen sections on microscope slides,were placed in a Coplin jar 
containing approximately 2m1 of formalin, to expose the sections to the 
vapour of the fixative; the lid of the Coplin jar was sealed with 
glycerol. After 1 minute, the slides were removed and placed over 
glass rods on the top of a staining trough. Sections were then 
treated with the following solutions, before being mounted in canada 
balsam,with clean glass cover slips, for light microscopic observation: 
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i) 100% ethanol, 10 -20 seconds 
ii) 50% ethanol, 10 -20 seconds 
iii) Distilled water,10 -20 seconds 
iv) 0.2% toluidine blue,30 seconds 
V) 100%% ethanol, 10 -20 seconds 
vi) Xylene 
5. ESTIMATION OF PROTEIN BY THE PROCEDURE OF LOWRY et al (374) 
i) For preparation of standards, 25mg of bovine serum albumin 
(fraction V, Sigma Chemical Co) were dissolved in 10m1 of buffer as 
the stock solution. Duplicate standards were prepared in the range 
of 15 -7558 protein per 3001 solution,by dilution of the stock solution. 
ii) 300p-1 of diluted sample or standards were vortex mixed with 3m1 
of reagent 1; a 'blank' with 3001 of buffer was also used. 
Reagent 1: 50 parts A: 1 part B 
where: 
A = 2% Na2CO3 in 0.1N NaOH 
B = 50% (1% Cus04. 5 H20) and 50% (2% COUK.CH(OH).CH(OH). 
COONa. 4H20) 
iii) After mixing and standing for 15 minutes, 0.3ml of reagent 2 were 
added to the tubes followed by vortex mixing. 
Reagent 2: Folin and Ciocalteu's phenol reagent, diluted 1:1.5 with 
distilled water. 
The tubes were vortex mixed and allowed to stand for 30 minutes. 
iv) The'blank' was corrected to zero optical density in a visible - 
light spectrophotometer (Guilford Instruments, Middlesex) at 750nm. 
The optical density of standards and samples were then measured, and 
a graph was plotted of optical density (ordinate) vs. protein concentration 
(abscissa). The protein concentration of the samples was calculated 
from the straight line graph, and after correction for sample dilution, 
the protein concentration of the undiluted samples was obtained. 
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6. PREPARATION OF RAT LIVER AND CEREBELOM ACETONE TISSUE POWDERS (194) 
Liver and cerebella were obtained from 4 male adult Wistar rats; 
the organs were washed clear of blood with cold physiological saline, 
and then diced with scissors in the same medium. The washed, diced 
material was then thoroughly homogenized with acetone, and the product 
was filtered. The deposit on the filter paper was then washed through 
several times with acetone,before being allowed to dry overnight at 
room temperature. The dried deposit was then ground in a mortar to 
obtain a fine grade powder. 
For absorption experiments with the powder, it was essential to 
thoroughly wash the powders several times in PBS prior to incubation 
with antibody, to remove soluble tissue components. Wet, rather than 
dried powder must be used in these experiments,to reduce non -specific 
adsorption of globulin molecules. 
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SUMMARY 
The technique of cyclic nucleotide fluorescence immunohistochemistry 
has been applied for the specific localization of cyclic GMP in rat cerebellum. 
We report immunofluorescence associated with fibres and membranes, 
contrasting with previously reported cytoplasmic localization of cyclic AMP 
in different cell populations, using a similar technique. 
We have been unable to detect changes in cyclic GMP staining in res- 
ponse to post -mortem changes, harmaline and pentobarbitone administration. 
A role of cyclic GMP is suggested in membrane ion transport. 
INTRODUCTION 
A role for cyclic GMP in cerebellar regulatory systems may be 
inferred from the high concentration of cyclic GMP2, the presence of a high 
affinity binding protein in rat cerebellum3, and a specific cyclic GMP depend- 
ant protein kinase which has been found in bovine cerebellum4. The involve- 
ment of cyclic GMP with a variety of transmitter systems has been suggested 
from a number of 'in vivo' and 'in vitro' studies5, 6' 7' 8. It is interesting that 
selective changes of cerebellar cyclic GMP independent of cyclic AMP can be 
obtained by a number of apparently unrelated agents and conditions (e.g. 
morphine9, alcohol1O and diazepam") possibly suggesting involvement with a 
basic neuronal mechanism. In this context, 'in vitro' studies have indicated 
that intracellular calcium ion concentration is a major factor in the regulation 
of brain cyclic GMP levels12 and data from a number of tissues suggest that 
cyclic GMP might participate in the feedback regulation of calcium transport13 
The localization of cyclic GMP within the cerebellum is unknown, 
although there are lines of evidence suggesting a cyclic GMP pool associated 
with the Purkinje cells. A 25 -30 fold increase in cerebellar cyclic GMP is 
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seen as rats develop from 12 days old to maturity correlating with the formatirr 
of mossy fibre synapsesi4. Studies on mutant, ataxic mice, which have a 
selective loss of 90% of cerebellar Purkinje cells, with an otherwise intact 
cerebellar cortex, similarly have very low levels of cyclic GMP, but normal 
levels of cyclic AMP15. Cerebellar microdissection studies employing radio - 
immunoassay report a distribution of cyclic GMP consistent with the concept 
of a Purkinje cell associated poo116 
In this paper, cyclic GMP has been specifically localized in rat cere- 
bellum using the technique of cyclic nucleotide fluorescence immunohisto- 
chemistry17. We report widespread localization of immuno- reactive cyclic 
GMP to fibres and membranes in rat cerebellum, a distribution which con- 
trasts markedly with the previously reported localization of cyclic AMP using 
the same technique18, 19. 
In an attempt to correlate changes in specific staining distribution and/ 
or intensity with biochemical changes of cyclic GMP, we have studied post- 
mortem change and two pharmacological agents, harmaline and pentobarbtone, 
which have been shown to produce significant changes of cyclic GMP in cere- 
bellum", 20, 22 
MATERIALS 
Isopentane - BDH Chemicals, Poole, England 
Paraformaldehyde - BDH Chemicals, Poole, England 
Fluorescein isothiocyanate conjugated goat anti -rabbit immunoglobulin 
(Lot 17), Miles Laboratories, Inc. , Miles Research Division, Elkhart, 
Indiana. 
Harmaline - Sigma, London 
Pentobarbitone - May and Baker, London 
A Zeiss fluorescent microscope was used fitted with BG3 (Schott) 
primary and 50 (Zeiss) secondary filters, and x1O and x40 Neofluar object- 
ives. Black and white photographs were taken using a 35 mm Olympus 0M -1 
camera using Ilford FP4 film with a constant exposure time of three minutes. 
METHODS 
200 -250g male Wistar rats were used. 
Specific localization of cyclic GMP in cerebellum was detected using 
an indirect immunofluorescence technique) ?. Highly specific antisera to 
cyclic GMP were raised in rabbits by repeated injections of 2'O -succinyl 
cyclic GMP conjugated to keyhole limpet hemocyanin21. Immunoglobulin (Ig) 
fractions of these antisera with high titre were used as the primary immuno- 
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reagent for cyclic GMP localization. 
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Rats were sacrificed by decapitation, and cerebella were removed and 
frozen in isopentane pre -cooled with liquid nitrogen. 4- 6r.cryostat sections 
were then cut at -250C in a cryostat, and thawed onto albumen coated glass 
slides. After air -drying a 1:8 dilution of Ig in phosphate -buffered saline (PBS) 
at pH 7.4 was placed on the unfixed sections and incubated at room temperat- 
ure in a moist chamber. After 30 minutes, sections were washed for 3 min- 
utes in PBS. Washings were repeated 3 times. Sections were then fixed by 
immersion in ice -cold 2% freshly depolymerized paraformaldehyde in PBS 
for 4 minutes. Sections were washed in PBS as before. This fixation pro- 
cedure unaffected the specific fluorescence but improved tissue morphology. 
Sites of bound rabbit immunoglobulin were located by incubation with a 1:10 
dilution of fluorescein conjugated goat anti - rabbit Ig for 30 minutes, followed 
by washing as previously described. Slides were then mounted with cover 
slips using PBS- glycerol (1:1) and sections were viewed using dark field 
fluorescent microscopy employing episcopic illumination. 
Several controls were carried out to establish the specificity of the 
staining procedure. 
No staining was observed when sections were incubated with an equi- 
valent concentration of immunoglobulin from an unimmunized rabbit. If 
fluorescein labelled anti - rabbit immunoglobulin was reacted with sections 
without prior exposure to rabbit anti -cyclic GMP, no staining was visualised. 
Constant immunohistochemical staining patterns were obtained using a number 
of different antisera to cyclic GMP, although intensity of specific staining 
relative to background tended to differ. This necessitated the selection of 
antisera for sharp localization of the cyclic nucleotide in brain tissue. As a 
final control, antibody adsorption using affinity chromatography resulted in 
removal of the specific staining pattern''. 
To determine the effect of post -mortem change on cyclic GMP staining, 
cerebella were removed and frozen at different times after decapitation. 
Harmaline and pentobarbitone at 40 mg /kg were given 30 minutes and 
5 minutes before sacrifice respectively using intra- peritoneal injections. 
Immunohistochemical localization was compared with that from control, 
saline injected rats. 
RESULTS 
Cerebellar sections treated with antibody to cyclic GMP showed a uni- 
form distribution of bright fluorescent staining, associated with fibres and 
membranes. In the granular and molecular layers of the cerebellar cortex, 
scattered cell outlines were stained which did not appear to correspond in 
distribution to the abundant granule cells or characteristic Purkinje cells 
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(Fig. 1). 
In the molecular layer, parallel fibres and radial fibres show specific 
staining for cyclic GMP (Fig. 2). 
In the white matter of the cerebella, specific staining was uniformly 
distributed in association with fibres and scattered cell outlines (Fig. 3). 
Staining was not observed with control sections, (Fig. 4) although non- 
specific fluorescence associated with blood vessels and the choroid plexus 
was occasionally seen. 
Effect of post -mortem change, harmaline and pentobarbitone. Sections 
taken from rat cerebella frozen at times after decapitation from 5 seconds to 
5 minutes showed no change in distribution or intensity of specific staining. 
Similarly, sections taken from rats injected with harmaline or pento- 
barbitone failed to show any difference from saline -injected controls, 
detectable by immunohistochemistry. 
DISCUSSION 
Immunohistochemistry has revealed differential localization of cyclic 
nucleotides in a number of mammalian tissues17. Cyclic GMP tends to be 
predominantly located in intimate proximity to the cell membrane, and in 
association with nuclear material, whilst cyclic AMP is often found in the 
cytoplasm and in plasma and nuclear membrane areas. We are now able to 
report a differential localization of cyclic nucleotides in rat cerebellum. 
Positive staining employing antibody to cyclic AMP has been reported with a 
cytoplasmic distribution within specific cerebellar neurones - the granule 
cells, Purkinje cells and some deep cerebellar neurones18i 19. The localiza- 
tion of cyclic GMP which we now report shows widespread association with 
fibres and membranes throughout the cerebellum. 
It should be considered whether or not the immunoreactive cyclic GMP 
that we are localizing represents the total content of this cyclic nucleotide in 
the cerebellum17. Only cyclic nucleotide which is tissue bound, presumably 
via specific receptor proteins, will be localized, since soluble or weakly 
bound nucleotides will be lost from the frozen tissue in the staining procedure 
prior to paraformaldehyde fixation. Another consideration is that the cyclic 
GMP will not be localized if any of its antigenic determinants lay 'hidden' in 
the tissue. 
We have employed immunohistochemistry under conditions which have 
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Fig. 1 Immunofluorescent localization of cyclic GMP in the granule 
layer of rat cerebellar cortex. associated with 
'fibres and outlines of scattered cells; the large Purkinje cells are unstained 
arrowed). Calibration bar = 25N. 
Fig. 2 Immunofluorescent localization of parallel fibres and radial 
ïbres in the molecular layer. Calibration bar = 25fm. 
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Fig. 3 Specific cyclic GMP localization in cerebellar white matter. 
Positive staining associated with fibres and scattered cell outlines can be 
observed. Calibration bar = 25km. 
Fig. 4 Control section of cerebellar cortex treated with immuno- 
globulin from an unimmunized rabbit. Note the absence of specific staining. 
Journal of Cyclic Nucleotide Research 281 
previously been shown to signifcantly alter biochemically assayable cyclic 
GMP14, 
20, 22, and have been unable to detect changes in localization and /or 
staining intensity. This contrasts with reported modification of cyclic AMP 
immunofluorescent staining with post -mortem change or pentobarbitone 
administration. It is unlikely that the technique as applied to brain tissue is 
unable to detect increased or decreased concentrations of cyclic GMP and 
possibly more subtle changes in fluorescence intensity within specific cells 
are occurring which have so far proved undetectable. 
Initial studies on the immunohistochemical localization of both cyclic 
AMP and cyclic GMP in other brain areas have similarly shown contrasting 
distribution. Cyclic AMP is uniformly distributed cytoplasmically, whilst 
cyclic GMP is found to be associated with fibres and membranes. 
It is interesting that this localization of cyclic GMP would support the 
hypothesis of an involvement as a regulator of ion transport. 
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